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II 
Abstract 
 
 
This thesis examines the relationship between coeliac disease (CD) and disordered 
eating attitudes and behaviours. The literature review describes the development of 
a theoretical model of disordered eating in CD that will be evaluated throughout this 
thesis. Chapter Three reports the results of a study that found a high prevalence of 
disordered eating in CD. Chapter Four reports the results of a qualitative study; 
participants in this study discussed an increased concern around food that affected 
their eating patterns. Chapter Five describes the development and validation of the 
CD Food Attitudes and Behaviours Scale (CD-FAB), which was designed to assess the 
increased food concerns reported in CD. Chapter Six reports the results of an online 
survey that explored the correlates of this tool; participants with increased food 
concerns were more psychologically distressed and had an impaired quality of life. 
Chapter Seven reports the results of a laboratory study that explored the 
relationship between food concerns, food intake and cognitive processes related to 
eating. Overall, this thesis provides novel experimental and theoretical insights into 
the relationship between CD and disordered eating. The findings have implications 
for the management and treatment of people with CD.  
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I 
CHAPTER ONE: DISORDERED EATING AND CD: WHAT IS CURRENTLY KNOWN 
1.0. Chapter Rationale 
Coeliac Disease (CD) is an autoimmune condition of the small intestine that 
affects approximately 1 in 100 individuals across the UK (World Gastroenterology 
Organisation, 2013). The condition is managed by maintaining a strict gluten-free 
diet (GFD) that requires individuals to attend to what and how they are eating. This 
increased focus on food may place some individuals with CD at risk for disordered 
eating patterns. 
The purpose of this chapter is to introduce and provide an overview of CD and 
disordered eating. The chapter will begin with an examination of the pathology and 
treatment of CD and explore risk factors that may place individuals diagnosed with 
CD at risk for disordered eating attitudes and behaviours. This chapter will also 
introduce and describe the phenomenon of disordered eating and provide the 
rationale for the overall thesis. 
  
 
 
2 
1.1.  Coeliac Disease 
1.1.1. Definition 
CD results from a genetic variant that creates an autoimmune reaction that causes the 
body’s cells to show a heightened response to gluten (NICE, 2015). Gluten is the protein that 
is found in  wheat, rye and barley (Green & Jabri, 2003). Some individuals are also sensitive 
to oats (La Vieille et al., 2016). In a healthy individual, the finger-like projections called villi 
increase the surface area of the small intestine, which allows nutrients passing through the 
intestine to be reabsorbed back into the blood stream (NICE, 2015). In individuals with CD, 
the consumption of gluten causes the villi to flatten (see Figure One), which is known as 
villous atrophy. Villous atrophy results in a reduced ability to absorb nutrients into the 
bloodstream (Sollid, 2002).  
 
Figure 1: Normal villi in healthy individuals (left); villous atrophy in those with untreated 
coeliac disease (right; Figure taken with permission from Sollid, 2002, Nature Reviews 
Immunology).  
 
 
3 
1.1.2. Prevalence 
CD is an autoimmune condition that affects approximately 0.5-1% individuals globally 
(Gjral et al., 2012). The prevalence of CD varies internationally, with diagnosis being less 
prevalent in the Orient and sub-Saharan Africa, where the diet is largely based on gluten-
free foods (Kang et al., 2013). However, these prevalence rates are confounded by the 
availability of diagnostic facilities. In the UK, CD is present in approximately 1 in 100 
individuals (West et al., 2014). Diagnosis is twice as common in females than males (Fasano 
& Catassi, 2012; West et al., 2014; World Gastroenterology Organisation, 2013). Unlike 
some other chronic health conditions, CD can present at any point across the life span, but 
there is an increase in diagnosis between 40 and 60 years (Rashtak & Murray, 2009). 
1.1.3. Presentation  
There is no typical presentation of CD but symptoms can be divided into gastrointestinal 
and non-gastrointestinal (NICE, 2015). Gastrointestinal symptoms include diarrhoea, 
abdominal pain, constipation and bloating (Bao et al., 2012). Non-gastrointestinal symptoms 
include anaemia, fatigue and osteoporosis (Ludvigsson et al., 2013). This collection of 
symptoms is common to other health conditions, such as irritable bowel syndrome and 
other food intolerances, making CD diagnosis challenging (Chowdhury & Osmani, 2016).  
To further complicate diagnosis, approximately 36% of individuals present as 
asymptomatic, meaning there are no clear symptoms associated with their CD (Whyte & 
Jenkins, 2013). CD also occurs alongside other autoimmune conditions that can mask the 
symptoms of CD. 10% of individuals with CD have type one diabetes and 7% have 
autoimmune thyroid disease (Elfstrom et al., 2008; Ludvigsson et al., 2006; Ludvigsson et al., 
2013; NICE, 2015).  
 
 
4 
1.1.4. Current Diagnostic Guidelines for Coeliac Disease 
CD is diagnosed via a two-stage process, during which the individual must continue to 
consume a gluten-containing diet. When CD is suspected, a serological blood test is offered 
(NICE, 2015). The most sensitive blood tests for CD detect endomysial and tissue 
transglutaminase antibodies (Tortora et al., 2014). If antibodies are detected, or CD is 
suspected, a biopsy of the small intestine is taken to assess the presence of villous atrophy, 
which confirms CD diagnosis (Lee & Green, 2005).  There are four guidelines that influence 
the UK CD diagnostic procedure, all of which recommend the combined use of an intestinal 
biopsy and serological blood tests (ESPGHAN, 2012; British Society of Gastroenterology, 
2014; NICE, 2015; World Gastroenterology Organisation, 2013).  
The ESPGHAN guidelines are specific to children with CD, and recommend using only 
non-invasive methods (serological blood tests) in children who have: 1) transglutaminase 
antibodies greater than ten-fold above the upper limit of normal; 2) positive endomysial 
antibodies in a separate blood sample and; 3) carry the genes responsible for CD. The World 
Gastroenterology Organisation guidelines for adults recommend serological testing and 
intestinal biopsy, but the biopsy is not mandatory for diagnosis. However, the British Society 
of Gastroenterology (BSG) guidelines for adults state that the use of intestinal biopsy is 
essential for CD diagnosis.  
Evidence indicates that 75-90% of individuals with CD remain undiagnosed (Kaukinen et 
al., 2010). Individuals with CD report dissatisfaction with the length of time to obtain a 
diagnosis (Gray & Papanicolas, 2012); the average time from presentation of symptoms to 
CD diagnosis is thirteen years (Gray & Papanicolas, 2012). This can result from a lack of CD 
screening across vulnerable populations, positive blood results with a negative biopsy, 
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negative blood results with a positive biopsy or the exclusion of gluten prior to or during the 
diagnostic process (Dharmesh et al., 2015).  
Failures in screening individuals for CD result from the unspecific nature of CD 
symptoms, which makes misdiagnosis common.  Chrowdhury and Osmani (2016) found that 
9% of individuals with an irritable bowel syndrome diagnosis were positive for CD 
antibodies. Although serological blood tests are highly sensitive, having an accuracy 
between 95-100% (Hourigan, 2006), false negatives occur, particularly if the individual has 
already removed gluten from their diet (Dharmesh et al., 2015). If CD is suspected despite a 
negative serological test, a biopsy may be used. However, misdiagnosis can occur if the 
biopsy is taken from an incorrect location or if the sample size of biopsies is insufficient 
(Freeman, 2008).  
Once CD diagnosis has been confirmed, there is referral to a gastroenterology clinic for 
monitoring of any complications associated with CD and to provide support for 
commencement of the gluten-free diet (GFD). Individuals should be followed-up twice in 
their first year after diagnosis to assess symptoms, dietary management, body mass index 
and serological features (Bai et al., 2013; Husby et al., 2012). Subsequently, annual follow-
up of individuals with CD is recommended (British Society of Gastroenterology, 2014; NICE, 
2015). 
1.2. Living with Coeliac Disease 
There is no cure for CD; the condition is controlled by maintaining a strict GFD that 
reverses villous atrophy, reducing physical symptoms and complications and increasing 
psychological well-being (Bao & Bhagat, 2012; Burger et al., 2016).  Untreated CD leads to a 
number of health complications including infertility, osteoporosis, weight loss, lymphatic 
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cancers and increased mortality largely resulting from cardiovascular disease (Garcia-
Manzanares & Lucendo, 2011; Rubio-Tapia et al., 2009; Tio, Cox & Eslick, 2012). To prevent 
these complications, it is essential to encourage strict management of the GFD. 
Living with CD and managing the GFD has physical, psychological and social 
consequences (e.g. Ford, Howard & Oyebode, 2012; Rose & Howard, 2014; Sainsbury, 
Mullan & Sharpe, 2013). As well as living with and managing a chronic health condition, the 
need to read food labels, the increased cost of gluten-free foods and the difficulties 
associated with eating gluten-free outside the home all influence the lives of people with 
CD.  
1.2.1. The Gluten-Free Diet  
Managing CD is demanding and involves the removal of all foods containing gluten from 
the diet. Gluten is found in wheat, barley and rye.  Some people are also sensitive to oats, 
because they contain the protein avenin, which is similar to gluten (Londono et al., 2013). 
However, a recent review indicates that most people with CD can tolerate oats that have 
not been contaminated by gluten (La Vieille et al., 2016). This GFD is restrictive and requires 
foods such as bread, cake, pasta, pastry, some condiments and many processed foods to be 
removed from the diet; this results in a limited diet that is quite different from the typical 
Western diet that is usually high in cereal-based staple foods; individuals with CD can feel 
dissatisfied with the restrictive nature of the diet (Bakshi et al., 2012). However, in the UK, 
staple gluten-free foods are available on prescription (although this is currently under 
review) and gluten-free food is becoming more readily available in supermarkets and online. 
People with CD have the option to consume naturally gluten-free foods such as fresh meat 
and fish, fruit, vegetables, rice and nuts (Martin & Mercer, 2013). 
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Gluten-free food can become contaminated by gluten when prepared in the same 
environment as gluten-containing foods; management of the GFD requires the monitoring 
of cross-contamination (Schuppan, Dennis & Kelly, 2005). Even trace amounts of gluten 
consumption can affect individuals with CD. A contamination level of less than 20 parts per 
million is the cut-off for labelling a food as gluten-free (Collin, Thorell, Kaukinen & Maki, 
2004). Cross-contamination is particularly common in social settings including work events, 
eating out at restaurants and when eating food prepared by others (Lee, Anderson & Ryu, 
2014; Schuppan et al., 2005). At home, when preparing food, individuals with CD have more 
control over the food preparation process ensuring cross-contamination is prevented. 
However, when eating outside the home, poor knowledge about the GFD, unsuitable food 
preparation and a lack of autonomy and communication from individuals with CD about the 
GFD can contribute to cross-contamination and accidental gluten exposure (Zarkadas et al., 
2012).  
Cross-contamination of gluten-free food products can also occur when they are 
produced on the same factory production line as gluten containing products, when the 
same utensils are used for serving gluten-containing foods and gluten-free foods, and when 
sharing kitchen appliances, such as a toasters (Schuppan et al., 2005). As a result, individuals 
with CD often use their own cooking utensils and have their own food products and kitchen 
equipment (Zarkadas et al., 2012). 
The majority of individuals respond beneficially to the GFD and feel better as the small 
intestine recovers and the villi regrow; however, this process can take up to five years 
(Newnham, Shepherd, Strauss & Hosking, 2016; Wahab, Meijer & Mulder, 2002). Although 
uncommon, approximately 5% of individuals with CD will not respond to the GFD and have a 
rare type of CD, called Refractory CD (Rubio-Tapia & Murray, 2010). These individuals 
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continue to experience gastrointestinal symptoms despite good management of the GFD. 
For those with refractory CD, nutritional support and steroid treatment may be provided in 
tertiary care centres; immunosuppression has been effective in encouraging clinical 
remission (Mooney, Evans, Singh & Sanders, 2012).  
1.2.2. Management of the Gluten-Free Diet 
GFD adherence ranges between 42-91%, indicating that a large proportion of adults 
struggle with dietary self-management (Hall, Rubin & Charnock, 2009). In a large cross-
sectional study of adults with CD, 40% reported intentionally consuming gluten over a 6-
month period and 54% reported accidental gluten consumption (Hall, Rubin & Charnock, 
2013). Cognitive factors including limited knowledge, attitudes and illness representations 
(Silvester et al., 2016; Villafuerte-Galvez, 2015); social factors including public awareness, 
dining out and social events (White, Bannerman & Gillett, 2016); and emotional factors 
including depression, anxiety and stress (Wagner et al., 2016) have been associated with 
poor GFD management (Hall, Rubin & Charnock, 2009). Medical support, being a member of 
a support group, and obtaining regular dietetic follow-up, older age and needing to gain or 
lose weight are all associated with improved GFD management (Dowd et al., 2014; Kurppa 
et al., 2012; Rajpoot et al., 2015).  
1.2.3. Label Reading 
An essential part of managing the GFD and identifying appropriate food requires the 
checking and reading of food labels. Label checking is an essential part of managing the GFD 
because product ingredients can change, meaning an individual with CD must keep updated 
with recipe adjustments. Individuals also need to be familiar with foods that contain hidden 
sources of gluten including some sausages, marinades and soups; this requires an 
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understanding of the sources of gluten-containing ingredients (e.g. malt extract which is 
derived from barley).  
Despite the challenges of identifying gluten-containing foods, labelling has improved 
considerably in recent years. In 2012, the European Commission introduced labelling 
standards for gluten-free foods. In order to be classified as “gluten-free”, the food product 
must have less than 20 parts per million of gluten. In addition, the European Commission 
introduced new food allergen labelling requirements in 2016 that requires food products to 
emphasise the inclusion of gluten on food ingredient lists (usually via a bold type-face). This 
legislation also requires that restaurants and food outlets provide food ingredient lists for 
their dishes, including the labelling of gluten-free foods.  
No studies have yet evaluated the impact of this change in legislation on the lives of 
people with CD. However, prior to these changes, Zarkadas et al. (2013) found that 79% of 
individuals with CD reported concern about the accuracy of food labels.  Furthermore, 
individuals with CD report that the continuous reading of food labels is a time-consuming 
activity that can be associated with both anger and distress, particularly in those who are 
newly diagnosed (Rose & Howard, 2014). 
1.2.4. Cost and Availability of Gluten-Free Foods 
The availability of gluten-free food has increased in recent years but individuals with CD 
still report difficulties in finding gluten-free products, particularly in smaller stores (Singh & 
Whelan, 2011). Despite improvements in gluten-free food availability, in 2014, only 41% of 
restaurants surveyed in the UK sold gluten-free food items (Aziz et al., 2014). The GFD is also 
considered to be more expensive and viewed as a considerable burden to undertake 
(Whitaker et al., 2009). Gluten-free food products tend to be 2-6 times more expensive than 
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their gluten-containing counterparts (Coeliac UK, 2009; Lee, Ng, Zivin & Green, 2007; Singh 
& Whelan, 2011) and this increased cost and the variable availability of gluten-free foods 
adds an extra barrier to GFD adherence (Hall et al., 2009; Roma et al., 2010). Individuals 
with CD who are on a lower income and have poor transport options may feel this burden 
most significantly (Burden et al., 2015; Lambert & Ficken, 2016). These factors may 
contribute to impaired quality of life and poor self-management of the GFD (Singh & 
Whelan, 2011).  
Individuals in the UK are entitled to gluten-free foods on prescription, provided by the 
National Health Service. These items are prescribed by a General Practitioner and include 
essential food items such as bread, rolls and flour. The number of items prescribed is 
capped based on the individual’s age, gender and co-morbid conditions (Coeliac UK, 2015).  
The prescription of gluten-free foods increases availability and reduces the cost of gluten-
free foods but in recent years, the availability of gluten-free prescriptions has reduced. Not 
all Clinical Commissioning Groups prescribe gluten-free items to people with CD, which 
results in differential access throughout the country (known as a postcode lottery effect). 
Evaluations of General Practitioner records indicate that 70% of Clinical Commissioning 
Groups are under prescribing gluten-free food products relative to the national guidelines 
(Coeliac UK, 2015; Martin & Mercer, 2014). The psychosocial and physical impact of reduced 
access to gluten-free prescriptions remains to be seen. 
1.2.5. Eating Outside the Home  
The need to maintain a strict GFD at all times, can affect social interactions, which often 
revolve around food (Olsson, Hornell, Ivarsson & Sydner, 2008). Eating out with CD becomes 
complicated due to the need to find restaurants that source gluten-free products and are 
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aware of the risks of cross-contamination. Individuals with CD can find it hard to identify 
suitable gluten-free items to consume outside the home and these concerns are not 
unjustified since reports indicate that UK chefs’ knowledge about CD and the GFD is lower 
than that of the general population (Karajeh, Hurlstone, Paten & Sanders, 2005). However, 
recent reports indicate that awareness and understanding are increasing within the food 
industry, which may alleviate the challenges for individuals with CD when eating outside the 
home (Aziz et al., 2014).    
Difficulties in eating outside the home can be associated with distress and social 
isolation (Silvester et al., 2016). When consuming food outside the home, individuals with 
CD report shame, fear and difficulties in maintaining their dietary management, all of which 
are associated with reduced quality of life (Hauser et al., 2006; Jacobson, Hallert, Midberg & 
Friedrichsen, 2012; Zarkadas et al., 2013). Individuals also find it challenging asking for 
gluten-free food products in public for fear of “being a bother” (Black & Orfilia, 2011; 
Sverker et al., 2005). Furthermore, poor management of the GFD often occurs in social 
settings, where eating gluten-free is perceived as a social inconvenience (Olsson, Hornell, 
Ivarsson & Sydner, 2008).  
1.3. Psychosocial Well-Being 
Living with CD can have a significant psychological and social impact (Silvester et al., 
2016). Eating and food consumption involves more than meeting our nutritional 
requirements; it is also important in meeting our social and emotional needs (Lee et al., 
2012). Although the GFD is essential in reversing gut damage and CD-related symptoms, the 
need to display dietary vigilance, and monitor food intake and preparation may have a 
critical impact on psychosocial well-being and quality of life (Barratt, Leeds & Sanders, 2011; 
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Casellas et al., 2015). Additionally, the diagnosis of a chronic health condition and the 
burden of living with this diagnosis can places individuals at risk for nonspecific 
psychological distress (Keles et al., 2007).  
1.3.1. Depression and Anxiety 
Large population studies indicate an increased risk for psychological distress after CD 
diagnosis (Ludvigsson et al., 2007; Smith & Gerdes, 2012). Depression persists after CD 
diagnosis and for some individuals this depression worsens when following the GFD 
(Addolorato et al., 2001; Zingone et al., 2014). Anxiety is also widely reported by individuals 
with CD; however, a meta-analysis concluded that anxiety in CD was comparable to the level 
of anxiety found in healthy controls (Smith & Gerdes, 2012). Levels of anxiety appear to 
increase prior to diagnosis but receiving the CD diagnosis is associated with feelings of relief 
(Ciacci et al., 2002). Addolorato et al. (2001) described an increase in anxiety at CD diagnosis 
but this decreased after the first year of maintaining the GFD, suggesting that the 
development of anxiety in CD is different to healthy controls.  
Before CD diagnosis, the feelings of uncertainty and CD-related symptoms may explain 
the pre-diagnosis increase in psychological distress (Kurppa et al., 2011). Anxiety may start 
to decrease when the individual has adapted to the GFD and learns how to manage their CD 
(Zingone et al., 2014). However, depression may persist as a result of the restrictions placed 
on one’s diet and the burden of living with a chronic health condition (Lee et al., 2012). 
Additionally, distress can affect CD outcomes and contribute to poor dietary self-
management, psychological comorbidity, social isolation and a negative evaluation of the 
GFD (Sainsbury, Mullan & Sharpe, 2014; Zingone et al., 2014). These psychological co-
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morbidities, as well as the general stressors of living with a chronic health condition, may 
further contribute to psychological distress in CD (Zingone et al., 2014).   
1.3.2. Quality of Life 
The majority of research exploring quality of life has used generic tools designed for 
chronic health conditions; however, more recently, specific CD quality of life tools have 
been designed (Dorn et al., 2010; Hauser et al., 2007; van Doorn et al., 2008). Quality of life 
is reduced in those with undiagnosed CD compared to healthy controls, particularly in those 
experiencing gastrointestinal symptoms (Gray & Papanicolas, 2010). However, the effect of 
the GFD on quality of life is unclear and the findings are mixed. 
Several papers using cross-sectional surveys have reported a positive effect of the GFD 
on quality of life; quality of life scores in CD are similar to the general population (Mustalahti 
et al., 2002; Lee et al., 2015; Paavola et al., 2012). In symptomatic individuals, time-course 
assessments indicate that most of the improvement in quality of life is seen three months 
after starting the GFD and this improvement is maintained at twelve months (Nachman et 
al., 2009). Furthermore, Rosen et al. (2011) found that after starting the GFD, the majority 
of individuals saw themselves as more healthy and reported improvements in quality of life.  
However, 5% of these participants viewed their diagnosis as a stigma that limited their daily 
lives, particularly in social domains.  
Although these studies largely indicate an improvement in quality of life after CD 
diagnosis, others suggest that the quality of life in CD is much lower than that of the general 
population, and this is particularly common in females with CD (Altobelli et al., 2013; 
Hopman et al., 2009). Although quality of life may improve after starting the GFD, these 
improvements are not necessarily maintained. When Nachman et al. (2009) followed their 
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participants up at four years, quality of life had reduced, particularly in those who reported 
poor management of the GFD. Furthermore, for those who had fewer symptoms at 
diagnosis, quality of life had also deteriorated at four years. The authors suggested this 
might result from the perceived burden of maintaining the restrictive GFD.  Individuals with 
CD often report avoiding social events and limiting food intake in social settings in order to 
prevent CD-related symptoms and to prevent being a burden on the social group (Biahetti, 
Naspi & Catassi, 2013; Skjerning, Mahony, Husby & DunnGalvin, 2014). Furthermore, 
qualitative findings have consistently reported the burden of the GFD and the negative 
impact this has on quality of life and psychological well-being (Roos et al., 2013; Rose & 
Howard, 2014; Skjerning, Mahony, Husby & DunnGalvin, 2014). Rose and Howard (2014) 
reported that after CD diagnosis, individuals experienced grief around the loss of gluten 
from their diet, which led to an identity change and a loss of social confidence and activities. 
The restrictive nature of the GFD negatively impacts quality of life for some individuals with 
CD. This need to focus on food may contribute to the development of depression, anxiety 
and the development of disordered eating patterns, in addition to reduced quality of life 
(Arigo, Anskis & Smyth, 2012). The next section will discuss disordered eating patterns and 
CD in more detail.  
1.4. Eating Disorders and Disordered Eating 
A healthy eating pattern describes a balanced diet that contains enough nutrition to 
meet the body’s needs (Freeland-Graves & Nitzke, 2013). Healthy eating attitudes are 
closely linked to eating patterns and describe a positive attitude around food, where foods 
are not labelled as “good” or “bad” and are strongly related to both physical and 
psychological health, and should be both flexible and enjoyable (Freeland-Graves & Nitzke, 
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2013). Although healthy eating patterns can fluctuate based on factors including food 
availability and proximity, this should not fluctuate to the point of nutrient deficiency or 
excess weight change. Thoughts around planning and preparing food may be present but 
should not dominate thoughts and dictate behaviours above and beyond that of other daily 
activities (Freeland-Graves & Nitzke, 2013).  
1.4.1. Eating Disorders 
Eating disorders can be understood on a spectrum ranging from disordered eating to 
clinically significant eating disorders. At one end of the spectrum, eating disorders describe 
a psychiatric illness that is marked by disordered eating and disordered beliefs surrounding 
food (APA, 2013).  
Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder, Pica, Rumination Disorder 
and Avoidant/Restrictive Food Intake Disorder are recognised in the current edition of the 
Diagnostic and Statistical Manual for Mental Disorders (DSM-5; APA, 2013). Anorexia 
Nervosa describes those who pursue marked weight loss, dietary restraint and a disturbance 
in the perception of one’s weight and/or body shape. Bulimia Nervosa describes those who 
engage in binge eating behaviours followed by compensatory behaviours (e.g. vomiting, 
excessive exercise, laxative misuse); there is also a disturbance in the perception of one’s 
weight and/or body shape. Binge Eating Disorder is characterised by recurrent episodes of 
overeating associated with feelings of guilt or depression. The diagnostic criteria for these 
eating disorders can be found in Table One. These eating disorders have a combined 
prevalence of approximately 13.1% in the general population (Stice, Marti & Rohde, 2013). 
Pica, Rumination Disorder and Avoidant/Restrictive Food Intake Disorder will not be 
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discussed in this thesis, as there is no evidence that they are associated with the diagnosis 
of chronic health conditions.  
Table 1 
DSM-5 Diagnostic Criteria for Anorexia Nervosa, Bulimia Nervosa and Binge Eating Disorder 
 Diagnostic Criteria (DSM-V, 2013) 
Anorexia Nervosa 
• Restriction of energy intake leading to a significantly low 
body weight in the context of age, sex, developmental 
trajectory, and physical health 
• Intense fear of gaining weight or becoming fat even 
though underweight 
• Disturbance in experience of weight or shape, undue 
influence of body weight or shape on self-evaluation, or 
denial of the seriousness of the current low body weight 
Bulimia Nervosa 
• Eating large amounts of food in a discrete time frame 
• A sense of lack of control over eating during episodes 
• Recurrent inappropriate compensatory behaviours to 
prevent weight gain (purging) 
• Self-evaluation is unduly influenced by body shape and 
weight 
Binge Eating 
Disorder 
• Eating large amounts of food in a discrete time frame 
• A sense of lack of control over eating during episodes 
• Associated with three or more of the following: 
Eating more rapidly than normal; eating until 
uncomfortably full; eating large amounts of food while not 
physically hungry; eating alone due to embarrassment; 
feeling disgusted, depressed, or guilty afterward 
 
1.4.2. Disordered Eating 
Disordered eating is characterised by dieting, purging, binge eating, fasting and the use 
of excessive physical activity in order to control weight and/or body shape (Grilo, 2006; 
Rosen, 2003). These eating patterns are deviations from healthy eating and may develop 
into clinically significant eating disorders (Cattarin & Thompson, 1994). Although damaging 
to physical and psychological health, these eating patterns may meet some of the criteria 
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for eating disorders but they do not meet the full diagnostic criteria for an eating disorder 
diagnosis (see Table One).  
1.4.3. Disordered Eating in Chronic Health Conditions 
Individuals with dietary-controlled chronic health conditions, such as CD, may be at 
increased risk for disordered eating patterns due to the need to restrict certain food groups 
and monitor the content of food (Quick et al., 2013). The identification of disordered eating 
is important in those with chronic health conditions, including CD because it may affect 
prognosis and treatment. Behaviours such as vigilance around food and dietary monitoring 
are essential in the care of dietary-controlled chronic health conditions but these 
behaviours may become dysfunctional when they are used to achieve weight loss, interfere 
with daily living, impair psychosocial well-being or become a health risk (APA, 2013). As the 
research on disordered eating in CD is limited, the next section will explore the relationship 
between disordered eating and diabetes, cystic fibrosis, irritable bowel syndrome and 
inflammatory bowel disease, all of which have dietary components to their treatment. 
Exploring disordered eating in the context of other dietary-controlled chronic health 
conditions can also provide insight into the causes of disordered eating and whether this 
results from the non-specific burden of a chronic health condition or factors specific to CD.  
1.4.4. Diabetes 
Disordered eating has been studied extensively in type one and type two diabetes, a 
condition characterised by blood glucose dysregulation (NICE, 2015). Type one diabetes 
results from an autoimmune reaction in the cells of the pancreas, meaning the body cannot 
produce insulin; it is commonly diagnosed in infancy to the late 30s (NICE, 2015). Type two 
diabetes is more common and occurs because the body’s cells develop a resistance to 
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insulin; it is usually diagnosed in those over 40; however, childhood diagnosis is becoming 
more common (D’Adamo & Caprio, 2011).  In order to regulate blood glucose levels, 
individuals with type one diabetes will inject insulin for the rest of their lives, and monitor 
their blood glucose levels and carbohydrate intake in order to calculate the insulin dosage. 
Individuals with type two diabetes can control their condition through insulin injections, 
tablets, other medication or dietary-management alone.   
Some studies indicate that an eating disorder diagnosis is more common in individuals 
with type one diabetes than healthy controls (Pinhas-Hamiel & Levy-Shraga, 2013; Young et 
al., 2013); however, others suggest that the risk is no higher than that of the general 
population (Baechile et al., 2014; Nielsen, 2002). A systematic-review suggested that the 
prevalence of disordered eating was 39.3% in those with type one diabetes, compared to 
32.5% found in healthy controls which represented a medium effect size (Young et al., 
2013). The most common types of disordered eating found in type one diabetes are 
bingeing and purging. In addition, insulin misuse has been reported as a tool to encourage 
weight loss, which can be defined as an inappropriate compensatory behaviour in the DSM-
5 (Favazza, 2010; Merwin et al., 2014; Wisting et al., 2013). The prevalence of insulin 
omission in individuals with type one diabetes ranges between 2 and 40% (Colton et al., 
2004; Stancin et al., 1989). 
Eating disorder diagnosis is also prevalent in type two diabetes, with Binge Eating 
Disorder being more common in those with type two diabetes compared to healthy controls 
(Affenito & Adams, 2001; Nicolau et al., 2015). The prevalence rates for Binge Eating 
Disorder in type two diabetes ranges between 2-25% (Crow, Kendall, Praus & Thuras, 2001; 
Mannucci et al., 2002). Individuals with both type two diabetes and Binge Eating Disorder 
tend to be younger and have greater depression scores compared to diabetics without 
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Binge Eating Disorder (Nicolau et al., 2015). Insulin omission has not been associated with 
disordered eating in individuals with type two diabetes.  
It is not clear why disordered eating presents in diabetes; however, this may result from 
factors common to all chronic health conditions, such as psychological distress, age at 
diagnosis and stigma (Colton, Rodin, Olmstead & Daneman, 1999) or factors related to the 
management of diabetes specifically (e.g. fear of injections, food preoccupation; Ismail et 
al., 2000; Young-Hyman & Davis, 2010). For individuals with type two diabetes, it is not clear 
whether the presence of Binge Eating Disorder contributes to the development of diabetes 
or whether this occurs post-diagnosis.  
1.4.5. Cystic Fibrosis 
Cystic fibrosis is a genetic disorder characterised by the production of abnormally thick 
mucus (Hayes, Sheehan, Ulchaker & Rebar, 1994). Individuals with cystic fibrosis are at high 
risk of malnutrition and long-term treatment includes increased energy intake with 35-40% 
of calories coming from fat (Mahan & Escott-Stump, 2004). The evidence for disordered 
eating in those with cystic fibrosis is mixed; some research indicates an increased 
prevalence compared to the general population (Abbott et al, 2007; Shearer & Bryon, 2004) 
whereas others report no difference (Bryon, Shearer & Davies, 2008; Raymond et al., 2000). 
Underweight females with cystic fibrosis may maintain their low weight status by not 
meeting their increased calorific needs (Warlters, 2001). Disordered eating behaviours in 
people with cystic fibrosis includes the spitting out of chewed foods, bingeing and purging 
behaviours and misuse of medication. Quick and Byred-Bredbenner (2014) reported that 
25% of their cystic fibrosis sample engaged in self-induced vomiting and medicine misuse, 
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and one third reported binge eating behaviours; however, this study was limited by a small 
sample size with only 9 individuals taking part. 
1.4.6. Inflammatory Bowel Disease and Irritable Bowel Syndrome 
Inflammatory bowel disease and irritable bowel syndrome describe a collection of 
gastrointestinal conditions, including crohn’s disease and ulcerative colitis, which result in 
uncomfortable and unpleasant gastrointestinal symptoms such as pain, altered bowel habit, 
bloating, nausea and acid reflux. Irritable bowel syndrome is a functional gastrointestinal 
disorder, meaning the gastrointestinal tract appears healthy, whereas inflammatory bowel 
disease is a non-functional gastrointestinal disorder where damage, such as ulcers of 
inflammation, can be seen in the bowel. Both conditions require the avoidance of certain 
foods that trigger gastrointestinal symptoms. Individuals with inflammatory bowel disease 
often take steroids to help manage the condition. 
 Young people with inflammatory bowel disease can struggle with their prescribed 
dietary regimens and weight gain resulting from steroid use, which may lead to disordered 
eating attitudes and behaviours (Eubanks et al., 2002; McDermott et al., 2015; Nicholas et 
al., 2007; Saha et al., 2015). Due to uncontrollable gastrointestinal symptoms such as 
bloating and bodily discomfort, greater body shame is more common in individuals with 
inflammatory bowel disease; this can be associated with negative psychosocial outcomes 
(Hakanson, Sahlberg-Blom, Nyhlin & Ternestedt, 2009). These factors may contribute to 
disordered eating attitudes and behaviours (Bayle & Bouvard, 2003; Muller et al., 2010). 
Disordered eating in inflammatory bowel disease and irritable bowel syndrome is an under 
researched area and there are no formal prevalence studies; however, comorbid disordered 
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eating practices and body shame have been reported (Bayle & Bouvard, 2003; Gilbert & 
Miles, 2002).  
1.4.7. Coeliac Disease 
The literature examining disordered eating in those with CD is largely dominated by case 
studies. A systematic review of the empirical evidence will be discussed in Chapter Two. 
However, evidence drawn from case studies, although limited by sample size, is essential in 
understanding the nuances of the relationship between CD and disordered eating attitudes 
and behaviours. Disordered eating in CD appears to be closely related to management of 
the GFD. Leffler et al. (2007) described the cases of two women with CD age 35 and 40 
years, who reported intentional gluten consumption as a strategy to promote weight loss by 
triggering gastrointestinal symptoms. The potential to promote intentional weight loss 
through poor gluten-free dietary-management may be observed in those whose weight was 
lower than expected as a result of untreated CD, or in those who had gained weight 
following the commencement of the GFD.  Weight gain can occur after commencing the 
GFD, as the intestine starts to recover and nutrients are absorbed into the bloodstream 
(Kabbani et al., 2012). Both individuals in the case study experienced weight gain when 
starting the GFD and responded to this by consuming gluten to keep their weight down. In 
contrast, Ricca et al., (2000) described a 23-year-old woman who followed her GFD 
extremely well but feared experiencing uncomfortable, coeliac-related symptoms. She 
avoided eating in public to reduce her exposure to gluten, and reduced the size of her meals 
to prevent weight gain. Ricca et al., (2000) suggested that the restrictive nature of the GFD 
might have acted as a trigger for the development of her eating disorder. However, this case 
of dietary restriction may also have resulted from concerns and anxiety around gluten-
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consumption and weight gain, as opposed to the restrictive nature of the GFD. Ricca et al., 
(2000) also reported evidence for a binge/purge pattern of eating. They described a woman 
aged 23 with CD whose eating behaviour was characterised by an apparent loss of control 
over eating, during which she would eat a large amount of gluten-free food (bingeing), 
followed by episodes of purging.  
For individuals with dietary-controlled chronic health conditions, an awareness of food 
and food intake may act as a risk factor for the development of disordered eating patterns 
(Quick, Byrd-Bredbenner & Neumark-Sztainer, 2013). In addition, the psychological burden 
that occurs alongside the diagnosis and management of a chronic health condition may 
indirectly place these individuals at increased risk for disordered eating behaviours. Colton, 
Rodin, Olmstead and Daneman (1999) propose that the nonspecific burden associated with 
chronic disease may lower the threshold for disordered eating in those who are susceptible.  
The literature regarding disordered eating and CD indicates that disordered eating may 
serve different functions across individuals and is related to a variety of factors.  These may 
include the general stressors of living with a chronic health condition or factors specific to 
living with CD (such as post-diagnosis weight change). To enable a clear and testable 
understanding of disordered eating in the context of CD, theoretical frameworks are needed 
to guide future research into the factors that may help us understand this phenomenon. The 
following section examines a number of theories that can be used to help us understand 
disordered eating within the context of CD. 
1.5. Theoretical Context 
A thorough search of the literature (Web of Science with Conference Proceedings, 1900-
2016; MEDLINE, 1950-2016; Pubmed; PsychINFO, 1967-2016; and Google Scholar) revealed 
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no theoretical model to explain disordered eating attitudes and behaviours in CD. At the 
theoretical level, disordered eating in CD needs to be better understood in order to develop 
appropriate prevention and intervention strategies, and the construct of disordered eating 
in relation to CD requires further exploration. With an understanding of the interplay 
between chronic physical and psychological health being a research priority, heath 
psychology models are used to understand the interface between long-term conditions, 
their management and psychological well-being. For those with CD, dietary-management, 
physical and psychological health are essential in adjusting to and managing the condition, 
making health psychology a strong framework for exploring disordered eating patterns 
within CD.  
Theories combining social, physical and psychological health are recommended for 
understanding the self management of gastrointestinal conditions (Pojoga & Stanculete, 
2014); of these, the Health Belief Model (Rosenstock, Strecher & Becker, 1988) and the 
Theory of Planned Behaviour (Azjen, 1985) have been applied to dietary-controlled 
gastrointestinal conditions, such as CD; however, these models do not directly support the 
understanding of disordered eating attitudes and behaviours. Stice’s dual pathway model of 
disordered eating (Stice, 2002) has been used to explain disordered eating in chronic health 
conditions; Peterson, Fischer and Young-Hyman (2015) have modified this model, using 
social, physical and psychological factors to explain disordered eating patterns in individuals 
with type one diabetes. These theories will be discussed in the following section.  
1.5.1. The Health Belief Model 
The Health Belief Model (Rosenstock et al., 1988) proposes that behaviour change is 
based on an analysis of the barriers to and benefits of behaviour change. This model has 
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been used to explain the management of chronic health conditions (DiMatteo, Haskard & 
Williams, 2007) and eating disorders (Akey, Rintamaki & Kane, 2013). There are four beliefs 
that are used to inform the cost-benefit analysis: Perceived Susceptibility (what is the 
likelihood that my behaviour will cause poor health outcomes), Perceived Severity (how 
severe are the consequences of my behaviour), Perceived Benefit (changing my behaviour 
will be good for my health) and Perceived Barriers (the GFD is expensive/ eating gluten-free 
food will cause weight gain). The idea of self-efficacy was later added to the model; this 
concept explains how competent one feels in engaging in a particular behaviour despite 
certain barriers (Strecher & Rosenstock, 1997); in CD this may include management of the 
GFD. Those with a high sense of self-efficacy are more likely to engage in behaviour change, 
crucial in the management of CD.  
The Health Belief Model is flexible, meaning it can be adapted to explain a variety of 
behaviours. An individual with CD and co-morbid disordered eating must believe they are 
susceptible to the negative consequences of their disordered eating behaviour before they 
will engage in more adaptive eating patterns (perceived susceptibility; e.g. my eating 
patterns are harming my CD-management and health); the individual must recognise the 
seriousness of their disordered eating upon their CD (perceived severity; e.g. my eating 
patterns will result in hospital treatment); the individual must believe in the alternative 
option to reduce their disordered eating (perceived benefits; e.g. if I eat better, I will feel 
better); and the barriers to adaptive eating must be reduced (perceived barriers; e.g. I find it 
hard to eat healthily because gluten-free food is hard to find).  
The Health Belief Model has been reviewed, across a variety of health behaviours (e.g. 
smoking cessation, breast cancer screening), in four meta-analyses (Carpenter, 2010; 
Harrison, Mullen & Green, 1992; Janz & Becker, 1984; Zimmerman & Vernberg, 1994). The 
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most recent (Carpenter, 2010) suggests that perceived benefits and perceived barriers were 
the most effective variables in predicting behaviour, however, weak relationships were 
found between perceived severity and behaviour. Based on these findings, Carpenter 
concluded that the current version of the Health Belief Model is no longer applicable to 
behaviour change in chronic health conditions. The constructs in the Health Belief Model are 
not valuable as individual constructs but exploring interactions amongst these constructs 
may explain further variability in health behaviours. In support of these conclusions, Umeh 
and Jones (2010) explored the interactions amongst the variables of the Health Belief Model 
in breast cancer screenings, finding that women who did not conduct breast cancer 
screenings perceived more barriers to this behaviour but only when they perceived the 
consequences of breast cancer as more severe. Interactions between perceived benefits of 
screening and perceived susceptibility to breast cancer were also noted. The findings of 
Carpenter (2010) and Umeh and Jones (2010) indicate that in its current form, the Health 
Belief Model is not appropriate for predicting health behaviours and interactions amongst 
the variables are critical to understanding health behaviours. 
For those with CD, factors including the presence of gastrointestinal symptoms and the 
burden of reading of food labels may play a role in influencing disordered eating attitudes 
and beliefs in CD (Arigo, Anskis & Smyth, 2012; Zarkadas et al., 2013). The Health Belief 
Model fails to account for these more habitual health-related behaviours that may become 
independent of conscious decision-making processes in CD (Janz & Becker, 1984). 
Additionally, the model assumes that all negative health behaviours stem from 
psychological processes, when in CD negative health behaviours, such as dietary restriction, 
may occur because of alternative factors such as the increased cost of gluten-free foods or 
poor explanation of the GFD from health care professionals (Nelson, Mandozat & McGough, 
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2007; Ukkola et al., 2012; Whitaker et al., 2009). In addition, this model fails to explain the 
positive effects of negative behaviours (Stroeb, 2000); this may be particularly important for 
disordered eating in CD, as dietary restriction may have a positive effect by reducing the risk 
of gluten consumption.  
1.5.2. The Theory of Planned Behaviour 
The Theory of Planned Behaviour (Azjen, 1985) has been used to understand behaviours 
in CD (e.g. Hall et al., 2013; Kothe et al., 2015; Sainsbury & Mullan, 2011; Sainsbury, Mullan 
& Sharpe, 2013c; Sainsbury, Mullan & Sharpe, 2014), and recognises that attitudes and 
beliefs do not account for all behaviours. According to the theory, intention to change 
behaviour is influenced by Attitudes (an individual’s positive or negative evaluation of self-
performance of the behaviour), Subjective Norms (an individual’s perception about the 
particular behaviour which is influenced by the judgement of significant others) and 
Behavioural Control (an individual’s perceived ease or difficulty in performing the 
behaviour). This model also includes the concept of self-efficacy; an individual needs to 
believe they can engage in a specified behaviour before they can adopt that behaviour.  
The Theory of Planned Behaviour has been used to explain GFD adherence in CD (Hall et 
al., 2013; Kothe et al., 2015; Sainsbury & Mullan, 2011; Sainsbury, Mullan & Sharpe, 2013c; 
Sainsbury, Mullan & Sharpe, 2014). Individuals with CD often report difficulties in managing 
their GFD, despite having good intentions towards this behaviour (Barratt et al., 2011). 
However, the application of the theory to CD has had mixed results. Sainsbury and Mullan 
(2011) found no evidence for the role of intentions in predicting GFD management; 
however, when including measures of knowledge and symptom severity, intention and 
Perceive Behavioural Control was associated with GFD management (Hall et al., 2013; 
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Sainsbury et al., 2013c). One interpretation is that the intention-behaviour relationship is 
poor at predicting GFD management (Sainsbury et al., 2013c). Participants struggling with 
GFD management had greater psychological distress, which may influence GFD 
management over and above the factors accounted for by Theory of Planned Behaviour. 
Alternatively, Kothe et al. (2015) suggests that this may reflect the role of habit in 
moderating the intention-behaviour relationship; habit is likely to be an important factor in 
CD as areas of GFD management may have become habitual such as reading food labels and 
asking questions about cross-contamination.  
A systematic review into health behaviours that influence individuals in a positive or 
negative way (e.g. smoking, weight loss; McEachan, Conner, Taylor & Lawton, 2011) found 
that the Theory of Planned Behaviour only accounted for 19.3% of variability in health 
behaviours. The review also found that the theory was less predictive of behaviour when 
research designs used self-report measures; other methods may find more support for the 
Theory of Planned Behaviour. Furthermore, the Theory of Planned Behaviour does not 
account for behaviour that may result from emotional states or negative affect, two factors 
which are particularly important in relation to disordered eating patterns and the 
management of CD (Godart et al., 2007; Sainsbury, Mullan & Sharpe, 2014). In addition, the 
theory cannot account for factors such as varying the salience of behavioural cues, which 
cause behaviour change without influencing intentions (Marteau, Ogden, Roland, Suhrcke & 
Kelly, 2011). For example, the Theory of Planned Behaviour cannot account for the 
association between availability of gluten free foods, improved GFD management and well-
being (White, Bannerman & Gillett, 2016).  
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1.5.3. Dual Pathway Models of Disordered Eating 
Stice’s (2002) Dual Pathway Model of disordered eating in Western cultures (Stice, 2002; 
see Figure Two) suggests that disordered eating develops through two pathways: 1) Dietary 
Restriction and 2) Negative Affect. The Dietary Restriction pathway describes how body 
dissatisfaction, resulting from the internalisation of society’s unattainable thin ideal, results 
in dietary restriction in an attempt to control weight. Prolonged dietary restraint is thought 
to trigger overeating as it increases hunger levels and appetitive response to food, in 
attempt to restore energy levels (Polivy & Herman, 1985). The Negative Affect pathway 
describes how body dissatisfaction leads to difficulties in emotional regulation; disordered 
eating behaviours are used as a distractor from this emotional arousal.  
 
 
 
 
 
 
 
 
Figure 2: The Dual Pathway Model of Eating Disorders (Stice, 2002) 
 
The Dual Pathway Model of disordered eating has received considerable empirical 
support (Dakanalis et al., 2014; Urvelyte & Perminas, 2015). In clinical and non-clinical 
samples, the perceived societal pressure to be thin predicts subsequent body dissatisfaction 
Pressure to be 
thin 
Thin ideal 
internalisation  
Body 
dissatisfaction 
Dietary Restraint 
Negative Affect 
Disordered 
Eating 
 
 
29 
and the onset of eating disorders in both developed and developing countries (Allen, Byrne 
& McLean, 2012; Kroon Van Diest & Perez, 2013; Unikel, Aguilar & Gomez-Peresmitre, 
2005). Additionally, emotional regulation difficulties are more common in those with eating 
disorders and increase with the severity of disordered eating behaviours (Hayes & 
Napolitano, 2012; Skinner et al., 2012). However, the model fails to describe why some 
individuals are more susceptible to society’s pressure to be thin and there is mixed support 
for the relationship between dietary restraint and binge eating (Andres & Saldana, 2014); 
not all binge eating occurs after dietary restraint (Johnson, Pratt & Wardle, 2012). In 
addition, the model describes relationships between negative affect and disordered eating 
but not disordered eating and negative affect. This is unusual given the amount of research 
that indicates a bi-directional relationship between these factors (Pan et al., 2012; Presnell 
et al., 2009; Skinner et al., 2012). 
Although limited in its application to disordered eating in chronic health conditions, the 
Dual Pathway Model has been modified to account for biological, psychological and social 
factors that occur in type one diabetes (Peterson, Fischer & Young-Hyman, 2015). This 
modification has included the addition of biological variables into the model, producing a 
bio-psychosocial framework (see below); the modified model suggests that factors specific 
to the diabetes diagnosis may increase the risk of disordered eating. For individuals with CD, 
a model needs to take into account biological factors such as gastrointestinal symptoms and 
weight changes that may influence disordered eating attitudes and behaviours.  
1.5.4. The Modified Dual Pathway Model 
Disordered eating patterns are prevalent in type one diabetes and are associated with 
poor diabetes-related outcomes and impaired quality of life (Hagger et al., 2016; Nicolucci 
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et al., 2013). The Modified Dual Pathway Model suggests four factors, in addition to the 
sociocultural factors described in the original Dual Pathway Model, that contribute to the 
development of disordered eating patterns in individuals with diabetes (Peterson, Fischer & 
Young-Hyman, 2015). These factors include diabetes-related hunger dysregulation, weight 
gain, diabetes-related distress and the need to follow a strict dietary regimen.   
Insulin administration is part of the diabetes treatment programme, which is associated 
with weight gain (Russell-Jones & Khan, 2007). The modified model suggests that this 
insulin-related weight gain may create an additional vulnerability to body dissatisfaction and 
subsequent dietary restraint. The second addition proposes that the required dietary 
regimen may trigger dietary restraint. In addition, the failure to manage this dietary regimen 
may encourage disordered eating, similar to the breaking of dietary regimens in the general 
population (Polivy & Herman, 1985).  
The Modified Dual Pathway model (Peterson, Fischer & Young-Hyman, 2015) suggests 
that fluctuations in blood glucose levels result in diabetic-related hunger dysregulation that 
creates changes in appetite regulation and increases calorie intake (Engstrom et al., 1999; 
Sabourin & Pursley, 2013; Young-Hyman & Davis, 2010). However, the interactions between 
diabetic-related hunger dysregulation, insulin and eating patterns have not been empirically 
supported. The last modification to the model is the addition of diabetes-related distress. 
Individuals with chronic health conditions, including diabetes, have increased rates of 
psychological distress (Johnson et al., 2013). This distress can be compounded by the 
diagnosis of diabetes or diabetes-related weight gain, which leads to disordered eating 
patterns (Young et al., 2013).  
The model for diabetes is in need of assimilation and validation by academic research, as 
it is not known how much variance in behaviour this model accounts for. Although diabetes-
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related weight gain has received considerable support in the development of disordered 
eating (Pinhas-Hamiel, Hamiel & Levy-Shraga, 2015), Larger’s (2005) review indicates that 
diabetes-related weight change is minimal, with an increase of 2.5kg over 7.5 years. This 
small weight change may be accounted for by age-related changes in weight, which were 
not controlled for in this study (Williams & Wood, 2006). Furthermore, depressive 
symptoms and emotional dysregulation are independently associated with disordered 
eating (Lavender et al., 2015), so it is unknown how these psychological risk factors act in 
the context of diabetes. However, this integrated model of disordered eating in diabetes 
allows the identification of disordered eating in a chronic health group, whilst accounting for 
factors specific to diabetes, in addition to risk factors found in the general population. The 
identification of disease specific features that can increase the risk of disordered eating, has 
the potential to inform clinical interventions, which may significantly improve physical and 
psychological health outcomes. Furthermore, the Modified Dual Pathway model has the 
potential to explain disordered eating patterns in a range of chronic health conditions 
making this a useful tool to aid in our understanding of disordered eating in CD. 
1.5.5. Applying the Modified Dual Pathway Model to Coeliac Disease 
Disordered eating in those with CD has received little attention. This is unusual given the 
importance placed on the GFD in the management of CD. The risk factors present in CD, 
such as managing a strict dietary regimen and disease-related distress, may increase the risk 
of disordered eating in CD, above and beyond the risk factors present in those without a 
chronic health condition. Although many of the additional risk factors for disordered eating 
in CD are similar to those found in diabetes, there are some additional factors that need to 
be considered. 
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1.5.6. Weight Gain Secondary to Treatment and Body Dissatisfaction 
Individuals diagnosed with the classical presentation of CD, characterised by the 
presence of gastrointestinal symptoms, tend to be underweight prior to their diagnosis 
(Olen, Montgomery, Marcus, Ekbom & Ludvigsson, 2009). However, more recently, studies 
indicate that up to 52% of individuals present as overweight or obese at diagnosis (Kabbani 
et al., 2012; Olen et al., 2009). Weight increase is likely after commencing the GFD due to 
changes in diet composition and the increase in nutrient absorption that results from the 
recovery of the small intestine (Dickey & Kearney, 2006; Kupper, 2005).   
The limited research describing weight changes after starting the GFD is contradictory 
(Dickey & Kearney, 2006; Murray, Watson, Clearman & Mitros, 2004). Dickey and Kearney 
(2006) described an increase in BMI across 371 adults, with 81% of individuals experiencing 
weight increase; this occurred across all BMI categories, with 82% of initially overweight 
participants gaining further weight. However, in a sample of 215, Murray et al. (2004) 
reported equal numbers of adults gaining and losing weight after commencing the GFD 
(34% gained and 38% lost weight).  In 369 adults with CD, Cheng et al. (2009) found 
favourable weight changes; individuals, who were underweight or overweight at diagnosis, 
reached an acceptable BMI after commencing the GFD. Although many participants gained 
weight on the GFD, this did not result in a change in BMI category.  
However, these data failed to take covariates such as GFD management into account. To 
address this, Kabbani et al. (2012) assessed changes in BMI in 1018 adults with CD, 
retrospectively assessing Body Mass Index (BMI) at diagnosis from medical records. After 
initiation of the GFD, the mean BMI of the cohort significantly increased with 21.5% 
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experiencing clinically significant weight gain (> 7% significant weight gain); this effect was 
largely seen in those reporting good dietary management whereas those with poor dietary-
management had a tendency to lose weight. One interpretation of these findings is that 
poor management of the GFD may contribute to weight loss whereas strict GFD 
management may contribute to weight gain; this study highlights the need to take GFD 
management into account when determining weight change after CD diagnosis. Overall, 
when controlling for covariates, it appears that weight gain may occur after CD diagnosis 
and initiation of the GFD. However, other covariates including the perception of this weight 
change and the emotional impact have not been assessed. These factors may further 
contribute to weight change after diagnosis and be important in determining how one 
reacts to these changes in weight.  
An increase in weight after initiating the GFD may increase vulnerability for body 
dissatisfaction and trigger disordered eating attitudes and behaviours. As discussed earlier 
Leffler et al. (2007) reported the cases of two adult females with CD, who experienced 
weight gain when starting the GFD and responded by engaging in dietary restriction. 
Although these females’ experienced weight gain after their diagnosis, they did not 
experience clinically significant weight gain and were still within healthy BMI ranges. The 
authors argued that the perception of weight gain contributed to the development of their 
disordered eating behaviours. Factors including the general burden of being diagnosed with 
a chronic health condition may also explain the post-diagnosis development of disordered 
eating. Research on the relationship between weight gain and the development of 
disordered eating has not been conducted in CD but factors related to the diagnosis of CD 
and living with a chronic health condition need to be considered. These include the role of 
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distress, the individual perception of weight changes, the restrictive natures of the GFD and 
the symptoms associated with CD.  
1.5.7. The Gluten-Free Diet and Imposed Dietary Restriction 
As described in the Dual Pathway Model of disordered eating (Stice, 2002), dietary 
restraint can lead to the development of disordered eating behaviours such as binge eating, 
or may encourage excessive food restraint through positive reinforcement (Herman & 
Polivy, 1984; Stice, 2002). These patterns of behaviour may result in a binge-restrict cycle of 
eating (Herman & Polivy, 1984). 
Despite the increase in the development of gluten-free food products in recent years, in 
comparison to gluten-containing food, gluten-free food availability is still limited and 
individuals with CD may feel limited in what they can consume (Estevez, Ayala Vespa & 
Araya, 2016; White, Bannerman & Gillett, 2016). The need to restrict food intake when 
gluten-free options are not available may encourage either overeating when gluten-free 
food becomes available, or conversely, excessive dietary restriction.  
At present, the eating patterns of individuals with CD are under-researched; however, 
increased food consumption may explain the weight changes that have been described in 
CD (Dicky et al., 2006); as discussed earlier, evidence for a cycle of binge and restrictive 
eating has been suggested by case reports (Ricca et al., 2000). These eating patterns may 
develop from the perceived limited availability of gluten-free foods. 
 
1.5.8. A Fear of Gastrointestinal Symptoms 
In the majority of individuals, the GFD will encourage intestinal recovery and over time 
gastrointestinal symptoms will resolve, however, some individuals will continue to 
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experience gastrointestinal symptoms despite following the GFD (Daum, Cellier & Mulder, 
2005). Gastrointestinal symptoms may become associated with certain types of food and 
could develop into a conditioned food aversion (Garcia, Kimeldorf & Koelling, 1955), which 
may influence disordered eating attitudes and behaviours (Berstein & Borson, 1986). Food 
aversions are important for our survival but these can become maladaptive when food 
aversion occurs in the aetiology of eating disorders (Bernstein & Borson, 1986). 
Gastrointestinal symptoms have been associated with food aversion in a variety of chronic 
health conditions including cancer (Coa et al., 2015), autism (Nadon, Feldman, Dunn & Gisel, 
2011) and gastroparesis (a condition characterised by delayed gastric emptying; NIDDK 
Gastroparesis Clinical Research Consortium, 2011). However, the role of gastrointestinal 
symptoms in CD and the development of disordered eating have received little attention.  
The 23 year old woman described by Ricca et al. (2000) managed her GFD extremely well 
but feared re-experiencing coeliac-related symptoms. She avoided eating in public and 
reduced the size of her gluten-free meals to prevent weight gain and to cope with her fear 
of gastrointestinal symptoms. Although this case study is essential in guiding our 
understanding of gastrointestinal symptoms, disordered eating and CD, there is a need for 
this to be replicated in larger samples to explore and explain associations between CD, 
gastrointestinal symptoms and disordered eating. Furthermore, the avoidance of gluten to 
prevent gastrointestinal symptoms is a sign of essential good dietary-management in CD, so 
there may be risk of over-pathologising behaviours that are adaptive in CD unless it can 
demonstrate that this food avoidance results in negative effects on physical and 
psychological well-being.  
1.5.9. Intentional Gluten consumption 
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Poor management of medical regimens has been identified as a mechanism to induce 
intentional weight loss in certain groups. For example, the omission of insulin has been 
described in diabetes (Rodin et al., 2002), the consumption of trigger foods in food allergies 
such as egg, peanut and lactose intolerance, (Kosky, McCluskey & Lacey, 1993) and poor 
dietary management in cystic fibrosis (Gilchrist & Lenny, 2008).  
For some individuals with CD, the potential to promote intentional weight loss through 
poor gluten-free dietary-management may be available to those who experience weight loss 
as a symptom of their untreated CD. Case reports of individuals’ intentionally consuming 
gluten in order to promote weight loss have been described (Leffler et al., 2007; Yucel et al., 
2006).  
1.5.10. Psychological Distress associated with Chronic Health Conditions 
In the general population, psychological distress can contribute to the development of 
disordered eating attitudes and behaviours (Stice, 2002). Chronic health conditions, 
including CD, have a high prevalence of comorbid psychological distress, which may 
contribute to changes in appetite or increase the risk of disordered eating in these groups 
(Dury, 2015; Turner & Kelly, 2000). This nonspecific burden of chronic health conditions may 
account for the development of disordered eating attitudes and behaviours in CD. Colton, 
Rodin, Olmstead and Daneman (1999) suggest that the diagnosis of a chronic health 
condition may lower the threshold for the onset of disordered eating in those who are 
susceptible to eating difficulties.  
Research consistently reports a high prevalence of psychological distress in CD (Smith & 
Gerdes, 2011). CD-related distress may further contribute to the development of disordered 
eating attitudes and behaviours, in addition to the non-specific burden of chronic health 
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conditions. Psychological distress associated with the diagnosis of CD and the difficulties 
living with the condition may further exacerbate psychological distress in CD (Rocha, 
Gandolfi & Santos, 2016). This CD-related distress may further add to the distress associated 
with managing a chronic health condition, to increase the risk of disordered eating attitudes 
and behaviours in CD.  
1.6. Gaps in the Research and Future Directions 
Research addressing CD and disordered eating is limited. Although the research on 
disordered eating in CD is expanding the focus has been on case studies. Knowledge about 
the extent of this issue is lacking, and there is a lack of understanding regarding the factors 
that contribute to disordered eating in CD. Furthermore, the types of disordered eating 
attitudes and behaviours present in CD are unclear. Greater understanding is needed in 
order to target interventions for those in need. This thesis will attempt to assess what is 
already known about disordered eating in CD, in order to develop a new theoretical model 
of disordered eating in CD using the sociocultural, disease specific and disease general 
factors that were highlighted in previous models. The second aim of this thesis was to test a 
number of hypotheses proposed by this model through a series of mixed-research 
methodologies. The insights from this thesis will be useful for devising new clinical strategies 
for preventing, assessing and treating disordered eating in CD.  
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CHAPTER TWO: A MODEL OF DISORDERED EATING IN GASTROINTESTINAL DISEASE 
 
2.0. Chapter Rationale 
Chapter One highlighted the potential relationships between disordered eating and a 
diagnosis of CD. A range of case studies have documented co-morbid disordered eating and 
CD; however, the construct of disordered eating in CD is not well conceptualised. An 
underlying theory and/or model is essential for understanding disordered eating in CD as it 
frames both the methodologies used and the assumptions made.  
This chapter will introduce a model to explain the potential relationships between 
disordered eating and CD and provide a contemporary review of the empirical literature. 
Due to the limited research exploring disordered eating patterns in CD, this chapter draws 
upon relevant research from disordered eating practices in dietary-controlled 
gastrointestinal (GI) conditions. This allowed the development of the Theoretical Model of 
Disordered Eating in Gastrointestinal Disease.  
Three key questions were examined: a) is disordered eating a feature of GI disorders?; b) 
what abnormal eating practices are present in those with GI disorders?; and c) what factors 
are associated with the presence of disordered eating in those with GI disorders? The 
synthesis of this evidence contributed to the development of a theoretical model of 
disordered eating development in GI disease, which later chapters will then apply to CD. 
This chapter provides the basis for the rest of the thesis, as subsequent chapters will test 
the assumptions held by the Theoretical Model of Disordered Eating in Gastrointestinal 
Disease. 
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2.1. Introduction 
Disruptions to the gastrointestinal (GI) tract result in GI disorders including CD, irritable 
bowel syndrome and inflammatory bowel disease. The symptoms associated with these 
disorders include nausea, bloating, constipation, diarrhoea, changes in weight and 
abdominal pain. CD, irritable bowel syndrome and inflammatory bowel disease can all be 
managed via a life-long modification of the daily diet to avoid GI symptoms (Gibson & 
Shepherd, 2010). Dietary plans and foods that trigger symptoms vary across GI conditions. 
In those with CD, it is necessary to follow a strict, life-long GFD, whereas individuals with 
irritable bowel syndrome and inflammatory bowel disease have a less structured dietary 
regimen that involves trial and error to identify trigger foods (NICE, 2015; Yamaoto, 
Nakahigashi & Saniabadi, 2009).  
Dietary-controlled GI disorders may place individuals at risk for the development of 
disordered eating attitudes and behaviours. Dietary restriction, GI symptoms, food 
awareness and the non-specific burden of chronic illness may act as triggers for the 
development of disordered eating attitudes and behaviours in those with CD, irritable bowel 
syndrome and inflammatory bowel disease.  
Numerous case studies have described the co-occurrence of GI disorders and disordered 
eating attitudes and behaviours (Bayle & Bouvard, 2003; Leffler, Dennis, Edwards-George & 
Kelly, 2007; Mallett & Murch, 1990; Nied, Gillespie & Riedel, 2011; Oso & Fraser, 2005). 
However, to our knowledge there has been no systematic review of the prevalence and 
aetiology of these difficulties in representative samples. The present chapter aimed to 
answer three questions: a) are disordered eating attitudes and behaviours a feature of GI 
disorders?; b) what disordered eating attitudes and behaviours are present in those with GI 
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disorders?; and c) what factors are associated with the presence of disordered eating 
attitudes and behaviours in those with GI disorders? 
2.2. Methods 
2.2.1. Search Strategy 
Articles were obtained from the two databases that form Web of Knowledge: Web of 
Science with Conference Proceedings (1900-2014) and MEDLINE (1950-2014), as well as 
Pubmed, PsychINFO (1967-2014) and Google Scholar. The search criteria were formed of 
two categories: (i) GI disorder and (ii) terms relating to disordered eating attitudes and 
behaviours (see Appendix A for search terms used). Retrieved articles were scrutinised for 
relevant citations.  
2.2.2. Eligibility Criteria 
To be included in the review, the articles had to meet stringent criteria. Only studies 
published during or after 1990 were included as this was a period of change for the 
diagnosis of GI conditions (ESPGHAN, 1990). In addition, articles had to be written in the 
English language and include participants between 10-80 years with a physician-validated 
diagnosis of CD, irritable bowel syndrome and inflammatory bowel disease. Those articles 
that had not been peer reviewed were excluded, as well as case studies and case series. For 
a summary of the selection process refer to Figure One.   
Participants: Studies included youths and working-age adults (10-80 years) with a 
physician provided diagnosis of CD, irritable bowel syndrome and inflammatory bowel 
disease. Those reports focusing on other GI food-related allergies were excluded. Any 
articles looking at the presence of GI disorders in populations already diagnosed with an 
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eating disorder were excluded. The relationship between eating disorder onset and 
subsequent GI symptoms has been well documented (Abraham & Kellow, 2013; Peat et al., 
2013; Perkins et al., 2005); this review concerns the presence of disordered eating attitudes 
and behaviours in those with diagnosed GI conditions.  
Outcome Measures: The articles included in the review were related to the eating 
patterns of those with irritable bowel syndrome and inflammatory bowel disease or CD. 
Studies were required to measure food intake or eating patterns as well as any presence of 
disordered eating attitudes and behaviours.  
Study Design: Studies of both a qualitative and quantitative nature were included in the 
review. However, those that had not undergone the peer review process were excluded. 
Case studies and case series were excluded from the review. 
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Figure 1. Overview of search strategy 
394 abstracts retrieved 
across 5 databases 
124 articles had their 
titles and abstracts 
reviewed 
50 articles had their full 
text reviewed and the 
inclusion/exclusion criteria 
and quality appraisals 
applied 
9 articles included in the 
review 
270 duplicates excluded 
74 articles were excluded 
for the following reasons: 
Review (5) 
Case Study/Series (24) 
Abstract not relevant (41) 
Not peer reviewed (4) 
 
41 articles were excluded 
for the following reasons: 
Did not meet the inclusion 
criteria (5) 
Studies published prior to 
1990 (8) 
Studies not in the English 
language (5) 
Participants not between 
10-80 years (2) 
Diagnosis was not 
physician provided (18) 
Full text was not relevant 
(3) 
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2.2.3. Quality Assessment 
Each article underwent an assessment of quality using an established tool (Kmet, Lee & 
Cook, 2004). Studies were independently rated by two researchers on a 3-point scale, 
according to established criteria, with a score of 2 (yes) indicating strong evidence for the 
criteria and a score of 0 (no) indicating a lack of evidence. If some evidence for the criterion 
was present, a score of 1 was allocated (partial). The criteria were not always applicable 
(NA) and these criteria were removed from the calculations. A total score was calculated 
((number of yes’s x 2) + partials) and this was divided by a total possible sum (28-(number of 
NA’s x 2)). This provided a total quality score ranging between 0 and 1. Scores closer to 1 
were suggestive of better quality. Difference in ratings between the reviewers was minor 
and resolved through consensus. The mean quality score across the papers ranged between 
0.62 and 1 (see Table One).  
2.2.4. Extraction of Data 
2.2.5. Participant Characteristics 
Sample size, GI diagnosis, age and exclusion criteria were extracted.  
2.2.6. Intervention/Study 
The research topics that were examined (e.g. Prevalence of disordered eating in GI 
disease) and the experimental procedure were extracted. Information concerning the 
method of eating behaviour or dietary assessment was also recorded.  
2.2.7. Comparator/Control Group 
The presence and characteristics of the control groups were noted. 
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2.2.8. Outcome Measure 
We extracted the percentage prevalence of disordered eating attitudes and behaviours 
evident in the samples, as well as the types of disordered eating attitudes and behaviours 
(bingeing, dietary restraint, vomiting) and any factors that were associated with or 
predicted disordered eating attitudes and behaviours. 
2.2.9. Study Design 
The study design was noted, whether it was within-subjects or between-subjects and 
whether it was a qualitative or quantitative investigation.  
2.3. Results 
This section will contain a brief overview of the selected studies. After applying the 
critical appraisal criteria, 9 articles were available for review. These articles used mixed 
methods. The data from these articles are presented in Table One. 
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Table 1 
Summary of studies includes in the literature review; irritable bowel syndrome (IBS), inflammatory bowel disease (IBD). 
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2.3.1. Participant Characteristics  
Only three of the investigations excluded male participants (Arigo et al., 2012; Fletcher 
et al., 2008; Guthrie et al., 1990). The remaining six papers had a majority of female 
participants. The average age of participants across the studies was 29.9 years (10-80 years). 
Surprisingly, there was a lack of information concerning body mass index across the papers.  
2.3.2. Comparator/Control Groups 
Five of the studies used control groups (Addolorato et al., 2012; Guthrie et al., 1990; 
Okami et al., 2011; Sullivan et al., 1997; Tang et al. 1997). Information about the participant 
characteristics was lacking in two of the papers (Okami et al., 2011; Sullivan et al., 1997).  
2.3.3. Outcome Measure 
Disordered eating attitudes and behaviours were assessed in all of the papers; however, 
only four of the studies provided information concerning the prevalence of disordered 
eating attitudes and behaviours across the samples (Addolorato et al., 1997; Arigo et al., 
2012; Guthrie et al., 1990; Karwautz et al., 2008). Seven papers provided information 
concerning the correlates of DE.  
A range of variables were measured but there was no common assessment of eating 
patterns. Two of the articles used the Eating Disorder Examination Questionnaire (EDE-Q; 
Hilbert et al., 2007), two used the Eating Attitudes Test (EAT; Garner, Olmstead, Bohr & 
Garfinkel, 1982) and three used the Eating Disorder Inventory (EDI; Garner, 2004). Other 
measures of disordered eating and body image were related to general psychosocial well-
being questionnaires.    
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2.3.4. Study Design 
The majority of studies used a cross-sectional design, except Fletcher et al. (2008) who 
used a qualitative design and Karwautz et al. (2008) who used a two-stage qualitative 
design. 
2.4. Synthesis of Results 
We discuss the studies in three categories according to the aims of the review: those 
looking at the prevalence of eating pathology in GI disease, those reporting the types of 
disordered eating displayed and those that examined the correlates of disordered eating 
attitudes and behaviours in those with GI disease.  
2.4.1. Studies Concerning the Prevalence of Disordered Eating in GI Disorders 
Four of the articles reported the prevalence of patterns suggestive of disordered eating, 
although this was assessed using differing methods (Addolorato et al., 1997; Arigo et al., 
2012; Guthrie et al., 1990; Karwautz et al., 2008). Across these four papers there were a 
total of 691 participants with GI disease. Of these, 23.43% displayed eating patterns that 
were suggestive of disordered eating attitudes and behaviours. Across these papers, 
disordered eating attitudes and behaviours ranged between 5.3-44.4% in those with GI 
disease.  
Prevalence rates for the Eating Disorders Examination (Fairburn & Beglin, 1994) ranged 
between 22-29.3% (Arigo et al., 2012; Karwautz at al., 2008). These scores are in excess of 
the scores reported for the general population (10%; Solmi, Hatch, Hotopf, Treasure & 
Micali, 2014). However, those papers using the EAT (Garner, Olmstead, Bohr & Garfinkel, 
1982) reported lower prevalence rates (Guthrie et al., 1990; Sullivan et al., 1997). Only one 
of the papers reported lower prevalence of disordered eating in participants with GI disease 
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than healthy controls (Sullivan et al., 1997). Unfortunately, Sullivan et al. (1997) reported 
only the means for the EAT scores and did not report what percentage scored above the 
cut-off criteria. However, they acknowledged that a subgroup of their participants with 
irritable bowel syndrome may have engaged in disordered eating practices.  
Studies that assessed eating patterns via a food diary reported that participants with GI 
disease had lower intake than healthy controls (Addolorato et al., 1997; Fletcher et al., 
2008). Addolorato et al. (1997) found that individuals with inflammatory bowel disease had 
a daily calorie intake that was significantly lower than that of controls. Furthermore, 37.2% 
of those with crohn’s disease and 44.4% of those with ulcerative colitis showed evidence of 
malnutrition, indicating that these individuals are not meeting their daily dietary needs. 
Although disordered eating attitudes and behaviours were not assessed, a lack of food 
intake was observed in this group, the cause of which remains unclear.  
When combined, the evidence indicates that the presence of disordered eating attitudes 
and behaviours may be greater in those with GI disease than the reported norms for healthy 
controls. The conflicting results may be accounted for by the differing use of screening tools 
as well as factors such as the duration of diagnosis and the type of medical support 
received.  
2.4.2. Studies Concerning the Types of Disordered Eating 
Eight of the articles made some reference to the type of disordered eating that was 
presented by participants (n=2988). This largely depended on the method used to assess 
disordered eating attitudes and behaviours. However, the majority of articles described 
disordered eating attitudes and behaviours as a whole, rather than breaking it into 
subtypes. 
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Dietary restriction was commonly referred to throughout the articles (Addolorato et al., 
1997; Fletcher et al., 2008; Okami et al., 2011).  Individuals with GI disease ate more 
irregular meals and skipped meals more frequently than control participants (Okami et al., 
2011). Although consumption of less food was observed in those with GI disorders, it is not 
clear why this was the case and if intentional dietary restriction was the cause. Fletcher et 
al. (2008) found that individuals reported using dietary restriction as a way to cope with 
their GI symptoms, often avoiding food when engaging in social activities. Participants said 
that they would not eat during the day but would eat normally when in the home during the 
evening, resulting in an abnormal pattern of food intake. In contrast, Tang et al.’s (1997) 
findings are suggestive of a purging eating pathology. Tang et al. (1997) found that those 
irritable bowel syndrome patients who reported greater vomiting symptoms were more 
likely to endorse the beliefs of the Bulimia subscale of the EDI. These individuals had 
thoughts of vomiting as a means of weight reduction but did not necessarily engage in these 
behaviours. Tang et al. (1997) suggest that those irritable bowel syndrome patients with 
severe vomiting and high scores on the Bulimia subscale (EDI) may have a characteristic in 
common with people with eating disorders, i.e. the desire to lose weight.  
Kauwautz et al.’s (2008) findings may shed light on the types of disordered eating 
attitudes and behaviours present in those with GI disease. When looking at the weight loss 
mechanisms used by these participants, Kauwautz et al. (2008) found that 58.1% used 
dieting behaviours, 12.9% used excessive exercising, 19.4% used vomiting and 3.2% used 
laxatives. This suggests that a range of disordered eating behaviours across the clinical 
spectrum were present, with a majority choosing to restrict their food intake.  
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2.4.3. Studies Concerning the Correlates and Co-morbidities of Disordered Eating 
Seven of the articles made reference to factors associated with higher disordered eating 
scores. Of particular interest is the reoccurrence of psychological distress, symptom severity 
and dietary management alongside higher disordered eating attitudes and behaviours 
scores. 
Out of the nine articles reviewed, six reported a relationship between disordered eating 
attitudes and behaviours and psychological distress (Arigo et al., 2012; Addolorato et al., 
1997; Fletcher et al., 2008; Guthrie et al., 1990; Okami et al., 2011; Sainsbury et al., 2013b). 
Eating disorder risk was associated with a reduced quality of life, maladaptive coping 
mechanisms, depression and perceived stress (Addolorato et al., 2012; Sainsbury et al., 
2013b). Furthermore, greater anxiety and depressive symptomatology was found in those 
presenting with eating disturbances (Addolorato et al., 1997; Guthrie et al., 1990; Okami et 
al., 2011). Addolorato et al. (1997) explain that the reason for undernourishment in this 
patient group is not clear but suggest that it might result from a fear of GI symptoms when 
consuming food. Fletcher et al.’s (2008) findings suggest that this may be due to anxiety in 
unfamiliar settings, as participants would restrict their intake in unfamiliar settings due to 
fears of cross-contamination. Anxiety and depression both seem to be key factors in the 
development of disordered eating in those with GI disorders. 
 Symptom severity was referred to across the papers (Arigo et al., 2012; Sainsbury et al., 
2013b; Tang et al., 1997). It is not clear at what point symptom severity is most important, 
with some reports suggesting that symptom severity prior to diagnosis may lead to the 
development of DE patterns (Sainsbury et al., 2013b), and others suggesting it is the 
frequency of symptoms during the course of the disease (Tang et al., 1997). More bulimic-
type thoughts were reported in those who experienced more extreme vomiting symptoms, 
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however, this does not necessarily translate into behaviour; these individuals acknowledged 
the use of vomiting as a weight loss strategy but did not necessarily engage in this behaviour 
(Tang et al., 1997). Arigo et al. (2012) reported that symptom severity was not associated 
with disordered eating attitudes and behaviours. The role that symptom severity plays is not 
clear and it may only play a role in the development of disordered eating in a subset of 
those with GI disease. 
Adherence to dietary regimens shows evidence of being related to disordered eating 
attitudes and behaviours, particularly in those with CD. Arigo et al. (2012) found that 
management of the prescribed diet was associated with a decreased range of psychological 
stresses, but was also linked to greater disordered eating attitudes and behaviours. This 
indicates that those who monitor their food intake more closely, to follow their prescribed 
dietary regime, may be at risk of disordered eating attitudes and behaviours. Karwuatz et al. 
(2008) reported that those with eating pathology also had significantly higher gluten 
antibody markers, suggesting poorer dietary self-management. Those with eating pathology 
also had a higher BMI and 85.7% reported the pathology as appearing after the onset of 
their CD.  
2.5. Discussion 
This review points towards some important factors that need to be considered in the 
management of patients with GI disorders. There is an indication that individuals with GI 
disorders may be more at risk of developing disordered eating attitudes and behaviours 
than the general population.  
One aim of the review was to examine the prevalence of disordered eating attitudes and 
behaviours in those with GI disease. Disordered eating attitudes and behaviours are present 
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in a subset of those with GI disorders and the prevalence exceeds the rates found in the 
general population. The prevalence rates identified in this review (5.3-44.4%) are similar to 
those found in other dietary controlled chronic health conditions (Markowitz et al., 2010; 
Shearer & Bryon, 2004). Quick, McWilliams & Byrd-Bredbenner (2012) found that those with 
dietary-controlled health conditions were twice as likely to have been diagnosed with an 
eating disorder compared to controls. The constant need to monitor food intake may place 
these individuals, and those with GI disorders, at risk for disordered eating attitudes and 
behaviours (Grilo, 2006; Schlundt, Rowe, Pichert & Plant, 1999). However, it is not clear 
whether the GI disorder is contributing any additional risk factors towards the development 
of disordered eating attitudes and behaviours, above and beyond that of other dietary 
controlled chronic health conditions.  
The types of disordered eating that were present in those with GI disease were also 
examined. The majority of papers presented in the review indicated that a restrictive eating 
pathology was most common. Although there was evidence for bulimic patterns of 
behaviour as well as excessive exercising, dietary restriction was more frequently reported.  
It is not clear why these behaviours are more common and if this finding will be replicated in 
larger samples. However, it may be that those with GI disorders are more likely to fit the 
psychological profile of someone with a restrictive eating disturbance. However, the 
majority of investigations simply examined eating disorder risk. This assesses the presence 
of dietary restriction, bingeing and purging behaviours. Therefore, it is difficult to get a clear 
picture of what types of disordered eating attitudes and behaviours are most prevalent in 
those with GI disorders. In addition, an extensive range of eating patterns such as emotional 
eating, over eating and nocturnal eating patterns have not been examined. This should be 
addressed in future research because the ranges of disordered eating attitudes and 
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behaviours are associated with distinct psychological profiles (Cassin & von Ranson, 2005). 
Moreover, the majority of investigations did not assess the presence of subclinical eating 
pathology. Future studies should also consider the role of subclinical eating symptoms in GI 
disorders; due to their risk of malnutrition, any deviation from traditional eating patterns 
may have a significant impact in this subset of the population.   
Another aim of this review was to examine the correlates of disordered eating attitudes 
and behaviours in GI disease. Psychological distress, symptom severity and dietary 
adherence were found to be associated with the presence of DE patterns. Anxiety, 
depression and impaired quality of life were reported in those with disordered eating 
attitudes and behaviours across the majority of papers. This is not surprising because 
psychological distress is frequently associated with altered eating patterns in those both 
with (Colton, Olmsted, Daneman & Rodin, 2013) and without chronic disease (Patrick, Stahl 
& Sundaram, 2011; Santos, Richards & Bleckley, 2007). However, the specific role that 
psychological distress plays is not clear. Distress may be both a cause and a consequence of 
DE behaviours. However, Arigo et al. (2012) suggested that anxiety might be playing a 
unique role in those with GI disease. According to Arigo and colleagues the fear and anxiety 
surrounding GI symptoms may lead to disordered eating attitudes and behaviours of a 
restrictive nature. Individuals with GI disease may be so anxious and fearful of the GI 
symptoms that have been associated with food consumption in their past, that their fear 
and anxiety results in an aversion to unfamiliar food types and subsequent dietary 
restriction.   
GI symptom severity may also play an important role in the development of disordered 
eating attitudes and behaviours. The role that GI symptoms play in the development of 
disordered eating attitudes and behaviours appears rather complex. Some authors report 
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that greater symptoms prior to diagnosis increases disordered eating risk (Sainsbury et al., 
2013b), whereas others report that greater symptoms throughout their diagnosis led to 
greater DE risk (Tang et al., 1997). In addition, both poor (Fletcher et al., 2008; Karwautz et 
al., 2008) and good dietary management (Arigo et al., 2012) have been associated with 
disordered eating attitudes and behaviours. It is possible that there are at least two 
pathways that lead to increased risk of disordered eating attitudes and behaviours in 
patients with GI symptoms. On the one hand, individuals who do not follow their dietary 
regimen experience GI symptoms throughout their diagnosis. These individuals may not be 
concerned about their diet, and choose to consume their trigger foods for a variety of 
reasons.  This group could be using their trigger foods to promote weight loss. These 
findings are in line with case studies of individuals with CD, irritable bowel syndrome and 
inflammatory bowel disease where deliberate consumption of trigger foods has been 
reported in order to aid weight loss (Leffler et al., 2007; Mallett & Murch, 1990). In those 
with good dietary management, their GI symptoms may be playing a unique role in the 
development of disordered eating patterns. Hypothetically, the presence of GI symptoms 
may create a food aversion in these individuals, causing alterations to their eating patterns 
(Garcia et al., 1955). These individuals may be extremely anxious and concerned with the 
preparation and potential cross-contamination of their food products. Concerns around 
cross-contamination and anxiety around unfamiliar foods is frequently found across the GI 
disorders (Schneider & Fletcher, 2008; Sverker, Hensing, & Hallet 2005). Although high 
concern around unknown food items may be advantageous in some situations, this may also 
feed into the development of disordered eating patterns. A hypothetical framework based 
on these two pathways has been developed. 
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2.5.1. A Hypothetical Framework 
Based upon the literature presented in the review, a theoretical model of disordered 
eating attitudes and behaviours patterns in GI disease has been developed (Figure Two). The 
model depicts the theoretical relationship between a collection of GI disorders and 
disordered eating attitudes and behaviours; however, it is likely that each GI disorder will 
have a more specific relationship with eating behaviour but to develop specific models more 
focussed research is required. In this context, disordered eating is defined as an eating 
pattern that does not fluctuate beyond the point of nutrient deficient or excess weight 
change. Although thoughts around planning and preparing food may be present, they 
should not contaminate thoughts or dictate behaviours above and beyond that of other 
daily activates (Freeland-Graces & Nitzke, 2013). In addition, the diagnosis of an eating 
disorder also falls under the criteria for disordered eating.  
The model begins at diagnosis, as diagnosis is associated with an imposed change in 
eating patterns in order to manage the GFD, an increase in psychological distress and weight 
changes. Receiving a diagnosis and adapting to the new condition brings about risk factors 
that may contribute to the development of disordered eating attitudes and behaviours. 
When diagnosed with a chronic health condition, depending on the individual’s 
circumstances, some will adapt well and accept the condition but for others denial may play 
a role (Alvani, Parvin, Seyed & Alvani, 2012). Coping with any form of chronic illness creates 
both physical and psychological challenges (Turkel & Pao, 2007). This can contribute to 
psychological distress, coping problems and a lack of compliance to a medical regime 
(Seiffge-Krenke & Skaletz, 2006; Suris, Michaud & Viner, 2004). 
Pathway one describes the potential development of disordered eating attitudes and 
behaviours for those who have adapted well to their condition. These individuals may have 
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greater GI symptoms at diagnosis; the implementation of their treatment and prescribed 
dietary regimens is effective in resolving these GI symptoms. Sainsbury et al. (2013b) found 
greater symptoms at diagnosis to be important in the development of disordered eating 
attitudes and behaviours. These individuals may be anxious about experiencing these GI 
symptoms again. They may overestimate the negative consequences of their condition and 
develop the belief that all foods have cross-contamination potential. As a result, these 
individuals follow their dietary regimens extremely well, like those described by Arigo et al. 
(2012). Due to their strict dietary self-management, uncertainty surrounding the content of 
food may be intolerable for this group. High concerns and anxiety around the preparation 
and cross-contamination of food dominate their thoughts and behaviours; this may result in 
the consumption of a limited range of foods or eating only in well-known environments. 
This is similar to the experiences Fletcher et al. (2008) described in those with irritable 
bowel syndrome and inflammatory bowel disease. These individuals may restrict their food 
intake during the day, in order to cope with their anxiety around cross-contamination and 
food preparation issues and subsequently there is the potential for an excessive amount of 
food to be consumed in the evening when in the home. These individuals display the dietary 
restriction that was found throughout the papers and this is associated with their anxiety 
surrounding GI symptoms that was described by Arigo et al. (2012) and reported under 
nutrition in these groups.  
Individuals in pathway two do not adapt well to their diagnosis and experience distress.  
When starting their treatment and prescribed dietary regimens, these individuals may react 
with fear when their weight is restored to a healthy level after diagnosis. This group may 
believe that their dietary regimen is causing them to gain weight, which leads to 
dysfunctional illness beliefs and behaviours regarding their dietary regimen.  Poor dietary 
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management may follow and the consumption of trigger foods may be motivated by the 
belief that this can aid with weight loss. These beliefs may lead to a lack of adherence to the 
prescribed dietary regimen, continued GI symptoms and psychological distress (Lohiniemi, 
Maki, Kaukinen, Laippala & Collin, 2000; Roth & Ohlsson, 2013). This explains the poor 
dietary management and increased symptom severity throughout diagnosis, described by 
Arigo et al. (2012), Tang et al. (1997), Fletcher et al. (2008) and Kawautz et al. (2008). 
Individuals in pathway two may be at risk for a clinically significant eating disorder. 
However, poor management of the GFD may be related to factors independent of 
disordered eating, including a lack of knowledge around the GFD and poor gluten-free food 
availability. Poor dietary management can be considered a type of disordered eating when 
gluten ingestion is combined with the belief that this will lead to weight loss. In addition, 
individuals with CD who skip meals or are cautious around food may indicate disordered 
eating attitudes or behaviours; alternatively, these individuals may be using these strategies 
to manage their GFD. These eating attitudes and behaviours, and the motivation behind 
these behaviours, are poorly understood in CD and further research is needed
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Figure 2. Hypothetical framework between GI disorders and disordered eating 
Diagnosis of Gastrointestinal 
Disease 
The point of diagnosis and 
implementation of prescribed 
dietary regimen 
Good Adaptation to Diagnosis 
Greater symptoms at diagnosis, resolution 
of these symptoms 
Dysfunctional Illness Beliefs 
Overestimation of negative consequences, 
intolerance of uncertainty, a belief that all 
foods have cross-contamination potential, 
high anxiety 
Dysfunctional Focus on Dietary 
Management 
Limited variety of foods consumed, fear of 
eating foods prepared by others, meticulous 
checking of food labels 
Dysfunctional Eating Patterns 
These eating patterns may meet the criteria for a 
clinical eating pathology and can span the 
spectrum of disordered eating behaviours 
Poor Dietary Management 
Consumption of trigger foods, this 
consumption may be combined with the 
belief that trigger food consumption will 
lead to weight loss 
Dysfunctional Illness Beliefs 
The belief that dietary regimen is associated 
with weight changes 
Poor Adaptation to Diagnosis 
Psychological distress in response to weight 
gain 
1 2 
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2.5.2. Strengths and Limitations of Review 
The prevalence of GI disorders is increasing rapidly and this is expected to 
increase as diagnostic measures improve (Lohi et al., 2007; Molodecky et al., 2012; 
West, Fleming, Tata, Card & Crooks, 2014). We believe our review brings together an 
important area of research for the first time. We outline gaps in the current 
literature and pose a number of important research questions that will need 
answering in the future. This review also highlights several limitations that need to 
be addressed in order to develop research into disordered eating attitudes and 
behaviours in GI disease. The development of a model of disordered eating in GI 
disease is of use clinically and provides a guide for future research. However, there is 
a need to explore the underlying causes of disordered eating attitudes and 
behaviours in GI disease and explore the functions that these eating patterns may 
have for this group. In addition, the studies described in the review failed to report 
long-term outcomes. It is essential for future research to prioritise the long-term 
effects of disordered eating attitudes and behaviours in GI disease.  
Only nine articles were included in this review, which highlights the need for 
research in this population. Despite this limitation, these nine articles had strong 
quality scores and eight of these articles suggested that disordered eating attitudes 
and behaviours were occurring in participants with GI disease, suggesting that the 
findings are reliable.  Due to improved diagnostic measures and better access to 
services, GI diagnosis is increasing rapidly (Lohi et al., 2007; Molodecky et al., 2012; 
West, Fleming, Tata, Card & Crooks, 2014; WGO, 2009). As more of the population is 
diagnosed with GI disease, there becomes a need to explore and highlight the 
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psychosocial and physical consequences of GI disease. This includes disordered 
eating attitudes and behaviours. An increased awareness of this phenomenon 
should improve awareness amongst healthcare professionals and ultimately can lead 
to early detection or prevention of the problem in those with GI disease.  
Unfortunately, the results could not be combined in a meta-analysis due to the 
differing methodologies, outcomes and populations. The development of the 
hypothetical model of disordered eating attitudes and behaviours in GI disease 
provides a framework to guide future research. There is a need for studies to 
document the levels of adherence and anxiety around food in those with GI disease. 
In addition, the function that these eating patterns may have, should be addressed 
from the patient perspective.   
2.5.3. Pathologising Behaviours that Work? 
It is important to note that the majority of individuals with GI disease will not go 
on to develop disordered eating attitudes and behaviours. Nevertheless this review 
indicates that some individuals with GI disease will eat in a manner that deviates 
from the cultural norms of three meals a day (Fjellstrom, 2004).  Some behaviour 
that could be considered disordered may actually result from features of the food 
environment, which make it difficult to stick to a prescribed diet such as gluten-free 
foods being unavailable. Further research is needed to explore the specific eating 
patterns associated with GI disease and how these patterns relate to external 
constraints on the diet. 
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2.6. Conclusion 
The review indicates that those with dietary-controlled GI disorders, including 
CD, may be at increased risk for disordered eating attitudes and behaviours. This is 
likely to interact with the presence of GI symptoms and psychological distress. The 
limited research in this area is concerning as it impacts both the physical and 
psychological well-being of this group. There is a need to fully examine the 
prevalence of this phenomenon in the GI population, as well as the interaction 
between the two disorders.  
The development of the Theoretical Model of Disordered Eating in 
Gastrointestinal Disease provides new assumptions, which have not been thoroughly 
tested in individuals with CD. Because of this, this model has the potential to direct 
new avenues of research and treatment. However, the core assumptions of this 
model need to be applied and tested in individuals with CD. This includes testing 
whether: 
1. Disordered eating attitudes and behaviours are related to the CD diagnosis 
(gastrointestinal symptoms, GFD management) and do not just result from 
the stressors of chronic health conditions (Chapter Three, Chapter Four, 
Chapter Six). 
2. Exploring the role of food concerns in CD (Chapter Four, Chapter Five, 
Chapter Six, Chapter Seven). 
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CHAPTER THREE: THE PREVALENCE AND PREDICTORS OF DISORDERED EATING IN 
WOMEN WITH CD  
3.0. Chapter Rationale  
Chapter Two highlighted the limitations in research exploring disordered eating 
attitudes and behaviours in gastrointestinal disease. The majority of studies have 
failed to establish whether disordered eating in CD results from the CD diagnosis 
itself or the general stressors associated with a chronic health condition. The 
Theoretical Model of Disordered Eating in Gastrointestinal Disease explains how 
factors specific to a GI diagnosis may be associated with the development of 
disordered eating. These include the presence of gastrointestinal symptoms, poor 
management of dietary regimens and increased concerns around food.  
This chapter will use the Theoretical Model of Disordered Eating in 
Gastrointestinal Disease to explore the associates of disordered eating in CD. These 
factors are important for identifying and supporting those with CD and disordered 
eating. In addition, this chapter will build on the limitations of previous research that 
were discussed in Chapter Two by assessing the prevalence of disordered eating in 
females with CD, compared with other dietary-controlled conditions. 
In order to differentiate between the general stressors of chronic health 
conditions and factors specific to a CD diagnosis, individuals with CD were compared 
to other chronic health conditions and the correlates of disordered eating 
(psychological distress, gastrointestinal symptoms, dietary management) was 
compared across chronic health conditions. 
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3.1. Introduction 
The management of a dietary-controlled health condition, such as CD, creates 
pressures that may harm one’s relationship with food and have been associated with 
an increased prevalence of disordered eating attitudes and behaviours (Quick, Byrd-
Bredbenner & Neumark-Sztainer, 2013). Disordered eating describes a spectrum of 
eating behaviours, which can range from clinical eating disorders to skipping meals, 
binge eating, restricting certain food types or fasting (Grilo, 2006).  
The risk of developing disordered eating behaviours increases with psychological 
distress, which frequently occurs in a range of chronic health conditions (Quick, 
Byrd-Bredbenner & Neumark-Sztainer, 2013). Furthermore there is an increased risk 
of developing disordered eating in individuals diagnosed with a chronic health 
condition during puberty, when their body shape is already changing (Smith, 
Latchford, Hall & Dickson, 2008). These factors are common across all chronic health 
conditions. For individuals with CD, the need to monitor the gluten content of food, 
combined with fears about the effectiveness of their GFD and concerns about the 
prevention of gastrointestinal symptoms, may additionally contribute to increased 
risk of disordered eating (Arigo, Anskis & Smyth, 2012; Karwautz et al., 2008).  
To date, there have been few studies of the prevalence of disordered eating in 
CD. The results of two cross-sectional surveys suggest that between 22% and 29% of 
individuals with CD score above the clinical cut-offs on measures assessing Anorexia 
and Bulimia Nervosa (Arigo, Anskis & Smyth, 2012; Karwautz et al., 2008).  Poor 
dietary management, psychological distress and physical symptoms related to CD 
were frequent in those with disordered eating attitudes and behaviours (Arigo, 
Anskis & Smyth, 2012; Karwautz et al., 2008; Wagner et al., 2015), however, the 
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absence of a control group means that it is impossible to determine if the disordered 
eating is related to the coeliac diagnosis or if it results from the nonspecific burden 
of a chronic health condition. These factors are essential to understand the 
mechanisms behind disordered eating in CD. 
Case studies offer an understanding of the complex relationship between 
disordered eating and CD (Leffler et al., 2007; Ricca et al., 2000; Yucel, Ozbey, Demir, 
Polat & Yager, 2006). Yucel et al. (2006) suggested that the long-term dietary 
restriction, necessary in CD, might contribute to disordered eating attitudes and 
behaviours whereas Leffler et al. (2007) suggested that problems with maintaining 
the GFD may be associated with disordered eating attitudes and behaviours. 
However, to fully understand the extent of this problem and to understand the 
mechanisms behind disordered eating in CD, larger sample sizes are required. 
Prior to diagnosis, some individuals with CD experience severe gastrointestinal 
symptoms, which may contribute to the development of disordered eating attitudes 
and behaviours (Arigo, Anskis & Smyth, 2012; Chapter Two). Although most 
individuals will experience clinical remission on the GFD, some will continue to 
experience gastrointestinal symptoms, which may result from refractory CD where 
the individual is not responsive to the GFD (Daum, Cellier & Mulder, 2005). 
Alternatively, Midhagen and Hallert (2003) suggested that the nutritional 
composition of the GFD might be responsible for persistent gastrointestinal 
symptoms, whereas Nachman et al (2010) suggested this results from poor dietary 
management. Untreated gastrointestinal symptoms may trigger an aversion to food, 
which can influence disordered eating attitudes and behaviours (Berstein & Borson, 
1986). Gastrointestinal symptoms have been associated with food aversion in a 
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variety of chronic health conditions including cancer (Coa et al., 2015), autism 
(Nadon, Feldman, Dunn & Gisel, 2011) and gastroparesis (a condition characterised 
by delayed gastric emptying; IDDK Gastroparesis Clinical Research Consortium). 
However, the role of gastrointestinal symptoms in CD and the development of 
disordered eating has received little attention.  
Gastrointestinal symptoms and dietary management are closely associated via a 
bidirectional relationship, where good dietary management is associated with fewer 
and/or less severe gastrointestinal symptoms, and poor dietary management is 
associated with increased/more severe gastrointestinal symptoms (Murray, Eason, 
Clearman & Mitros, 2004).  In addition, the severity of symptoms can influence 
management of the GFD. One interpretation of the associations between 
gastrointestinal symptoms and disordered eating attitudes and behaviours may be 
explained by the deliberate consumption of gluten in those diagnosed with CD; 
Leffler et al. (2007) described cases in which individuals would consume gluten in 
order to encourage gastrointestinal symptoms to promote weight loss. However, 
this phenomenon has only been described in case studies and it is not clear how 
these findings will generalise to larger samples. Misuse of dietary regimens has been 
reported in diabetes (Young-Hyman & Davis, 2010) and there is potential for this to 
occur in CD. However, not all individuals who display poor dietary self-management 
will do so because of disordered eating attitudes and behaviours. 
The Theoretical Model of Disordered Eating in Gastrointestinal Disease (Chapter 
Two) suggests that disordered eating differs depending on beliefs about the disease 
and dietary management. The first pathway describes individuals who experience 
extreme anxiety around unfamiliar foods and/or overestimate the negative 
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consequences associated with their condition. These individuals may fear food 
prepared outside of their control, and cope with this by eating a limited variety of 
foods. The second pathway describes individuals who experience weight gain after 
commencing their prescribed dietary regimen and may use techniques to reverse 
this weight gain. Not all individuals with CD will experience weight gain after 
commencing the GFD; however, good dietary management has been associated with 
a post-diagnosis increase in weight (Kabbani et al., 2012). Prior to coeliac diagnosis, 
individuals may present as underweight, meaning that increased weight is an 
indicator of recovery of the intestine, however, for some individuals this weight 
change may be negatively interpreted and trigger disordered eating. These 
individuals may recognise the association between weight gain and the GFD and aim 
to reduce their weight gain through poor dietary management (Leffler et al., 2007). 
This model has the potential to help us to interpret and understand the relationships 
between disordered eating and CD by testing specific hypotheses.  
This study is the first to apply The Theoretical Model of Disordered Eating in 
Gastrointestinal Disease to CD. Given the limitations of prior studies, this study 
assessed the prevalence, predictors and types of disordered eating in CD compared 
to other conditions with dietary controlled components. Individuals with CD, who 
follow a strict GFD, were compared to those with inflammatory bowel disease and 
type two diabetes (both of which have dietary components to their management) 
and healthy controls. Dietary management in inflammatory bowel disease and type 
two diabetes is unlike that for CD as it is less strict and regimented when compared 
to the GFD and other medical interventions may be required, which is generally not 
the case in CD. Individuals with inflammatory bowel disease experience 
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gastrointestinal symptoms associated with the ingestion of certain restricted foods, 
which can differ between patients, but will avoid these trigger foods during a flare-
up and may use medical or surgical approaches to manage flare-ups (NICE, 2015); 
those with type two diabetes do not have gastrointestinal symptoms as a feature of 
their diagnosis and do not avoid particular food types, but will follow a balanced diet 
with an emphasis on consuming high fibre and low-glycaemic index foods. This may 
be combined with blood glucose monitoring and insulin injections (NICE, 2015). 
These control groups allowed us to explore the role of nonspecific factors common 
to all dietary-controlled conditions (years with condition, psychological distress), 
factors common to gastrointestinal disease (gastrointestinal symptoms) and factors 
unique to the CD diagnosis (GFD management). The most common types of 
disordered eating patterns related to Binge Eating, Anorexia Nervosa and Bulimia 
Nervosa, were assessed (NHS, 2015).  
The following were anticipated: 1) individuals with dietary-controlled conditions 
(CD, inflammatory bowel disease and type two diabetes) would score greater on 
disordered eating measures than healthy controls; 2) psychological distress, a 
nonspecific factor, would be associated with disordered eating across all groups; 3) 
in those with gastrointestinal disorders (inflammatory bowel disease and CD), factors 
unique to these conditions (gastrointestinal symptoms) would explain additional 
variance in disordered eating scores; 4) additional variance in disordered eating 
would be explained by dietary-management in CD and 5) based on The Theoretical 
Model of Disordered Eating in Gastrointestinal Disease (Chapter Two), two types of 
disordered eating were expected to be present in CD..  One group of disordered 
eaters was expected to show good dietary self-management and few gastrointestinal 
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symptoms, associated with increased anxiety around new foods. The second group 
was expected to have poor dietary management and experience increased 
gastrointestinal symptoms, associated with gluten ingestion. 
3.2. Methods 
The cross-sectional survey was conducted between June and December 2014. 
Individuals living in the United Kingdom, aged between 18-69 years and who 
reported a diagnosis of CD, type two diabetes or inflammatory bowel disease, were 
eligible to participate. Healthy controls with no reported health conditions or food 
allergies were also recruited. Participants were excluded if 1) they reported having a 
dietary-controlled condition other than CD, type two diabetes or inflammatory 
bowel disease (e.g. cystic fibrosis, type one diabetes) and 2) if they had any other 
food allergies.  Individuals with type two diabetes were required to be following a 
prescribed dietary regimen as a part of their treatment programme and individuals 
with CD were required to self-report a biopsy confirmed diagnosis.  
Participants with long-term conditions were recruited through adverts on online 
support forums (e.g. Facebook) and through Coeliac UK, Diabetes UK and Core, the 
main charities supporting people with CD, type two diabetes and inflammatory 
bowel disease in the UK. Healthy controls were university psychology students 
recruited from the School of Psychology Research Participation Scheme at the 
University of Birmingham. Interested individuals were directed to an online survey to 
complete the following questionnaires. Men were recruited but only 14 took part, so 
data not analysed.  
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3.2.1. Measures 
3.2.2. Demographic and General Health Information 
For participants with type two diabetes, inflammatory bowel disease and CD, 
information was gathered on demographics, information relating to diagnosis 
(method of diagnosis, date of diagnosis, dietary management) and health status 
(allergies, medication). For individuals with CD, diagnostic method was assessed on a 
3 item scale including 1) biopsy provided diagnosis; 2) blood test; 3) I diagnosed 
myself based on dietary changes, and dietary self-management was rated on a 5-
point Likert scale, in response to the question “In general, how strictly do you 
maintain a gluten free diet?” ranging from ‘1) All of the time’; 2) ‘Most of the time’; 
3) ‘Some of the time’; 4) ‘Now and then’; 5) ‘Not at all’ (Ford, Howard & Oyebode, 
2012). For those with inflammatory bowel disease and type two diabetes dietary 
self-management was also rated on a 5-point Likert scale but the item was phrased 
“In general, how strictly do you maintain your prescribed dietary-regimen?” 
The presence of gastrointestinal symptoms was assessed using the Illness 
Perception Questionnaire Revised (IPQ-R; Moss-Morris et al., 2002). Participants are 
asked to rate whether they have experienced a range of symptoms since their 
diagnosis (yes/no). For the purpose of this analysis, a total symptom score was 
calculated by adding up the total of gastrointestinal symptoms (nausea, weight loss, 
upset stomach, abdominal pain, bloating, excessive wind, constipation, indigestion) 
experienced in the last four weeks, providing a score between 0 and 8, with 8 
indicating a greater number of gastrointestinal symptoms.  Non-gastrointestinal 
symptoms were removed from the analysis, as they were not central to the aims of 
  
74 
 
this chapter (sore throat, breathlessness, fatigue, stiff joints, sore eyes, wheeziness, 
headache, sleep difficulties, dizziness, loss of strength, mouth ulcers, hair loss). 
3.2.3. Psychological Distress 
The Depression, Anxiety, Stress Scale 21 (DASS-21; Lovibond & Lovibond, 1995) 
assesses levels of depression, anxiety and stress. The items consist of statements 
referring to the past week, rated on a 4-point scale. To enable comparison with the 
longer version of the DASS each subscale is multiplied by 2 creating a total score 
between 0-63 with higher scores indicating greater distress. The DASS-21 has strong 
psychometric properties (Brown et al., 1997).  
3.2.4. Food Anxiety 
The Food Neophobia Scale (FNS; Pliner & Hobden, 1992) is a ten-item scale that 
measures willingness to try new foods. Scores above 35 are considered high, with 
lower scores indicating greater willingness to try unfamiliar foods (Pliner & Hobden, 
1992). The FNS is a 10-item questionnaire rated on a 7-point Likert-scale from 
disagree strongly to agree strongly, with total scores ranging from 10 to 70. The scale 
has been validated numerous times and is the standard measure of food neophobia, 
with good reliability and validity (Miselman, King & Gillette, 2010). At present no 
appropriate measures of food anxiety have been developed. The FNS was chosen as 
the best available tool to measure anxiety around new foods.  
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3.2.5. Disordered Eating 
Two questionnaires were used to target the differing attitudes and behaviours 
surrounding disordered eating, to account for any overlap in disordered eating 
categories (Eddy et al., 2008; Swanson et al., 2011).   
The Eating Attitudes Test (EAT-26; Garner & Garfinkel, 1979) is used to assess 
eating disorder risk by measuring the attitudes and behaviours suggestive of 
Anorexia and Bulimia Nervosa. It has been used to identify eating disturbances in 
non-clinical samples.  It is used as a screening tool for eating disorders, but is not a 
diagnostic tool. The 26 items are scored on a 3-point scale, with a score of 20 or 
above requiring further evaluation. The tool has strong psychometric properties 
(Garner et al., 1982) and has been used in populations with dietary-controlled 
conditions (Guthrie, Creed & Whorwell, 1990). Confirmatory factor analysis found 
poor support for Garner et al.’s (1982) three-factor model (RCFI=.889, RMSEA=.075),  
strongest support was found for a one factor model (RCFI=.922, RMSEA=.066). 
Therefore, total EAT-26 scores were used throughout the analysis and subscales 
were not explored.  
The Binge Eating Scale (BES; Gormally et al., 1982) assesses the behavioural 
aspects of binge eating and the thoughts and feelings associated with these 
behaviours. The BES is a screening tool to help identify individuals who may be at 
risk for binge eating behaviours. Scores on the BES range from 0-46, with scores 
above 17 indicating moderate binge eating and scores greater than 27 indicating 
severe binge eating. The BES has been validated in both obese and non-obese 
population and used in those with gastrointestinal disorders (Duarte, Pinto-Gouveia 
& Ferreira, 2015; Passananti et al., 2013; Timmerman, 1999).  
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3.2.6. Ethical Approval 
Ethical approval was granted by the Psychology Research Ethics Committee, 
University of Birmingham.  
3.2.7. Statistical Analysis 
Data were analysed using the Statistics for the Social Sciences (SPSS) version 
22.0. 69 CD participants were excluded across the groups due to the absence of a 
biopsy-proven diagnosis, 8 additional participants were excluded for not meeting the 
inclusion criteria.  Overall, 77 individuals were removed from the CD group, 27 from 
type two diabetes and 9 from inflammatory bowel disease and 4 from health 
controls, providing 503 participants for analysis. 
To assess the predictors of disordered eating, regression analyses were 
conducted to examine the relationships between disease specific factors, disease 
non-specific factors and disordered eating scores and to compare these amongst the 
different diagnostic categories. Correlations were run between BES and EAT-26 
scores and all other variables to select covariates for the regression models. The 
covariates and nonspecific predictors were added into stage one of the hierarchical 
regression, followed by disease specific predictors (dietary management, 
gastrointestinal symptoms). All variables were centred before being entered into the 
regression models. Bonferroni corrections were used to control for multiple 
comparisons and reduce the chance of type one errors (Armstrong, 2014). 
The fit of the model across the groups was assessed using three stages: 1) does 
the predictor set work better for CD than other groups; 2) are the models 
substitutable and 3) are the regression weights across the groups different. 1) 
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Fishers Z test was used to compare the R2 values from each of the groups regression 
models. A significant p-value (<.05) would indicate a difference in model fit across 
the groups. 2) Differences in model structure across the diagnostic groups were 
explored using a cross validation technique (Palmer & O’Connell, 2009). The 
regression model from each group was applied to every other group (e.g. the CD 
regression model was applied to all other diagnostic groups) to create both a 
“direct” and a “crossed” model. The resulting crossed R2 and direct R2 were 
compared using Hotelling’s t-test, a significant p-value (<.05) indicates a difference in 
model structure across the groups, which requires further investigation. 3) To 
examine the individual predictors within the models, regression weights across the 
groups were compared.   
To investigate the types of eating behaviours, a two-step cluster analysis was 
performed on the CD sample. Three theoretical groups were hypothesised to come 
out of the analysis (two disordered and a healthy type), so we specified three groups 
to emerge from the analysis. Years with diagnosis, psychological distress, disordered 
eating scores, food neophobia scores, dietary-management and gastrointestinal 
symptoms were entered into the analysis.  Variables with a predictor importance 
less than 0.2 were subsequently removed from the analysis. The average silhouette 
measure of cohesion and separation (ranging from -1 to +1) was used to determine 
the goodness of model fit. A silhouette measure <0.2 is considered poor, between 
0.2 and 0.5 is considered a fair solution and >0.5 is considered a good solution (Mooi 
& Sarstedt, 2011).  
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3.3. Results 
Overall, 72.8% of participants identified as White British, 18.6% as White Other, 
2% as Asian, 1% as Black and 2.8% as Mixed Background. Table One displays the 
mean age, Body Mass Index (BMI) and years since diagnosis across the groups. The 
type two diabetes group were older and had a higher BMI when compared to other 
diagnostic groups. There were no other differences between the groups. The BMI, 
ethnicity and years with diagnosis for each condition were similar to previous 
samples; however, across all groups our samples were younger than previous 
reports (Hauser et al., 2010; Koro, Bowlin, Bourgeois & Fedder, 2004; Wada et al., 
2015).  
68.5% of participants with CD reported that they followed their GFD “all the 
time”.  Of the remaining 31.5%, 9.4% were completely non-adherent and 22.1% 
were partially adherent to the GFD 
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Table 1 
Demographic Information (Age, Body Mass Index, Years with Condition) Displayed as 
Means and Standard Deviations. Ethnicity Displayed as Number and Percentage.  
 
CD 
(n=157) 
Inflammatory 
Bowel Disease 
(n=116) 
Type Two 
Diabetes 
(n=88) 
Healthy 
Controls 
(n=142) 
Group 
Differences 
Age 
(years) 
38 (13.4) 36 (12.0) 47 (12.8) 33 (13.7) T2D > CD, 
IBD, HC 
Body Mass 
Index 
22.9 (3.8) 23.1 (4.9) 29.1 (3.6) 22.4 (4.8) T2D > CD, 
IBD, HC 
Years since 
Diagnosis 
9 (10.3) 8 (7.6) 9 (7.3) - CD= IBD= 
T2D 
Ethnicity 
(White) 
150 (95.5) 108 (93.1) 84 (95.5) 133 (93.0) CD= IBD= 
T2D= HC 
Ethnicity 
(Non-
White) 
7 (4.5) 8 (6.9) 4 (4.5) 10 (7.0) CD= IBD= 
T2D= HC 
CD: Coeliac Disease; T2D: Type Two Diabetes; IBD: Inflammatory Bowel Disease; 
HC: Healthy Controls. Standard deviations are displayed in brackets (for ethnicity, 
percentage is displayed in brackets).  
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3.3.1. Prevalence of Disordered Eating in CD compared to Controls 
Table Two displays the proportion of participants scoring above the clinical cut-
off for the EAT-26 and the BES and the mean total scores for each group. The Kruskal 
Wallis tests found significant differences in mean EAT-26 scores across the diagnostic 
groups (H(3)=31.8, p<.001). EAT-26 scores were higher in those with CD than healthy 
controls (U=5312.5, p=.001) and those with CD scored higher than those with type 
two diabetes (U=2532, p=.001). There was a significant difference in BES scores 
across the diagnostic groups (H(3)=82.4, p<.001). Those with CD had higher BES 
scores than healthy controls (U=3947, p<.001) but scored lower than those with type 
two diabetes (U=2268, p=.001).
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Table 2 
Mean Scores and Percentage scoring above the clinical cut-offs for measures of disordered eating 
Measure CD  
(n=157) 
Type Two 
Diabetes 
(n=88) 
Inflammatory 
Bowel Disease 
(n=116) 
Healthy 
Controls 
(n=142) 
Group Differences 
Eating Attitudes 
Test (>20) 
11.1 (15.7%) 7.4 (8.8%) 12.8 (20%) 7.7 (3.8%) CD > T2D, HC; IBD > T2D, HC 
Binge Eating Scale 
(>17) 
11.2 (19.4%) 13.6 (25%) 9.9 (22.2%) 3.9 (2.3%) CD, T2D, IBD > HC 
CD: Coeliac Disease; T2D: Type Two Diabetes; IBD: Inflammatory Bowel Disease; HC: Healthy Controls.  
The number in brackets represents the percentage of participants scoring above the pre-determined clinical cut-offs for the BES and EAT-26. 
EAT-26 and BES scores were compared across all groups (p<.05; see group differences column). 
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3.3.2. Predictors of Disordered Eating  
Associations (p<.008) were found for scores on the EAT-26 and BES, and 
measures of psychological distress, as well as age, BMI, symptoms and GFD 
management. These factors were added as covariates. Based on the significant 
relationships with disordered eating and between the subscales, total DASS-21 
scores were entered into step one of the regression model. Years with condition, 
BMI and age were also added. This model accounted for 23.1% of the variance in 
EAT-26 scores  (F=(4, 90)=8.4, p<.001; see Table Three) with distress having a 
significant positive regression weight.  
The disease specific variables were entered in step two (dietary-management 
and gastrointestinal symptoms). For the CD group, when predicting EAT-26 score, 
this model accounted for 54.3% of the variance in EAT-26 scores (F=(6, 90)=20.4, 
p<.001; see Table Three) with dietary-management and gastrointestinal symptoms 
having significant positive regression weights. Based on the examination of ß 
weights, dietary-management had the major contribution.  
The overall model predicted total EAT-26 score equally well for all of the 
diagnostic groups. Comparison of the fit of the model across those with type two 
diabetes (z=2.9,p=.004) and inflammatory bowel disease (z=6.1,p<.001) revealed 
that there was no significant difference between the respective R2 values for the 
EAT-26 score.  
When examining the model structure across the groups, structural differences 
were found. When looking at CD and inflammatory bowel disease, the combined 
direct R2 = .60 and crossed R2 = .40 were significantly different (z=2.9,p=.004). There 
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are structural differences between the best regression model for predicting EAT-26 
score in those with CD and inflammatory bowel disease. When looking at CD and 
type two diabetes together, the combined direct R2 = .60 and crossed R2 = -.43 were 
significantly different (z=6.1,p<.001), indicating that there are structural differences 
between the best regression model for predicting EAT-26 score in those with CD and 
type two diabetes.  
Further analysis revealed that dietary self-management (z=3.6, p<.001) and 
DASS-21 scores (z=-2.8, p=.006) had significantly different regression weights in the 
CD and inflammatory bowel disease groups, with dietary-management having more 
influence on EAT-26 scores in those with CD and DASS-21 scores in those with 
inflammatory bowel disease. Dietary self-management (z=4.6 p<.001) had a 
significantly different regression weight in the CD and type two diabetes groups, 
with poor dietary self-management being associated with  EAT-26 scores in those 
with CD. The regression weights for gastrointestinal symptoms were close to 
significance across CD and type two diabetes (z=1.9, p= .057). The regression models 
for the comparison groups are provided in Appendix B for comparison but are not 
central to the aims of this chapter.  
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Table 3 
Disease specific and Non-Specific Factors in Predicting EAT-26 Scores in CD 
Predictors B B R2 F R2 Change 
Model 1) Non-specific Factors  
Age -.02 -.03    
Body Mass Index -.24 -.12    
Years with Condition .01 .08    
DASS-21 .21 .04* .26 8.36* .26* 
Model 2) Disease Specific Factors  
Age .02 .03    
Body Mass Index -.11 -.06    
Years with Condition .05 .06    
DASS-21 .09 .22    
Gastrointestinal 
Symptoms 
.65 .50*    
Dietary-
management 
2.52 .24* .57 20.42* .31* 
* = significance at p<.008. The significance of the F value refers to the F associated 
with each step.  
For the CD group, when predicting BES score, collectively this model (disease 
non-specific factors) accounted for 41.8% of the variance in BES scores 
(F=(4,86)=17.5, p<.001; see Table 4) with distress having a significant positive  
regression weight. The addition of disease-specific factors only explained no 
additional variance.  
The overall model fit for all of the diagnostic groups fit equally well. Comparison 
of the fit of the disease-nonspecific model across those with type two diabetes (z=-
1.3,p=.180) and inflammatory bowel disease (z=0.6,p=.521) revealed no significant 
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difference between the respective R2 values for BES scores between inflammatory 
bowel disease, type two diabetes and CD. These predictors do equally well across 
the groups. Examination of ß weights found a positive association between 
depression and BES scores across all of the groups.  
Table 4 
Disease specific and Non-Specific Factors in Predicting BES Scores in CD 
Predictors B B R2 F R2 Change 
Model 1) Non-specific Factors 
Age -.13 -.14    
Body Mass Index .71 .23    
Years with Condition -.07 -.06    
DASS-21 .33 .51* .44 17.53* .44* 
Model 2) Disease Specific Factors 
Age -.13 -.15    
Body Mass Index .69 .22    
Years with Condition -.09 -.07    
DASS-21 .35 .55*    
Gastrointestinal 
Symptoms 
-.14 -.07    
Dietary-
management 
-.34 -.02 .67 11.61* .00 
* = significance at p<.008. The significance of the F value refers to the F associated 
with each step.  
3.4.3. Typologies of Eating Attitudes and Behaviour in CD 
Three groups emerged from the cluster analysis producing a “fair” model with a 
silhouette measure of cohesion and separation of 0.5 (Mooi & Sarstedt, 2011). The 
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first group was the largest (N=60) containing those with low psychological distress, 
few gastrointestinal symptoms, good dietary-management and low scores on all 
disordered eating measures. These were determined to be the “low risk” group. The 
second group contained 25 participants. This group was named the “critical” group. 
These individuals’ scored high on EAT-26, and reported poor dietary self-
management, many gastrointestinal symptoms and moderate stress scores. The 
“high distress” group included 11 individuals with high BES scores; this group scored 
highest on all measures of psychological distress but show good dietary-
management.  The Kruskal Wallis tests found significant differences in all variables 
across the three groups (see Table Five). Further post-hoc Mann-Whitney tests 
revealed that when the critical group and the high distress group were compared to 
the low risk group, significant differences were found across all of the variables 
(p<.05).  
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Table 5 
Cluster Analysis in Individuals with CD 
Variable Low Risk (60) Critical (25) High Distress (11) 
Depression (0-21) 1.72 5.4 12 
BES Total (0-46) 6.58 11.44 39 
Stress (0-17) 3.57 8.72 14.45 
GFD Management 
(Always-Never) 
Always Most of the time Always 
EAT-26 Total (10-
40) 
8.3 18.96 10.36 
Gastrointestinal 
Symptoms (0-8) 
7.13 11.72 13.82 
GFD, gluten-free diet; BES, Binge Eating Scale; EAT-26, Eating Attitudes Test-26 
 
Surprisingly, years with diagnosis had a predictor importance less than 0.2 and 
was subsequently removed from this cluster analysis. We calculated the age of 
diagnosis and divided this into adult diagnosis, childhood diagnosis and less than 4 
years. However, the sample sizes were too small to conduct further analysis. 
3.4. Discussion 
The primary goal of this study was to explore the prevalence, predictors and 
types of disordered eating in CD, inflammatory bowel disease, type two diabetes and 
healthy controls, and examine whether factors unique to the diagnosis of CD 
contributed to reports of disordered eating above the impact of having a dietary-
controlled health condition.  
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This study used two screening tools for disordered eating, measuring a 
combination of disordered eating attitudes and self-reported behaviours. Our 
findings were consistent with previous research; the prevalence of disordered eating 
as assessed by the EAT-26 was greater in CD compared to healthy controls, with 
15.7% scoring above the clinical cut-off. This is lower than previous reports of 22-
29% but significantly higher than healthy controls (Arigo, Anskis & Smyth, 2012; 
Karwautz et al., 2008).  
Uniquely, this chapter compared the prevalence of disordered eating across 
dietary-controlled health conditions.  Of those with inflammatory bowel disease, 
20% scored above the cut-off on the EAT-26, with no significant differences in 
prevalence scores between inflammatory bowel disease and CD. Individuals with 
dietary-controlled gastrointestinal conditions may be placed at a unique risk for the 
development of Anorexic-type attitudes and behaviours. The nature of these 
associations is unclear but the presence of gastrointestinal symptoms may be 
important in the development of disordered eating in those with gastrointestinal 
disease (Tang et al., 1997). It is not clear how gastrointestinal symptoms are 
associated with disordered eating but potential mechanisms may include accidental 
or intentional gluten ingestion, which is consistent with The Theoretical Model of 
Disordered Eating in Gastrointestinal Disease (Chapter Two). Case reports indicate 
that for some individuals with gastrointestinal disease, their prescribed dietary-
regimen may interact with disordered eating; the consumption of foods that trigger 
gastrointestinal symptoms may be used to promote weight loss (Leffler et al., 2007; 
Yucel et al., 2006). Furthermore, larger studies in CD have found associations 
between disordered eating scores and dietary transgressions (Wagner et al., 2015). A 
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similar phenomenon has been described in type one diabetes, where individuals may 
withhold insulin to promote weight loss (Jones, Lawson, Daneman, Olmsted & Rodin, 
2000). Future research should focus on the role of gastrointestinal symptoms, 
dietary-management and disordered eating in CD.  
This chapter has identified specific factors that are associated with disordered 
eating in CD. In CD, disease specific factors explained additional variance in EAT-26 
scores (29.7%) when compared to disease-nonspecific factors, and dietary 
management was only important for the CD group. In line with previous research, 
poor dietary self-management explained additional variance in EAT-26 scores for 
those with CD  (Arigo, Anskis & Smyth 2012; Karwautz et al., 2008; Wagner et al., 
2015). In addition, distress was associated with EAT-26 scores in CD; however, 
distress scores were no longer significant when accounting for gastrointestinal 
symptoms and dietary management in CD. Furthermore, the cluster analysis 
produced a “critical” group who scored high on the EAT-26 but reported poorer 
dietary self-management. This suggests that a small group of individuals with CD 
may have a difficult relationship with food.  Some individuals may engage in poor 
dietary self-management in order to promote villous atrophy and subsequent weight 
loss (Leffler et al., 2007). This offers one interpretation of these results; however, the 
self-reported measures of dietary self-management and the motivations behind 
poor management are unclear.  
When compared with healthy controls, all dietary-controlled diagnostic groups 
had increased scores on the BES. Binge eating is commonly reported in those with 
type two diabetes, so it is unsurprising that those with type two diabetes scored 
highest on these measures (Crow, Kendall, Praus & Thuras, 2001). Binge eating has 
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not previously been reported in those with CD. In the United Kingdom, it has been 
reported that up to 81% of individuals gain weight after commencing the GFD 
(Dickey & Kearney, 2006). This weight gain has been attributed to factors including 
the poor nutritional quality of some gluten-free foods, resulting in an increased 
energy intake, and intestinal recovery (Garcia-Manzanares & Lucendo, 2011; Kabbani 
et al., 2012); however for a subset of individuals, our results suggest that binge 
eating may also play a role in weight gain. Future research should focus on the 
relationship between binge eating and weight changes in CD.  
Factors common to all conditions (years with condition, psychological distress) 
were more strongly associated with BES scores across all diagnostic groups. Binge 
eating in CD may be influenced by distress associated with the presence of a long-
term condition. Greater psychological distress has frequently been associated with 
binge eating behaviours (Dide & Fitzgibbon, 2005). Furthermore, the cluster analysis 
highlighted a “High Distress” group who were characterised by increased BES scores 
and psychological distress. Alternatively, following a restricted dietary regimen, like 
the GFD, may increase the risk of binge eating behaviours through disinhibition 
(Herman & Polivy, 1985).  
3.4.1. Limitations and Future Research 
The cross-sectional nature of this study limits any conclusions about the 
sequence of events between disordered eating and CD diagnosis. Longitudinal 
studies are essential in determining the timeframe between disordered eating onset 
and CD diagnosis. Furthermore, online recruitment may create a bias in sampling 
which may over/under-inflate problems with eating behaviours and dietary self-
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management. In addition, these samples were younger than those previously 
reported across all conditions. This may be due to the nature of online sampling, 
which is likely to attract a younger population (Remillard et al., 2014). Despite these 
limitations, this study provides an important extension in exploring disordered 
eating in those with CD and online methods allowed recruitment of a large sample. 
Due to the nature of online data collection, CD diagnosis, dietary management, 
disordered eating scores and psychological distress were all based on self-report. 
These findings need replication in a biopsy-confirmed sample of individuals with CD 
and should focus on more objective measures of dietary-management such as anti-
tissue transglutaminase assays, questionnaires designed to assess gluten-free dietary 
management (Leffler et al., 2009) and multi-modal approaches, including self-report 
and dietician assessment. However, the comparison across different chronic health 
conditions, recruited in the same manner, is a strength of this study and provides an 
extension of existing research in CD and disordered eating.  
No evidence was found for the role of anxiety in the development of disordered 
eating behaviours. Surprisingly the FNS was not a good predictor of disordered 
eating. We had anticipated that FNS scores might tap into fears about cross-
contamination and trying new foods. However, the FNS may lack sensitivity to assess 
this mechanism in those with CD. The development of a scale measuring food 
anxiety in CD may allow further investigation of the role of anxiety around food in 
disordered eating in CD. 
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3.4.2. Clinical Implications  
The observation that individuals with dietary-controlled chronic health 
conditions have increased scores in disordered eating tools when compared to 
healthy controls suggesting that the use of screening tools for disordered eating may 
be valuable in these individuals. More specifically, the observation that 
gastrointestinal symptoms and poor dietary management were associated with EAT-
26 scores in CD, indicates that individuals experiencing difficulties in managing their 
GFD and reporting gastrointestinal symptoms may benefit from have their eating 
attitudes and behaviours explored. In addition, for those who do score above clinical 
cut-offs, it is important to consider how their chronic health condition may interact 
with disordered eating attitudes and behaviours. 
3.5. Conclusions 
This chapter indicates factors both common to all dietary-controlled health 
conditions (psychological distress), gastrointestinal symptoms and factors unique to 
the CD diagnosis (GFD management) require further assessment in relation to CD 
and disordered eating.  
A small group of people with CD display poor dietary management and this is 
associated with disordered eating attitudes and beliefs, lending some support to The 
Theoretical Model of Disordered Eating in Gastrointestinal Disease (Chapter Two). 
The majority of individuals with CD display a typical eating pattern, but for some, 
disordered eating behaviours are a feature of their CD. This chapter has isolated 
some factors that are specific to CD that may place individuals at increased risk for 
disordered eating attitudes and behaviours. Future research should focus on 
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understanding this sub-group of individuals with CD and look at ways to identify 
them and provide support.  
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CHAPTER FOUR: DISORDERED EATING PATTERNS IN CD, A FRAMEWORK ANALYSIS 
4.0. Chapter Rationale 
Chapter Three suggested that factors specific to a CD diagnosis (gastrointestinal 
symptoms, GFD management), as well as the non-specific stressors associated with 
chronic health conditions, were associated with disordered eating attitudes and 
behaviours in CD.  This supports some of the ideas proposed in the Theoretical 
Model of Disordered Eating in Gastrointestinal Disease (Chapter Two). However, the 
role of anxiety around food, which is central to the Theoretical Model of Disordered 
Eating in Gastrointestinal Disease, was not found to play an important role and the 
motivations behind these disordered eating attitudes and behaviours were not 
explored.  
The aim of this chapter was to explore the experiences of typical and disordered 
eating in CD to gain a greater understanding of these processes and explore specific 
pathways within this model of disordered eating, particularly in relation to food 
anxiety.  
A qualitative methodology is employed in this chapter to understand the reasons 
behind disordered eating attitudes and behaviours in CD in order to evaluate the 
Theoretical Model of Disordered Eating in Gastrointestinal Disease. 
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4.1. Introduction 
Management of the GFD requires vigilance around cross-contamination of food 
products, because small amounts of gluten can cause symptoms in some individuals 
(Sverker, Hensing & Hallert, 2005). In the majority of people with CD, successful 
management of the GFD reverses damage to the gut and reduces symptoms. 
However, the GFD can be challenging to follow and can create concerns around 
eating outside the home and cross-contamination of food products (Sverker, 
Hensing & Hallert, 2005). Although the GFD is physically beneficial for the individual, 
its restrictive nature may impact quality of life and result in maladaptive behaviours, 
including disordered eating patterns (Leffler et al., 2007; Lohiniemi, Mustalahti & 
Collin, 1998; Chapter Two). 
The majority of individuals with CD score in the healthy range on self-report 
measures of disordered eating (Karwautz et al., 2008; Chapter Three). However, for 
some, CD may act as a risk factor for the development of disordered eating via a 
number of mechanisms. Factors essential in managing the GFD, including food 
preoccupation and awareness, may harm relationships with food (De Rosa et al., 
2004). Additionally, factors relating to the diagnostic experience, including 
gastrointestinal symptoms and changes in weight, may affect body image and eating 
patterns (Capristo et al., 2000). Alternatively, the non-specific burden of chronic 
illness may account for the presence of disordered eating in this population. The 
results of Chapter Three suggested that factors both unique to the CD diagnosis 
(gastrointestinal symptoms, dietary management) and nonspecific factors 
(psychological distress) are important factors in disordered eating and CD. 
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The present study was theoretically informed by the Theoretical Model of 
Disordered Eating in Gastrointestinal Disease (Chapter Two). Central to this model 
are two pathways; the first pathway describes individuals who experience anxiety 
around food and cope with this by consuming a limited variety of gluten-free foods. 
The second pathway describes those who struggle with weight changes experienced 
after diagnosis (usually weight gain) and engage in poor dietary self-management to 
promote gastrointestinal symptoms and associated weight loss. In an evaluation of 
this model, dietary-management and gastrointestinal symptoms were associated 
with disordered eating scores, lending some support to pathway two (Chapter 
Three). However, the relationships between gastrointestinal symptoms, dietary-
management and disordered eating were not clear. Furthermore, no evidence was 
found to support pathway one, the role of anxiety in disordered eating. This was 
attributed to a lack of appropriate tools to measure concerns around food in 
individuals with CD. Understanding these factors and their role in the development 
of disordered eating is essential if appropriate supportive strategies are to be 
adopted by healthcare professionals.  
The present study aimed to gain a holistic view of the experiences of typical and 
disordered eating in CD.  This was done by exploring the pathways of the Theoretical 
Model of Disordered Eating in Gastrointestinal Disease by using a structured 
framework to analyse interviews with people with CD. According to the model, the 
type of disordered eating pattern that develops will depend on beliefs about CD and 
the GFD, as well as the psychological response to weight changes after CD diagnosis. 
By using this model to create the framework for the interviews, we were able to 
assess how well this model was supported by qualitative data.  
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4.2. Method 
Participants (18-69 years) with a self-reported biopsy-confirmed diagnosis of CD, 
for at least 2 years, without additional food allergies or health conditions, were 
eligible to participate. Purposive sampling was used to recruit both typical and 
disordered eaters from a previous database. Participants were categorised as 
disordered eaters (DE) or typical eaters (non-DE) based on a score above 20 on the 
EAT-26 or a score above 17 on the BES (Garner et al., 1982; Gormally et al., 1982). 
The EAT-26 is a screening tool that measures symptoms and concerns characteristic 
of eating disorders and the BES screens for the presence of binge eating behaviour. 
These are not diagnostic tools but screen for the presence of disordered eating 
behaviours.  
Sample size was based on data saturation, by repeatedly comparing data across 
participants, which occurred when no new information was obtained from the 
interviews (Higginbotham, Albrecht & Connor, 2001). Twenty-five participants were 
invited to take part in the interviews but three withdrew their data and one was 
removed from analysis, as the inclusion criteria were not met. Participants were 
informed that the interview would explore eating patterns in CD. Demographic 
(gender, age, years since diagnosis, Body Mass Index (BMI)) and health information 
(EAT-26 and BES scores) were taken from the existing database.  
A semi-structured interview schedule allowed us to frame questions to fit the 
Theoretical Model of Disordered Eating in Gastrointestinal Disease (Chapter Two). 
The interview explored key themes concerning the diagnosis of CD, the daily 
management of the GFD and how CD has affected participants’ relationship with 
food and body image.  
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4.2.1. Procedure 
Participants provided written consent before their interviews. The lead 
researcher (RS) conducted and audiotaped the interviews. Each interview lasted 
between 30 and 45 minutes and was conducted in the participant’s home. If any 
current or past disordered eating was reported, participants were asked to discuss 
this in more detail, and reflect on any links with their CD diagnosis.  The interviewer 
encouraged participants to elaborate on relevant themes.  
4.2.2. Data Analysis 
Ritchie and Spencer’s (1994) Framework methodology was used as it allows the 
use of a theoretically-driven framework to structure and explore the data. 
Framework analysis was beneficial for this study because it can include a priori 
themes drawn directly from the Theoretical Model of Disordered Eating in 
Gastrointestinal Disease (Chapter Two), as well as emergent concepts.  
Interviews were transcribed verbatim by the lead researcher (RS), and read 
repeatedly in order to identify key themes. These themes were developed into a 
framework for coding the entire dataset. Additional categories were created for data 
that did not fit into the framework. To enhance reliability, the coding process and 
emerging themes were discussed among the authors until consensus was achieved.  
Trustworthiness of the data was enhanced using a decision trail to ensure 
transparency (Koch, 1994).   
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4.2.3. Ethical Approval 
Ethical approval was granted by the Research Ethics Committee, University of 
Birmingham.  
4.3. Results 
Five males and 16 females took part in the interviews (mean age = 39 years; 
mean time since diagnosis = 5 years). Of these, 10 participants scored above EAT-26 
or BES cut-offs resulting in them being classified as “disordered eaters”. Participant 
information can be found in Table One.  Illustrative quotes presented are annotated 
with pseudonyms and participants’ disordered eating status (DE or non-DE). 
‘Disordered eaters’ and ‘typical eaters’ displayed significantly different BES (t(19)=-
7.1, p=<.001) and EAT-26 (t(19)=-.6, p<.001) scores. There were no significant 
differences between participants for age, BMI or years since diagnosis. 
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Table 1 
Participant Characteristics and Disordered Eating Scores 
 Pseudony
m 
Age (years) 
Years since 
Diagnosis 
EAT-26 Score BES Score 
‘T
yp
ic
a
l E
a
te
rs
’ 
Katy 19 3 6 8 
John 53 2 3 3 
Mel 26 2 0 3 
Louise 29 10 8 1 
Sue 49 5 0 11 
Colette 59 19 5 2 
Richard 49 4 4 5 
Anna 28 3 7 1 
Katherine 32 3 9 5 
George 36 7 0 2 
Andrea 29 6 3 3 
Mean 37.2 5.8 4.1 4 
‘D
is
o
rd
er
ed
 E
a
te
rs
’ 
Caroline 48 3 12 23** 
Amy 48 3 26* 18** 
Paula 41 3 26* 8 
Georgia 48 2 26* 30** 
Dan 40 6 21* 25** 
Julie 22 4 30* 13 
Martha 35 4 27* 14 
Steve 38 6 19 22** 
Holly 29 2 26* 21** 
Lisa 54 8 27* 19** 
Mean 40.3 4.1 24 19.3 
 
Note. * >20 on EAT-26; ** >17 on BES 
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The Theoretical Model of Disordered Eating in Gastrointestinal Disease (Chapter 
Two) describes three stages in the development of disordered eating: adaptation to 
diagnosis, illness beliefs and dietary management. These stages provided the 
analytic framework for the hierarchical themes. Each hierarchical theme was coded 
in depth to identify subordinate themes. Each of these subordinate themes was 
explored, resulting in 8 sub-themes (see Table Two). All themes were reported 
across participants but experiences and opinions differed across individuals.  
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Table 2. 
Final Thematic Structure and Example Quotes from Disordered and Typical Eaters 
Superordinate 
Theme 
Sub-Theme Example Quotes from Disordered Eaters Example Quotes from Typical Eaters 
Adaptation 
The New Self 
Caroline: I’ve lost a lot of confidence in the way I 
look. 
Julie: My stomach is a lot bigger now, it’s hard to 
accept that that’s healthier.  
Dan: My weight kept going up and down, I found 
that very difficult.  
Sue: I have more strength and energy, so I perceive 
myself as better. 
John: My weight hasn’t changed much at all. 
Richard: I’ve lost some weight, I think that’s one of 
the benefits of being a Coeliac.  
Mourning of Gluten 
Julie: Viennese whirls. I miss them, they were my 
favourite and I get sad thinking about them. 
Dan: I ate a lot of gluten, to say goodbye to the 
foods I wouldn’t be able to eat anymore.  
Caroline: My diet is so restrictive, it’s impossible not 
to miss old foods.  
Richard: I don’t really miss any foods because they 
made me so ill. 
Louise: It felt like a mourning for what you couldn’t 
have, I was angry but made peace with it in the end. 
Sue: I feel so much better now, I don’t think I could 
miss gluten.  
Illness Beliefs 
The Dangers of 
Cross 
Contamination 
Amy: I clean the surfaces before cooking and 
reduce the contamination risk. 
Georgia: I don’t let cross-contamination control me, 
I just do a quick check before eating.   
Julie: It doesn’t overly concern me, I might get ill 
but a small bit of gluten won’t kill me. 
Sue: I’m worried about the crumbs, if my husband’s 
bread is in my kitchen, I won’t eat. 
Louise: Sometimes it’s safer not to eat because 
cross-contamination is everywhere. 
Mel: I have a gluten radar on at all times, if that 
radar is activated, it’s best not to eat.   
My GFD Makes me 
Fat                    
Georgia: Gluten-free foods are full of calories, they 
make me feel fat. 
Caroline: Gluten-free food is full of rubbish, it 
definitely contributed to my weight gain. 
Katy: Gluten-free cakes are unhealthy but I limit 
them like anyone else would limit cakes. 
Richard: I knew that I would gain weight as my body 
healed. 
  
103 
 
Dietary 
Management 
Risk-Taking 
Paula: Sometimes I’ll take a very small risk. 
Georgia: I think I should probably be more careful 
than I am. 
Caroline: It’s hard outside the home, I may take 
some risks then.  
Mel: Gluten is poison, I would never cheat. 
Richard: I’m very ill when I make mistakes, I can’t 
let it happen. 
Louise: I haven’t had gluten. I just don't allow it.  
Eating 
Knowledge 
and Practices 
Eating for Pleasure 
Georgia: Food is my enemy at the moment.  
Paula: Food makes me upset. It makes me scared. It 
makes me jealous. 
Amy: Eating isn’t enjoyable anymore, it causes a lot 
of stress, particularly outside the home  
John: Food is just a tool for my body now. 
Sue: I’ve gone off food, it causes me a lot of 
anxiety. 
Richard: Eating is a lot more difficult than it used to 
be, it can be done but it involves a lot more 
planning and isn’t as relaxed.  
Food Preoccupation 
Caroline: I’m a lot more aware of the calories in 
food now and more careful about what I eat. 
Julie: The gluten-free foods are full of fat and 
calories, I just avoid them. 
Georgia: Food is always on my mind, I think I’m a 
little bit obsessive about food.  
Katy: You’re always thinking about food. You’re 
always cooking food. 
Mel: It does make you a bit conscious about how 
you are with foods.  
Richard: Food is always on my mind but it 
motivates me to cook and I now want to make a 
gluten free cake shop.  
New Eating 
Patterns 
Julie: I overcompensate with cakes and cookies. 
Caroline: I eat a limited range of foods but it works 
for me. 
Dan: I always search for the new gluten-free treats. 
They're hard to find, so I feel like I deserve them 
when I can have them.  
Colette: I will eat anything, as long as it’s gluten-
free. 
Richard: I cook a lot more now and I’m more 
interested in cooking, which makes sourcing food a 
lot easier.  
Sue: I don’t eat out as much now, but in my home 
it's just the same as it used to be. 
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4.3.1 Thoughts, Feelings and Behaviours Underlying Disordered Eating  
4.3.2 Adaptation to Diagnosis 
The New Self 
The diagnostic process was related to physical changes in body image, which 
were important in the adoption of disordered eating patterns. Disordered eaters 
described distress around weight changes after diagnosis. This was linked with a 
desire to lose weight by restricting food intake.  
I liked being thin. I was over 30 and I wasn’t putting on weight. I’ve definitely got 
a big belly now, I’ve put on weight and it’s really bothering me. I really have lost a lot 
of confidence in terms of the way I look. So I go on more diets now, to try and get 
back to how I was. I’d like to be back to my pre-diagnosis weight. (Georgia, DE) 
These weight changes were challenging for disordered eaters and Dan felt that 
more support could have been provided from healthcare professionals. 
Associating thinness with unhealthiness is strange. Putting on weight but being 
healthy, it goes against the things you read about. I think the dietician could have 
explained that once your stomach goes back to normal there will be a process where 
you start to gain weight. I don’t remember her explaining that. That may have helped 
me feel better. (Dan, DE) 
Some individuals did not experience post-diagnosis weight changes and others 
felt happier with their weight once they were following the GFD. Typical eaters felt 
better after diagnosis because of their increased energy, which was associated with 
an improved body image.  
  
105 
 
The thing I’ve really noticed is that when I’m feeling ok, I’ve got so much more 
strength and energy. And that makes me perceive my body better. (Amy, non-DE) 
Mourning Gluten  
Participants described the challenging process of mourning gluten-containing 
foods after diagnosis, which was accompanied by distress. Twelve participants 
described a ritualistic consumption of gluten “for the last time”. These feelings of 
loss were still present in disordered eaters and were associated with a desire to 
consume gluten-containing foods.  
There’s a certain food that I’d normally eat, I remember I cried when I ate that for 
the last time. I ate loads of it, to try and say goodbye. That was really upsetting. I still 
miss the food, it’s really hard. I just want to eat it again. I get upset seeing friends eat 
it. (Paula, DE)  
For typical eaters, this mourning process was brief and no longer occupied their 
thoughts. 
There is a sort of grieving process for maybe a few months. But now it’s just a 
part of life. There’s no reason to miss food that made me ill. (Colette, non-DE) 
After the adjustment process and acceptance of their diagnosis, participants 
began to develop beliefs about their CD and the GFD.  
4.3.3. Illness Beliefs 
The Dangers of Cross Contamination 
Cross-contamination was frequently referred to during the interviews. However, 
disordered eaters were less concerned about cross-contamination than were typical 
eaters, and believed that accidental gluten ingestion would not impact their long-
term health.    
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I’m rarely ill from cross-contamination, so I take risks and deal with the 
consequences. A tiny amount of gluten every so often won't have adverse effects on 
your long-term health; it just might make you feel sick. (Julie, DE) 
Typical eaters had greater concerns around cross-contamination and went to 
greater lengths to avoid cross-contamination than did the disordered eaters. Louise 
coped with these concerns by limiting her food intake when outside of her home 
environment.  
Sitting in the staff room with everyone else eating food, that’s scary. Um, I know 
they’re not going to touch me or make me eat it or anything but I won’t eat anything. 
There’s just too much risk. I only eat my own foods in my own home… if I’m out 
shopping all day, I won’t eat but I’ll eat my own safe food when I get home. (Louise, 
non-DE) 
For three individuals, these cross-contamination concerns extended into their 
own home: the kitchen was viewed as an unsafe environment and resulted in a 
restricted food intake.  
The kitchen isn’t safe. It’s gluten-free, but it’s more that food in general isn’t safe. 
I get worried around food. I have a few safe things that I do eat but food has become 
the enemy now. It’s just safer not to eat. (Mel, non-DE) 
For two individuals, these beliefs around cross-contamination extended to non-
food items.  
I won’t let my husband put up wallpaper because I’m worried about the gluten in 
the wallpaper paste. Those hidden gluten sources make it hard to eat safely.  (Sue, 
non-DE) 
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Response to Weight Changes due to GFD  
Participants were asked about the causes of any weight changes experienced 
after commencing the GFD. Seventeen participants experienced weight gain after 
starting the GFD whereas the remainder experienced no change or weight loss. 
Disordered eaters attributed weight changes to the GFD and the poor nutritional 
quality of gluten-free foods; they responded by restricting their food intake. 
And the gluten-free foods, if it’s not super fatty, it’s super sugary. Eating gluten-
free food made me really fat. It’s hard to stay slim on a gluten-free diet. I’ve had to 
go on diets to lose the weight but it’s hard. (Paula, DE)  
For typical eaters, weight changes were attributed to the recovery of the 
intestine and improved health.  
My weight has been quite stable, I put on a bit at first but I was really 
underweight. I read all the books and they said that when your body recovers your 
weight should be normal. And that’s what happened. (Mel, non-DE) 
4.3.4. Dietary Management 
Risk Taking 
The majority of participants managed their GFD well. However, four disordered 
eaters reported consuming small amounts of gluten.  
There was this really good sauce and I did take a really small piece of crusty 
bread. Because crusty bread is the thing I miss the most. And I very gingerly sort of 
scooped up all the sauces and ate it. It would be a small piece that hopefully I’m 
going to sort of eat without my stomach noticing. (Dan, DE) 
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Not all individuals with disordered eating reported deliberate gluten ingestion 
and this was not recognised as a technique to promote weight loss.  
For typical eaters, their concerns around cross-contamination and the fear of re-
experiencing unpleasant symptoms meant that risk taking was not tolerated.  
I don’t take risks. I can’t take risks. Gluten poisons me, why would you risk being 
poisoned? (Sue, non-DE) 
4.3.5. Patterns of Disordered Eating  
 4.3.6. Eating Knowledge and Practices 
All participants felt that their eating patterns and the way they thought about 
food had changed since their diagnosis. Their thoughts and feelings about their CD 
affected both their attitudes towards food and the way they consumed food. Three 
sub-themes emerged related to these changes in eating patterns and beliefs: food 
preoccupation, eating for pleasure and new eating patterns.  
Food Preoccupation 
 All participants reported that their diagnosis of CD had made them more aware 
of the foods they were consuming and more aware of the nutritional content of 
food. This awareness arose from the need to manage the GFD and the preparation 
and planning that this involved. Participants were always thinking about food, what 
meal they were having next and where this food was coming from. For disordered 
eaters, this food preoccupation dominated their thoughts.  
You’ve got to think about the range of colours you’re eating, the nutrients and 
about the quantity, you’re thinking about a whole range of stuff. I’m a bit obsessive 
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about food. It does change your relationship with food. You’re always thinking about 
food. (Paula, DE) 
This awareness of food often led to an increased awareness of the calorific 
content of food. Seven individuals became dissatisfied with the amount of calories 
they were consuming and became dissatisfied with their body image. 
Since becoming coeliac I’m also a lot more calorie conscious as well. And the 
gluten free foods. They’re full of calories and fat, and that has made me, well, fat.  
Now I’m much more conscious, about everything I eat. (Georgia, DE) 
Typical eaters described an awareness of food, but they were able to integrate 
these thoughts around food into their life.  
I’m a lot more aware of food now, it’s on my mind a lot but that doesn’t bother 
me. I might see a Chinese recipe but I’d just wonder how I could make it gluten-free. 
It’s just a part of life. (Richard, non-DE) 
Eating for Pleasure 
After CD diagnosis, emotional relationships with food had changed. Meal times 
were described as challenging and eating was no longer enjoyable. For disordered 
eaters, a loss of pleasure around eating was common and was strongly interlinked 
with emotions: food became a source of distress.  
Initially I was anxious. Finding out all these foods you couldn't have and thinking 
why the hell does that have gluten in it, was upsetting. Food is now my enemy, food 
kills me, food attacks me. I know that sounds really melodramatic but that’s how it 
feels. (Dan, DE) 
A lack of enjoyment in the eating process resulted in typical eaters simply 
viewing food as fuel for the body.  
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I’ve gone off food really. Food is the baddie in my life at the moment. I just eat 
what I have to; I’ve lost the enjoyment of sitting down and going out for a meal. 
(Amy, non-DE)  
In comparison, the majority of typical eaters enjoyed eating outside the home, 
whilst managing their GFD.  
It’s harder to eat out but you can’t let that dictate your life. I still enjoy going out 
with friends for a meal, I just have to be careful. (Richard, non-DE) 
New Eating Patterns 
Some participants reported an improvement in their diet since diagnosis; 
however, others reported eating patterns that appeared disordered in nature.  
For eight disordered eaters, overconsumption of food was reported and this was 
linked with emotional distress. The restrictive nature of the GFD made participants 
long for certain foods. When these foods were available, they would be bought in 
bulk and consumed in a short space of time, indicating a binge-type eating pattern. 
However, the consumption of this food was not associated with guilt.  
When you’re unable to eat certain foods, you then overcompensate with other 
things like wine, chocolate, biscuits. It’s depressing not getting these foods, so when 
you do, you just enjoy it. And eat loads of it. I don’t feel guilty, when I eat it, I feel 
happy again. The cakes aren’t going to be there tomorrow, so eat it while you can. 
(Paula, DE) 
Some disordered eaters felt that because of the restrictive nature of their GFD 
they deserved to indulge in certain foods. Some participants hoarded gluten-free 
foods and ate them at a fast rate. 
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When the gluten-free Kit Kat bars first came out, I hoarded those because they 
were delicious. If it’s good, I’ll be hoarding. Sometimes I eat them all myself. I think 
that’s probably my way of dealing with it. And I eat faster than I used to, I just eat it 
quickly before someone’s like – no you can’t eat that. (Julie, DE) 
Other disordered eaters felt a need to limit their food intake due to concerns 
around weight increase since their CD diagnosis.  
It’s like being on several diets at once. I can’t eat gluten, I eat naturally gluten-
free because of all the calories in gluten-free breads and pasta, and I’m on a 
Slimming World diet because of all the weight I put on after my diagnosis. I just want 
to lose the weight. (Martha, DE) 
Typical eaters used strategies to improve food availability. This included cooking 
large quantities of food and storing them to consume during the week.  
I kind of, I think I make up for the fact that I can’t eat gluten by baking a lot of 
gluten free cookies and meals. I portion them and freeze them for later in the week.  
(Katy, non-DE) 
Five typical eaters developed a fear of trying new foods or trying foods in new 
environments. This stemmed from concerns around cross-contamination and the 
belief that it was dangerous to eat foods outside the home. Some typical eaters 
reported going for long periods of time without eating outside the home. These 
participants no longer enjoyed eating in general and felt more at ease when they 
were not around food, which resulted in restricted food intake. 
If I’m out shopping all day, I prefer not to eat. It’s just not safe to eat. Eating has 
become scary because of my coeliac. I only eat if I’m desperate. Food is too 
dangerous now, when I’m not eating I feel safe. (George, non-DE) 
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Others felt that their eating patterns were not affected by their CD diagnosis. 
They were still able to maintain a nutritionally balanced diet. These participants 
were able to consume a range of foods both inside and outside the home, despite 
sticking to their GFD. 
As long as I know it is gluten free, I’ll try anything. I’m not a fussy eater at all. I’ve 
always been that way. The only restriction to that is whether it’s gluten free or not. 
(Katy, non-DE) 
4.4. Discussion 
This chapter investigated the experiences of disordered eating in CD, in order to 
test the Theoretical Model of Disordered Eating in Gastrointestinal Disease (Chapter 
Two). Disordered eaters reported eating patterns suggestive of a binge/restrict cycle, 
which was associated with psychological distress, poor dietary-management and a 
preoccupation with food.  
4.4.1. Disordered Eaters 
Disordered eaters, as assessed by the EAT-26 and the BES, developed eating 
beliefs that stemmed from concerns around weight changes associated with 
commencing the GFD. These weight changes caused distress and participants found 
it challenging to adapt to their new body image. They described a desire to reach 
their pre-diagnostic weight and responded by restricting their dietary intake. Weight 
increase is a known trigger for disordered eating behaviours that may be viewed 
positively by those who are underweight at diagnosis but may be unwelcome in 
those who begin at a normal or higher weight (Andres & Saldana, 2014). These 
findings are in line with Leffler et al. (2007) who described three cases where 
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concerns around weight increased after starting the GFD, which led to disordered 
eating behaviours.  
Distress and mourning the loss of gluten-containing foods were associated with 
disordered eating status. All participants experienced a mourning period, but for 
disordered eaters, there was an extended period of distress surrounding the loss of 
gluten-containing foods, that lasted for years after diagnosis. Participants coped with 
these feelings by overcompensating with high energy-dense, gluten-free foods such 
as cakes and biscuits. Consumption of high-energy dense foods has frequently been 
reported in those with CD (Mariani et al., 1998), but our results indicate that this 
may occur to help manage distress. Participants reported no guilt around the 
consumption of these foods because they felt they “deserved” to eat them. This 
resulted in the hoarding of foods and fast food consumption. This could be an 
indication of binge-eating type behaviour in a sub-group of participants, all of whom 
were classified as disordered eaters according to the BES (APA, 2013). 
Disordered eaters reported that overconsumption occurred in combination with 
restrictive eating: weight loss was promoted by restricting food intake but this 
resulted in a preoccupation with food and psychological distress, which resulted in 
binge eating. These findings are in line with Herman and Polivy’s (1984) Boundary 
Model, which suggests that those who restrict their intake are more responsive to 
external stimuli and at risk for both under and overconsumption of food. Similar 
patterns of eating have been described in people with type two diabetics who also 
follow a prescribed dietary regimen (Herpertz et al., 2001). These findings highlight 
the complex interplay of emotions and food, which may alter eating attitudes and 
behaviours in CD. An increased intake of high-density gluten free foods may be used 
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to cope with feelings of distress that arise from the restrictive nature of the GFD. 
Mazzeo and Bulik (2009) suggested that disordered eating arises after a stressful 
event as a way to manage emotions and acts as a coping mechanism.  
Intentional gluten consumption to promote weight loss was not reported. When 
asked about gluten-consumption in an anonymised web-meditated survey, poor 
dietary management was associated with disordered eating (Chapter Three). In 
addition, case studies have documented the interaction between intentional gluten 
consumption and a desire to promote weight loss through villous atrophy (Karwautz 
et al., 2008; Leffler et al., 2007). However, only four participants, categorised as 
‘disordered eaters’, described occasional gluten ingestion or risk-taking behaviours.  
Participants may not have been willing to talk about intentional gluten consumption 
as a way of losing weight with the interviewer due to perceived lack of anonymity.  
4.4.2. Typical Eaters  
Typical eaters differed from disordered eaters in thoughts, feelings and 
behaviours. Despite experiencing weight changes after diagnosis, typical eaters felt 
healthy and energetic with increased confidence. This is in line with findings 
suggesting that quality of life increases after initiation of the GFD (Casellas et al., 
2015; Sainsbury & Mullan, 2011). Typical eaters also experienced a mourning period 
after diagnosis but these feelings of loss were no longer present at the time of 
interview.  Typical eaters associated gluten-containing foods with the symptoms 
they had experienced prior to commencing the GFD and had no desire to consume 
these items again.  
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Caution around cross-contamination is essential for those with CD but may 
contribute to limited food consumption, both inside and outside the home. Some 
typical eaters reported going for long periods of time without consuming food 
because they believed that limiting food consumption was keeping them safe, 
particularly when outside the home. Furthermore, two typical eaters described a 
concern around non-food products, these beliefs affected their ability to eat outside 
the home. Neither the EAT-26 nor the BES captured the consequences of these 
cross-contamination beliefs on eating patterns. However, this form of dietary self-
management may result in eating behaviours that could be considered ‘disordered’ 
(i.e. restricting and bingeing behaviours) as they deviate from the norm (Polloni et 
al., 2013).  
Importantly, not all participants displayed high levels of concern around food. 
Eight individuals were happy to try new foods that they believed were gluten-free. 
These individuals described a healthy eating style and adaptive beliefs about food, 
with the caveat that their diet was gluten-free.   
4.4.3. The Theoretical Model of Disordered Eating 
These findings provide support for the Theoretical Model of Disordered Eating in 
Gastrointestinal Disease (Chapter Two). The first pathway of the model suggests that 
an unwanted increase in weight after diagnosis results in the belief that the GFD is 
responsible for this weight gain, which results in poor dietary self-management to 
lose weight. Although our data suggests that distress around weight change is 
associated with disordered eating attitudes and behaviours, there was no evidence 
for the role of intentional gluten ingestion to promote weight loss. In addition, the 
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mourning and distress around the loss of gluten-containing foods was associated 
with a desire to consume gluten. These findings are closely in line with the CD grief 
process described by Rose and Howard, whereby the benefits of following a GFD 
were not always viewed as beneficial, resulting in problems with dietary 
management (Rose & Howard, 2014). Future revisions of the theoretical model 
should consider the role of distress and feelings of loss in relation to gluten-
containing foods.  
The second pathway describes those who adapt well to their CD diagnosis and 
have good dietary self-management but overly extreme concerns around cross-
contamination may develop. Our findings suggest that some participants developed 
an extreme vigilance around food, which was associated with limited food intake 
and concerns around food preparation and consumption. However, these individuals 
did not score above clinical cut-offs on measures of disordered eating. Vigilance 
around cross-contamination is essential for GFD management but it is unclear from 
the current data whether these extreme concerns around cross-contamination are 
maladaptive. Future revisions of the theoretical model need to consider the types of 
concerns around food in those with CD to identify factors that may promote 
maladaptive concerns.  
Strengths and Limitations 
All participants were diagnosed at 16 years of age or older; however, age of 
diagnosis may have an impact on interactions with food, and this is often associated 
with the development of disordered eating in chronic health conditions (Davidson, 
2014). Childhood diagnosis may differ from adolescent and adult diagnosis in the risk 
for disordered eating patterns, as diagnosis under four years has been associated 
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with better dietary-management and better psychological well-being whereas those 
diagnosed in adolescence show more problems with social interactions and more 
physical health problems (Hogberg, Grodzinsky & Stenhammar, 2003; Wagner et al., 
2008). In addition, the EAT-26 and the BES allow screening of disordered eating but 
cannot be used as diagnostic tools. Future research could focus on looking at those 
who display clinically significant disordered eating patterns, assessed through clinical 
interview and the use of diagnostic tools.   
4.5. Conclusions 
This qualitative study was guided by the Theoretical Model of Disordered Eating 
in Gastrointestinal Disease and allowed us to gain in-depth understanding into the 
application of this model to CD (Chapter Two) and has provided insight into the 
factors that may contribute to the development of disordered eating patterns in CD. 
The results suggest that experiences of disordered eating differ across individuals 
with CD but relate closely to the CD diagnosis and management of the GFD. Greater 
understanding is still needed, especially in regards to atypical eating patterns, which 
are not detected by current measures of disordered eating. The BES and EAT-26 
appear to be effective in identifying individuals who display binge/restrict-eating 
patterns. However, these tools were not able to select individuals who limited their 
food intake due to concerns around food and cross-contamination. Directions for 
future research should focus on tools to assess concerns around food and cross-
contamination in CD.  
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CHAPTER FIVE: DEVELOPMENT AND VALIDATION OF THE COELIAC DISEASE FOOD 
ATTITUDES AND BEHAVIOURS SCALE 
5.0. Chapter Rationale 
The qualitative results from Chapter Four suggest that the EAT-26 and the BES 
are useful for identifying a binge/restrict style of eating in CD. However, despite 
scoring below the EAT-26 and BES cut-offs, some participants from Chapter Four 
described concerns around food and the potential for the cross-contamination of 
food products. As a result, these individuals would only eat food that they had 
prepared, in familiar environments. This led to food being described as a fearful 
stimulus and difficulties, or even a refusal, in eating outside the home. Current 
disordered eating questionnaires were unable to identify individuals who described 
concerns around food and patterns of food avoidance. 
The aim of this chapter was to explore these disordered eating attitudes and 
behaviours in the context of CD by developing and validating a scale to assess 
thoughts and behaviours around food and cross-contamination in CD. This chapter 
describes the development of a tool that is designed to target the attitudes and 
behaviours described in Chapter Four, as well as the concerns around food that are 
highlighted in the Theoretical Model of Disordered Eating in Gastrointestinal Disease 
(Chapter Two). 
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5.1. Introduction 
Case studies of comorbid CD and disordered eating, although limited by small 
sample sizes, are concordant with studies suggesting 22-29% of individuals with CD 
score above clinical cut-offs for disordered eating attitudes and behaviours (Arigo et 
al., 2012; Karwautz et al., 2008; Leffler et al., 2007). Chapter Two used the Binge 
Eating Scale (BES; Gormally, Black, Daston & Rardin, 1982) and the Eating Attitudes 
Test (EAT-26; Garner et al., 1982) to identify disordered eating attitudes and 
behaviours in CD. These tools appear to be effective at identifying disordered eating 
attitudes and behaviours in CD that are motivated by the desire to alter weight and 
reflect a binge/restrict style of eating (Chapter Four). However, some individuals 
who score below the clinical cut-offs on these measures describe eating attitudes 
and behaviours that appear disordered in nature (Chapter Four). Fears around cross-
contamination and food safety were discussed in combination with a reduced 
willingness to eat outside the home and a fear around attending social events 
involving food. Therefore, existing measures of disordered eating may lead to 
inaccurate estimations of disordered eating in CD, as dietary restriction alongside 
concerns around food and cross-contamination are not captured by current 
disordered eating measures (Chapter Four).  
The management of CD requires vigilance around food intake and knowledge of 
food preparation. Although control around food is essential for those with CD 
following a GFD, these beliefs about food may result in disordered eating attitudes 
and behaviours (Chapter Four). To better understand how these beliefs develop from 
adaptive coping mechanisms to disordered attitudes and behaviours, they must be 
measureable in CD.  
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Accordingly, we developed a CD food attitudes and behaviours scale (CD-FAB) 
that will identify disordered eating attitudes and behaviours resulting from beliefs 
around cross-contamination and food safety. Items in the CD-FAB are based on the 
Theoretical Model of Disordered Eating in Gastrointestinal Disease, which was used 
to guide item development (Chapter Two). This chapter will report the development 
of the CD-FAB, including the psychometric properties comprising subscale structure, 
reliability and validity.  
5.2. Methods 
A mixed methods approach using three studies was used to develop the CD-FAB 
(see Figure One).  
 
 
 
 
 
 
 
 
 
 
Figure 1. Flow chart of the CD-FAB questionnaire development and validation 
process.  
 
  
121 
 
5.2.1. Ethical Approval 
Ethical approval was granted by the Psychology Research Ethics Committee, 
University of Birmingham.  
5.3. Study 1: Item Generation 
5.3.1. Methods of Item Generation 
CD-FAB items were generated using one online focus group moderated by the 
lead researcher (RS) using an online platform (LiveMinds). Individuals with a self-
reported biopsy-confirmed diagnosis of CD were recruited from online forums. 
Interested individuals emailed the lead researcher to complete a screening 
questionnaire and to confirm focus group attendance. All participants gave verbal 
consent over the phone and then gave online consent before being directed to the 
focus group. This provided the opportunity for questions about the study to be 
answered. Participants were aged between 18 and 69 years. Participants 
experiencing other dietary controlled health conditions (e.g. cystic fibrosis, diabetes 
mellitus) and food allergies were excluded.  
Eight open-ended questions relating to feelings and concerns about food and 
cross-contamination were designed to answer the key questions of the study: 1) the 
construct of food attitudes in CD and 2) the everyday interactions with food in CD. 
These were used as a guide during the 90-minute focus-group session. These 
questions were developed based on the five stages of the Theoretical Model of 
Disordered Eating in Gastrointestinal Disease: diagnosis of CD, adaptation to 
diagnosis, illness beliefs, dietary management and eating patterns (Chapter Two). 
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5.3.2. Data Analysis 
Key themes related to food attitudes, concerns and eating behaviours were 
identified using thematic analysis (Braun & Clarke, 2006). The lead researcher (RS), 
who is experienced in qualitative analysis, and under the supervision of experienced 
academics, read through the transcripts noting down initial thoughts and ideas; she 
then re-read transcripts several times to allow data immersion. After immersion, the 
notes were consulted and the coding phase began. The codes identified 
characteristics that were related to food attitudes, concerns and eating behaviours, 
which were grouped by similarity to create themes. Emerging themes were used to 
develop items for the CD-FAB. Items were created using interviewee statements 
from the focus group to target each of the identified themes. Each item was 
transformed into a 7-point Likert scale (strongly agree to strongly disagree). 
Questions were phrased so that higher scores indicated greater food concerns; 
however, four items were reverse scored to minimise response bias. Individuals from 
the focus group and members from the Birmingham Coeliac UK committee were 
asked to rate the 33 pilot items of the CD-FAB based on clarity, adequacy and 
relevance to the focus group discussion. These questions were rated on a 5-point 
scale (1, Strongly Agree – 5, Strongly Disagree), and those items that consistently 
scored low were considered for removal. 
5.3.3. Results of Item Generation  
Twelve individuals took part in the online focus groups (10 females), (mean age 
=29.1 years, SD=5.7; mean time since diagnosis = 6.2 years, SD=2.3). Of the twelve 
participants, three had been diagnosed with CD for 10 years or more.  The remainder 
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had been diagnosed for between 1 and 7 years.  The majority of participants (66%) 
were in their late teens or 20’s.  The remainder ranged in age from 30 to 51 years. 
5.3.4. Thematic Analysis 
Four themes underlying dimensions of food concerns in CD were identified: 
handling of food, trust, risk-taking and food safety. Theme one, handling of food, 
refers to feelings around gluten-containing products, including preparing gluten-
containing food for others, having gluten in the home and touching gluten-
containing foods. Some individuals would prepare gluten-containing foods for others 
and had no concern being around gluten, as long as they did not have to consume 
gluten. Others described a fear around food that was attributed to their need to be 
vigilant about food content and feelings of anxiety would increase when they were 
around gluten. These individuals would not allow gluten in the home and for some, 
feelings of anxiety increased when they were in close proximity to gluten. “I also get 
concerned in supermarkets when the gluten-free bread is next to the normal bread. I 
know they’re all wrapped up but they’re so close to each other. It just scares me. 
(Ashley)”  
The second theme, trust described the need for control during food preparation 
especially where others were involved in this process, which affected willingness to 
consume food. Concerns stemmed from the belief that others may not be vigilant 
around cross-contamination or may lack understanding of dietary requirements. To 
reduce concerns around eating food prepared by others, trust in the individual 
preparing food was needed. “I don't let him (my boyfriend) prepare my food, I do 
that all myself. Only I cook for me! I like to be in control of my food, I can’t trust 
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others to do it (Charlie)”. Clem described the impact of trust on the ability to eat 
outside the home “Any time people talk about going out for a meal I always have to 
double check. If they (the restaurant) sound unsure I won't go. I need to be able to 
trust them (Clem)”  
The third dimension risk-taking, reflects the ability to consume new foods in new 
environments. 12 participants indicated that an element of risk was necessary in 
order to live a normal life. However, for some individuals, a lack of risk-taking led to 
isolation from events involving food because of concerns around cross-
contamination.  “I have to take risks or I'd never eat anything. I used to be really 
paranoid that everything had gluten in it but I have to take small risks if I want to 
have a normal life! (Jamie)” 
Food safety describes the eating strategies that were employed by some 
participants to manage food concerns. Although the majority of participants were 
willing to try new gluten-free foods, or employed strategies to ensure that new 
foods were gluten-free, some viewed food as the enemy. These individuals 
experienced anxiety around food and felt safer when they were not eating. These 
individuals reported consuming a limited range of foods, or using long periods of 
dietary restriction in order to promote their safety and prevent gastrointestinal 
symptoms. “I think I cope with my fear of getting glutened by not eating. That makes 
me feel safe.” (Ashley). These attitudes were related to participant’s ability to recall 
their symptoms and adverse food experiences prior to diagnosis. “I don't go to 
restaurants. They remind me of being ill. I don’t want to feel like I did before going 
gluten-free again, so I don’t eat much (Alex)”  
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5.3.5. Item Development 
These four themes were used to generate 33 items for the CD-FAB. Individuals 
from the focus group were asked to rate the 33 pilot items of the CD-FAB based on 
clarity, adequacy and relevance to the focus group discussion. In addition, three 
service users with CD, recruited via email from the Birmingham Coeliac UK 
committee, who did not take part in the focus groups, were asked to comment on 
the clarity, adequacy and relevance of the questions to individuals with CD. These 
questions were rated on a 5-point scale (1, Strongly Agree – 5, Strongly Disagree), 
and those items that consistently scored low were considered for removal. Based on 
the feedback, 13 items were re-worded and 3 items removed to create the pilot CD-
FAB. Thirty items remained in the pilot CD-FAB to be used in Study Two. 
5.4. Study 2: Item Analysis and Initial Exploratory Factor Analysis 
5.4.1. Methods of Item Analysis and Initial Exploratory Factor Analysis 
Study two identified items for the final scale. Data collection occurred between 
November-December 2015. The pilot CD-FAB was distributed to a new sample 
recruited from our research participant database (n=157). This database consists of 
adults (18-69 years) with self-reported biopsy confirmed CD, recruited from online 
forums and coeliac food fairs, who had previously volunteered to take part in our 
research. These individuals have consented to being contacted about taking part in 
future research. Interested individuals were directed to an online site to complete 
the questionnaire. The questionnaires included demographic and health information 
and the pilot CD-FAB.  
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5.4.2. Data Analysis 
Items were reduced to only those that contributed to the questionnaires 
explanatory power (see Table One for removal criteria; Stevens, 1992). One item that 
was determined theoretically relevant due to its prevalence in responses during the 
focus groups, “I am afraid to touch gluten-containing foods”, was retained despite 
the removal criteria.  
Principle components analysis with orthogonal rotation was used to identify 
loading patterns within the CD-FAB. The scree plot and factors Eigen values >1 
identified the most appropriate factor solution. Factor loadings >0.4 identified the 
clustering of items onto each factor (Kline, 1994). 
Table 1 
Criteria Used to Remove Items from the CD-FAB. 
Spread of 
responses across 
options 
High endorsement of a single item suggests poor 
discriminatory power. Items were considered for 
removal if >80% or <20% were an agree-type 
statement or a disagree-type statement 
16 
removed 
Internal 
consistency 
Items with a corrected item-domain total 
correlation <0.3 or in a domain with a poor 
Cronbach’s alpha <0.7 were considered for 
removal  
1 
removed  
Timing of 
administration of 
questionnaire 
Needs to be applicable to people from the point 
of CD diagnosis onwards, so all individuals with 
CD can complete the scale 
2 
reworded  
Clarity and 
relevance of items 
Difficult to understand items were reworded or 
considered for removal 
13 
reworded  
Items deemed 
theoretically 
important 
These items were retained despite meeting the 
above criteria because they were deemed 
theoretically important 
1 retained 
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5.4.3. Results of Item Analysis and Initial Exploratory Factor Analysis 
One hundred and two individuals (96 females) completed the pilot stage (mean 
age = 38.6 years; SD = 16.7; 9.6 years with CD diagnosis; SD = 18.2). Twelve 
participants were excluded because they reported self-diagnosis and not a biopsy-
diagnosis of CD.  
5.4.4. Internal Reliability 
The CD-FAB was reduced from 30 to 13 items based on the criteria described 
above. The Cronbach’s Alpha for the total score was .88 indicating a good level of 
internal consistency. The Cronbach’s alpha for each subscale was >.7 (see Table 
Two).   
5.4.5. Exploratory Factor Analysis  
A three-factor solution was extracted that explained 65.3% of the variance.  
Factor one, “Food Attitudes” contained items describing concerns around 
interacting with food and cross contamination. Factor two, “Fear Response” 
contained items that described behaviours designed to control food preparation and 
a fear of trying new foods. Factor three, “Adaptive Response” described behaviours 
that allowed individuals to manage their food attitudes without compromising their 
lifestyle.  
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Table 2 
Factor Loadings and Cronbach Alpha Coefficients for CD-FAB Factors 
 
Fear 
Response:  
Food 
Attitudes:  
Adaptive 
Response:  
Cronbach’s Alpha for Scale .788 .786 .790 
I am afraid to touch gluten-containing 
foods 
.844   
I get concerned being near others when 
they are eating gluten 
.806   
* I will happily prepare gluten for others .734   
I am afraid to eat outside my home .516   
I find it hard to eat gluten-free foods that 
look like the gluten-containing-foods that 
have made me ill in the past 
 .808  
I have a lack of variety in my diet  .799  
I get worried when eating with strangers  .679  
My concerns about cross-contamination 
prevent me from going to socal events 
involving food 
 .548  
I will only eat food that I have prepared 
myself  
 .413  
* If I ask questions, I can normally find 
gluten-free food to eat 
  .819 
* I enjoy going out for meals as much as I 
did before my diagnosis 
  .734 
* Being contaminated by gluten in the past, 
hasn’t stopped me from enjoying 
restaurants 
  .692 
* I am comfortable eating gluten-free food 
from other people’s kitchens 
  .586 
 
* Represents items that are reverse scored. Numerical values represent factor 
loadings, a value>.4 is identified the clustering of the items onto each factor. 
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5.5. Study 3: Confirmatory Factor Analysis and Psychometrics 
Study Three assessed the feasibility, reliability and psychometric properties of 
the CD-FAB, and validated the underlying factor structure.  
5.5.1. Methods of Confirmatory Factor Analysis and Psychometrics 
Recruitment posters in the food outlets and across campus at the University of 
Birmingham, UK, directed interested individuals to an online survey. Data collection 
occurred between January-March 2016. Individuals were asked not to complete the 
questionnaire if they had completed Study One. All participants completed the 
online questionnaire (time 1), and were invited to complete the CD-FAB and items 
assessing predictive validity for the second time, 4 weeks later (time 2). Two-
hundred individuals with CD were targeted as this is a sufficient sample size for 
confirmatory factor analysis (Guilford, 1954). The inclusion/exclusion criteria were as 
described in Study One. 
5.5.2. Data Analysis 
Floor and ceiling effects were examined to assess feasibility of the total CD-FAB 
score and the subscales; these were considered when more than 15% of 
respondents achieved the lowest or highest possible score.  
Confirmatory factor analysis (CFA) was used to confirm the model found in Study 
Two, based on the goodness fit and assessed using several indices: the comparative 
fit index (CFI; >.95 indicates acceptable fit), Tucker-Lewis Index (TLI; >.95 indicates 
acceptable fit) and root mean square errors of approximation (RMSEA; <.08 indicates 
acceptable fit; Hu & Bentler, 1999). Modification indices were examined and 
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modifications were made to improve model fit. Higher-order confirmatory factor 
analysis, with food attitudes and beliefs as the higher order factor, was conducted to 
explore whether the 3 CD-FAB factors could be combined to create a total score. 
Total CD-FAB scores were calculated by summing the responses on each item 
(responses for each item range between 1 and 7). Total CD-FAB scores ranged 
between 13 and 91, with higher scores indicating greater CD-related food attitudes 
and behaviours.   
A minimum of 50 participants per time period is required to assess test-re-test 
reliability (Atkinson and Nevi, 2000; Hopkins, 2000). Correlation coefficients (r) were 
used to assess test-re-test reliability of the total CD-FAB scores, an r >.7 is indicative 
of strong reliability (Terwee et al., 2007). 
5.5.3. Measures for Validation 
Food Neophobia Scale (FNS; Pliner & Hobden, 1992): The FNS was used to assess 
anxieties around food in Chapter Three, so was used to assess convergent validity. 
The FNS measures willingness to try new food, with lower scores indicating a greater 
willingness to try new foods. The scale consists of 10 items and is the standard 
measure of food neophobia (Pliner & Hobden, 1992). Correlations were sought to 
determine the degree to which the CD-FAB reflected a fear of trying new foods. We 
anticipated a moderately positive relationship between CD-FAB and FNS scores, as 
individuals with high CD-FAB scores may also be fearful of trying new foods.  
Depression, Anxiety, Stress scale 21 (DASS-21; Lovibond & Lovibond, 1995): The 
Anxiety subscale from the DASS-21 was used to assess convergent validity. This 
subscale measures behavioural feelings of anxiety over the last 4 weeks with higher 
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scores indicating greater anxiety. The DASS-21 has strong psychometric properties; 
with higher scores indicating greater anxiety (Brown et al., 1997). To demonstrate 
convergent validity, scores on the CD-FAB should correlate with scores on the 
Anxiety subscale. 
CD Quality of Life scale (CD-QoL; Dorn et al., 2010): The Treatment subscale was 
used to assess discriminative validity. This subscale assesses satisfaction with one’s 
treatment (the GFD). There is no reason for CD-FAB total scores to be associated 
with treatment beliefs, so no relationship between these scores was anticipated.  
Behavioural Item: Known groups discriminant validity was assessed using the 
behavioural item, “Do you consider yourself to be anxious around food?” This item 
was rated yes/no. A further behavioural item “How many times have you eaten 
outside the home over the last month?” was assessed at time 2, to assess predictive 
validity. To show predictive validity, individuals who score high on the CD-FAB at 
time 1 will eat outside the home less than those scoring low on the CD-FAB at time 2.  
Gluten-Free Management: Dietary management was rated on a 5-point Likert 
scale, in response to the question “In general, how strictly do you maintain a GFD?” 
ranging from ‘1) All of the time’; 2) ‘Most of the time’; 3) ‘Some of the time’; 4) ‘Now 
and then’; 5) ‘Not at all’ (Ford, Howard & Oyebode, 2012). 
5.5.4. Results of Confirmatory Factor Analysis and Psychometrics 
Participants at time 1: 203 (35 males, 2 “other”) participants took part in the 
validation stage with a mean age of 30.9 years (SD = 11.4) and 6.2 years with CD 
diagnosis (SD = 8.4). Nineteen participants were excluded as they reported a self-
diagnosis and not a biopsy proven diagnosis of CD. This sample was older than the 
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participants recruited for study two (t(1, 285)=-4.2, p<.001). No difference was found 
in years since diagnosis across the two samples (t (1, 286)=-1.8, p=.072). 56.1% of 
participants with CD reported that they followed their GFD “all the time”.  Of the 
remainder, 1% were completely non-adherent and 42.9% were partially adherent to 
the GFD. 
Participants at time 2: 112 of those recruited at time 1 consented to be 
contacted at time 2, of these 67 completed the second questionnaire. This sample 
consisted of 13 males and 54 females with a mean age of 32.8 years (SD=16.5) and 
these individuals had been diagnosed for a mean of 7.5 years (SD=11.4). 
When comparing participant contact details to those participants recruited in 
Study One, there was only a 3% overlap in participants across the samples. We can 
be confident that the participants in the current sample were different to those 
recruited in the original sample. These individuals were removed from the analysis. 
Missing data for each of the items ranged from 1.4–4.1% and was missing at 
random. Participants with missing data were removed from the analysis. 
5.5.5. Reliability and Feasibility 
Floor and ceiling effects ranged between 0.5-1% across all CD-FAB subscales 
(Table Three). This indicates strong feasibility across the CD-FAB. As demonstrated in 
Study Two, the CD-FAB subscales and total score showed good internal consistency 
with Cronbach’s Alpha above 0.7 in all cases.  
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Table 3 
Floor and Ceiling Effects for Total CD-FAB Scores and Subscales with Cronbach Alpha 
Coefficients  
Subscales Mean SD Cronbach’s 
Alpha 
Floor (%) Ceiling 
(%) 
Food Attitudes 16.70 4.45 .805 0.5 0.5 
Fear Response 19.59 7.53 .701 1 0.5 
Adaptive Response 15.66 5.77 .833 1 1 
CD-FAB Total 20.57 15.70 .887 0.5 0.5 
 
5.5.6. Confirmatory Factor Analysis 
All items loaded onto their respective factors (standardised loadings ranged 
between 0.4-1.1 and are all statistically significant (p<.01); see Figure Two). Figure 
Two shows the structural equation model containing the standardised path 
estimates between the items and factors for the final model. Items 4 (I have a lack of 
variety in my diet) and 9 (I will happily prepare gluten for others) were removed from 
the model due to low factor loadings and improved model fit after removal. Despite 
item 6 (I find it hard to eat gluten-free foods that look like the gluten-containing-
foods that have made me ill in the past) having a low factor loading (0.4), this item 
was retained, as its removal did not improve model fit. The path coefficients 
represent the direct structural relationship between each factor and its indicators. 
The correlation between the three factors of the CD-FAB ranged between -.78 and 
1.06, suggesting a high level of affinity between the three factors, even though they 
tap into distinct underlying constructs. An examination of the modification indices 
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indicated that fit could be improved by co-varying the errors on items 7 and 8, 1 and 
3, and 5 and 7. The resulting model fit was good (TLI=.97; CFI=.98; RMSEA=.06). Total 
CD-FAB scores and subscales were based on this CFA, meaning items 4 and 5 were 
removed from analyses. Subsequently, the resulting CD-FAB contained 11 items with 
total scores ranging from 11 to 77. These calculations were used in subsequent 
analyses.  
 
Figure 2: Confirmatory Factor Analysis with standardised Item loadings onto each 
Factor for the three factors of the CD-FAB. The numbers shown on the diagram from 
bottom to top are: 1) covariance of the errors, 2) error terms (E), 3) path coefficients 
of indicators and 4) correlations between the three factors.   
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5.5.7. Higher Order Factor Analysis 
The three factor model (Food Attitudes, Adaptive Response and Fear Response) 
with food attitudes and beliefs (total CD-FAB score) as the second order factor found 
a good model fit (TLI=.97; CFI=.98; RMSEA=.05).  
5.5.8. Content Validity 
Convergent Validity: As hypothesised, the total CD-FAB positively correlated with 
the FNS (r=.25, p<.001) and the Anxiety subscale of the DASS-21 (r=.16, p=.025). This 
indicates that the CD-FAB is similar to measures of anxiety and fear around trying 
new foods. The relationship between the total CD-FAB score and the Anxiety 
subscale of the DASS-21 was significant but weak.  
Discriminant Validity: As hypothesised, beliefs about the effectiveness of the GFD 
were not related to total CD-FAB scores (r=-.01, p=.880), indicating good 
discriminant validity. 
Known Groups Validity: Overall, 37.2% of participants considered themselves to 
feel anxious around food. In CD-FAB subscales and total score, those that reported 
being anxious around food had significantly higher CD-FAB scores than those who 
were not anxious around food (see Table Four). However, those who reported being 
more anxious around food had significantly lower scores on the Adaptive Response 
subscale.  
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Table 4 
Means and standard deviations for CD-FAB total and subscales (with reverse scoring 
for Adaptive Response subscale) for CD patients with and without food anxiety, in 
response to the item “Do you consider yourself to be anxious around food?”  
Subscales “Do you consider yourself to be anxious 
around food?” 
P-Value 
Yes; Mean (SD) No; Mean (SD) 
Food Attitudes 16.6 (3.5) 10.1 (4.4) <.001 
Fear Response 18.9 (4.3) 13.0 (4.9) <.001 
Adaptive Response 12.5 (4.9) 17.4 (5.5) <.001 
CD-FAB Total 48.0 (6.4) 40.6 (7.0) <.001 
 
5.5.9. Predictive Validity  
Total CD-FAB scores taken at time 1 were associated with responses to the item 
“How many times have you eaten outside the home over the last month?” taken at 
time 2 (r=-.36,p=.048), and individual CD-FAB subscale scores showed correlations 
with this item (p<.05). The Adaptive Response subscale showed significant 
correlations in the opposite direction. High scores on the Adaptive Response 
subscale, indicating healthy food attitudes and behaviours, were associated with a 
higher number of times eaten outside the home over the last month, taken at time 2 
(r=.36, p=.047). 
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5.5.10. Test-Re-Test Reliability 
Correlation coefficients between the total CD-FAB scores at time 1 and time 2 
were strong (r=.92, p<.001). Similar results were found for all three CD-FAB 
subscales. The CD-FAB and its subscales show good test-re-test reliability.  
5.6. General Discussion 
Recent research has highlighted the potential for disordered eating to develop in 
individuals with CD (Arigo et al., 2012; Karwautz et al., 2008; Chapter Three). 
Qualitative studies suggest that existing measures of disordered eating do not 
identify all atypical eating patterns reported in CD (Chapter Four). These 
questionnaires do not consider factors related to CD that are essential in managing 
the GFD that may become maladaptive, including a hypervigilance around cross-
contamination of food with gluten. Although vigilance around food is essential in CD, 
a hypervigilance around food may contribute to the development of disordered 
eating attitudes and behaviours. Beliefs around cross-contamination and food safety 
have been implicated in the development of disordered eating attitudes and 
behaviours in CD (Chapter Four) but there are no specific measurement tools 
available. Here we developed and validated a self-report food attitudes and 
behaviours measure for adults with CD (the CD-FAB).  
The CD-FAB set out to measure the four themes identified in the focus group, 
which explored underlying food attitudes, concerns and eating behaviour themes  
(i.e. handling of food, trust, risk-taking and food safety). However, only three factors 
emerged, but items targeting each of the themes were distributed randomly across 
the three factors. These factors explained 65.3% of the variance: Food Attitudes, 
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describing the beliefs one has around food and cross-contamination; Fear Response, 
which describes avoidance behaviours and changes in the diet to cope with these 
food attitudes; and Adaptive Response, describing techniques to obtain nutritional 
information to allow food consumption in a range of environments. 
Food cross-contamination and eating outside the home are important concerns 
for people with CD (Sverker et al., 2005), and these are described by the items in the 
Food Attitudes subscale.  The Adaptive Response and Fear Response subscales reflect 
two differing strategies to cope with food attitudes. These distinctions mirror the 
“depressive-anxious” (those who respond to CD with fear, sadness and anger) or 
“passive-adaptive” (those who have become accustomed to their CD) responses 
described by Ciacci et al., (2002).   
The CD-FAB shows strong psychometric properties with high Cronbach’s alphas 
for all subscales (>.7) and good predictive validity. High inter-factor correlations and 
similar relationships with the validation measures indicate that the three factors are 
not independent but the scree plot and Eigenvalues indicated a three-factor solution 
that was supported by a CFA.  The CD-FAB had excellent test-re test reliability over 4 
weeks. This may indicate that CD food attitudes and behaviours are a stable trait, 
supporting previous literature highlighting this issue (Sverker et al., 2005). 
Additionally, the CD-FAB has good discriminant validity; it is able to identify subtypes 
of individuals with CD and shows no correlation with the CD-QoL Treatment 
subscale. The direction and magnitude of the correlations between the CD-FAB and 
the FNS and Anxiety subscale of the DASS-21 indicate good convergent validity and 
moderate correlations with the FNS and Anxiety subscales indicate that the CD-FAB 
is measuring a construct similar to, but unique from food neophobia and anxiety.  
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A strength of this study lies in the use of focus groups and participant feedback 
to create the CD-FAB. This information, alongside a priori themes, including the 
framework developed in Chapter Two, was used to make these items relevant to 
participant experiences. Furthermore, constructs identified by respondents as 
relevant to their experience, related to social settings, gastrointestinal symptoms 
and eating behaviours are measured for the first time by the CD-FAB. Pertinent 
examples of this are that eating at social events is less enjoyable after a CD diagnosis 
as the GFD can lead to feelings of embarrassment, isolation and a fear of 
gastrointestinal symptoms and for some, this fear of symptoms and anxiety around 
food may lead to disordered eating attitudes and behaviours (Chapter Four). 
Despite the strengths of the current study, future research needs to examine 
long-term changes in CD-FAB scores over time, particularly during the first year of 
diagnosis when the GFD is being initiated, to explore adaptation to CD and the GFD, 
and the stability of self-management behaviours. In addition, although we included a 
broad range of individuals with self-reported biopsy proven CD, it is not clear how 
these results will generalise to those with an objective biopsy confirmed diagnosis. 
Furthermore, participants in the developmental stages of the CD-FAB were 
predominantly female. This is representative of the CD population, as diagnosis is 
two times more common in females than in males (West et al., 2014); however 
further validation of the CD-FAB is needed in males with CD  (Ciacci et al., 2009). 
Finally, expert review was not used to assess content validity, but the involvement of 
service users and individuals with CD in generating the items and providing feedback 
on the overall CD-FAB provides evidence for content validity. Future research should 
  
140 
 
consult with healthcare professionals working alongside individuals with CD, to fully 
assess the content validity of the CD-FAB. 
These limitations do not detract from the clinical utility of the CD-FAB for 
assessing those with disordered eating attitudes and behaviours related to a CD 
diagnosis. The instrument may be used as an outcome measure in clinical research, 
to evaluate the effectiveness of interventions on eating patterns, and enables eating 
behaviours to be evaluated in clinical practice to identify people requiring additional 
support. This will allow a broader understanding of the impact of a CD diagnosis on 
eating attitudes and behaviours. Given the potential health implications of these 
attitudes and behaviours, future research should focus on the psychological and 
physical consequences of high CD-FAB scores. Furthermore, there is a need to 
establish the responsiveness of the questionnaire to detect the minimal important 
change and establish clinical cut-off points by calculating receiver operating 
characteristics curves in larger samples before recommending its use in clinical 
settings. Further guidance regarding the interpretation of CD-FAB scores (e.g. 
referral to dietician, clinical psychologist or specialist eating disorders service) can be 
given following the identification of population norms and health implications.  
In summary, the CD-FAB is a brief, self-report questionnaire that shows good 
reliability and validity in measuring disordered eating attitudes and behaviours in CD. 
The measure may be a useful tool for clinical practice to help understand eating 
attitudes and behaviours in adults with CD.  
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CHAPTER SIX: FACTORS ASSOCIATED WITH SCORES ON THE CD FOOD ATTITUDES 
AND BEHAVIOURS SCALE  
6.0. Chapter Rationale  
Chapter Five described the development and validation of the CD Food Attitudes 
and Behaviours scale (CD-FAB), a tool designed to understand disordered eating in 
the context of CD that is not detected by current tools of disordered eating. The CD-
FAB showed strong reliability and validity; however, at present, it is not clear how 
scores on the CD-FAB are related to physical and psychosocial wellbeing.  
The aim of this chapter was to explore the associations between CD-FAB scores 
and physical and psychosocial outcomes to gain a greater understanding of the 
influence of disordered eating attitudes and behaviours in CD. This chapter used 
cross-sectional survey techniques to explore the correlates of CD-FAB scores. In 
addition, this chapter aimed to replicate the results of Chapter Three in a second 
sample of individuals with CD.  
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6.1. Introduction 
The Theoretical Model of Disordered Eating in Gastrointestinal Disease, 
developed in Chapter Two, proposes two pathways that explain the development of 
disordered eating in gastrointestinal disease. The first pathway describes individuals 
who struggle with weight changes experienced after diagnosis. In terms of CD, 
individuals may associate weight change (commonly weight gain) with the GFD, and 
aim to reduce their weight gain through poor dietary self-management (Leffler et al., 
2007). The second pathway describes those who experience extreme anxiety around 
unfamiliar foods and overestimate the negative consequences associated with their 
condition. These individuals may fear food prepared outside of their control, and 
cope with this by restricting food intake (Chapter Four). 
The EAT-26 and the BES are effective in identifying disordered eating attitudes 
and behaviours in CD that are associated with psychological distress, dietary 
management and gastrointestinal symptoms (Arigo et al., 2012; Karwautz et al., 
2008; Chapter Three). However, qualitative studies suggest that these tools do not 
identify all disordered eating attitudes and behaviours found in CD (Chapter Four). 
Some individuals with CD describe fears when eating outside the home, difficulties 
trusting others to prepare their food and difficulties not having control over the food 
preparation process, and cope with this by limiting their food intake (Chapter Four). 
Concern and vigilance around food may result in a unique type of disordered eating 
specific to those with CD and are similar to the beliefs and behaviours described in 
the second pathway of the Theoretical Model of Disordered Eating in 
Gastrointestinal Disease. There is a need to understand these types of disordered 
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eating in CD and explore whether this may result in CD-specific disordered eating 
attitudes and beliefs.  
The CD Food Attitudes and Behaviours scale (CD-FAB; Chapter Five) was 
developed to screen for these disordered eating attitudes and behaviours related to 
food concerns and concern around cross-contamination. Those who score high on 
the CD-FAB may display a hypervigilance around food and limit food intake, not for 
weight loss but because they believe that food is dangerous to their health and may 
encourage gastrointestinal symptoms (Chapter Four). Vigilance around food and 
limiting food intake when there is a high risk of gluten cross-contamination is 
essential for individuals with CD (Collin et al., 2004) but hypervigilance can become 
maladaptive and may negatively impact physical and psychosocial well-being 
(Pilowsky, 1978).  
Negative physical effects may occur in individuals who score high on the CD-FAB, 
as restricted diets tend to involve the exclusion of important foods groups, such as 
bread and pasta, which may result in a calorie deficit or a poor nutritional profile 
(Misra et al., 2006). In addition, the planning and isolation that may result from this 
hyper-vigilance around food may be associated with a limited social life, increased 
anxiety, depression and impaired quality of life (See et al., 2015; Chapter Four). 
Control around food may lead some individuals to limit food intake in certain 
settings rather than eating food that has been prepared by others (Chapter Four). As 
well as examining the physical and psychosocial correlates of the CD-FAB, we hoped 
to extend the discriminative validity of the CD-FAB. For this tool to be clinically 
useful, it needs to differ from current disordered eating tools. High scores on the CD-
FAB may describe behaviours, such as food preoccupation and dietary restriction, so 
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some overlap with other measures of disordered eating such as the EAT-26 may be 
expected. However, the CD-FAB also identifies concerns around food and cross-
contamination that are specific to CD; although some overlap in disordered eating 
tools may be expected, the CD-FAB should identify a pattern of behaviour that is 
distinct from established tools.  
In the only evaluation of the Theoretical Model of Disordered Eating in 
Gastrointestinal Disease (Chapter Three) a combination of CD-specific factors 
(dietary management and gastrointestinal symptoms) and non-specific factors 
(psychological distress) explained a significant proportion of disordered eating scores 
in CD. A subsequent cluster analysis produced three typologies of disordered eating 
in CD, a “low risk” group, a “critical” group and a “high distress” group. The “critical 
group” contained individuals who had difficulty managing their GFD, greater current 
gastrointestinal symptoms and symptoms of Anorexia and Bulimia Nervosa, as 
assessed by the Eating Attitudes Test (EAT-26; Garner, Olmsted, Bohr & Garfinkel, 
1992). The “high distress” group contained individuals who scored high on binge 
eating measures, as assessed by the Binge Eating scale (BES; Gormally, Black, Daston 
& Rardin, 1982), and psychological distress. The data from Chapter Three provides 
some support for the notion of poor dietary management described in pathway one 
of the Theoretical Model of Disordered Eating in Gastrointestinal Disease. Although a 
significant step forward in the CD and disordered eating literature, Chapter Three 
used online recruitment strategies from online support forums, potentially resulting 
in sample bias.  In addition, these findings drop in clinical utility unless they can be 
observed in a second, independent study.  
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The present study examines the physical and psychosocial correlates of CD-FAB 
scores. Furthermore, we hoped to further examine the discriminative validity of the 
CD-FAB by comparing it to the EAT-26 and the BES. Given the limitations of previous 
research, an additional aim was to find out whether the findings of Chapter Three 
would replicate in a new sample of individuals with CD recruited without the use of 
the Internet.  We anticipated that high CD-FAB scores would be associated with 
impaired physical and psychosocial well-being and the CD-FAB will show modest 
correlations with the EAT-26 but no association with the BES.  
6.2. Method 
The methods used were similar to those described in Chapter Three.  Briefly, this 
cross-sectional survey was conducted between January and February 2016. Females 
living in the United Kingdom aged between 18 and 69 years and who self-reported a 
physician-confirmed diagnosis of CD were eligible to participate. Participants were 
excluded if 1) they reported having a dietary-controlled condition in addition to CD 
(e.g. cystic fibrosis, type one diabetes); 2) they did not have a self-reported biopsy 
confirmed diagnosis for their condition; and 3) if they had any other food allergies.    
Chapter Three recruited individuals from online support forums whereas in the 
present study, participants were recruited from the University of Birmingham 
campus. This method was selected to avoid the potential biases of the previous 
study, related to online recruitment. Adverts were distributed across the University 
of Birmingham campus food outlets. Participants were asked to contact other 
individuals with CD who may be interested in taking part in the research, by 
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distributing the participant information sheet. Interested individuals were directed 
to an online survey, hosted by Qualtrics, to complete the questionnaires. 
6.2.1. Measures 
All of the measures and procedures used in this study are described in Chapter 
Three. Participants completed the Depression Anxiety Stress 21 scale (DASS-21; 
Lovibond & Lovibond, 1995), the Food Neophobia Scale (FNS; Pliner & Hobden, 
1992), the EAT-26 (Garner, Olmsted, Bohr & Garfinkel, 1992) and the BES (Gormally, 
Black, Daston & Rardin, 1982). Gastrointestinal symptoms were assessed using the 
Identity subscale of the Illness Perception Questionnaire Revised (IPQ-R; Moss-
Morris et al., 2002), dietary-management was assessed on a 5-point Likert scale, in 
response to the question “In general, how strictly do you maintain a gluten free 
diet?” ranging from 1) ‘All of the time’; 2) ‘Most of the time’; 3) ‘Some of the time’; 4) 
‘Now and then’; 5) ‘Not at all’ (Ford, Howard & Oyebode, 2012). The only exceptions 
were the addition of the newly developed CD-FAB (Chapter Five) and the CD Quality 
of Life scale (Dorn et al., 2010), which are detailed below. 
The CD Food Attitudes and Behaviour scale(CD-FAB; Chapter Five): The CD-FAB is 
a CD-specific measure that assesses beliefs and concerns around food and food 
environments. It consists of 11 items, scored on a 7-point Likert scale. The CD-FAB 
has good reliability and validity (Chapter Five) and is formed of three subscales: Food 
Attitudes, Fear Response and Adaptive Response.  
The CD Quality of Life Scale (CD-QoL; Dorn et al., 2010): The CD-QoL assesses 
quality of life across four clinically relevant subscales (CD-related limitations, 
dysphoria, health concerns and inadequate treatment). The scale consists of 20 
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items, with higher scores indicating greater quality of life (maximum score is 100). 
There is no defined clinical cut-off for this scale. 
6.2.2. Ethical Approval 
Ethical approval was granted by the Psychology Research Ethics Committee, 
University of Birmingham.  
6.2.3. Statistical Analysis 
Data were analysed using the Statistics Package for the Social Sciences (SPSS) 
version 22.0. Cronbach’s alphas were calculated for all scales and all measures 
exceeded the acceptable minimum of 0.7 (DeVelis, 2003). Missing data for each of 
the items ranged from 2.4–3.1% and was missing at random. Participants with 
missing data were removed from the analysis. 
A tertiary split was applied to the CD-FAB responses received in this dataset, to 
divide individuals into high, medium and low scorers based on the 33rd and 66th 
percentiles. By using a tertiary split, we were able to explore differences in outcomes 
between high and low CD-FAB scores whilst avoiding noise within the data from 
participants that scored close to the high/low cut-off. Analysis of variance was used 
to compare physical and psychosocial outcomes across the three groups and t-tests 
were used to compare the means across the low and high scorers on the CD-FAB. 
To replicate the results of Chapter Three, independent t-tests were used to 
compare the studies in terms of participant characteristics. The regression analyses 
used in Chapter Three were repeated. To test the stability of the cluster analysis, 
Blashfield and Macintyre’s (1980) method was used. This procedure performs the 
cluster analysis using the same rules and parameters from the original cluster 
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analysis (Chapter Three) and applies these rules to the new data set. The results 
from the original sample are used to classify the data in the current sample. The 
cluster centres from the second sample are then compared to the original sample 
and the Cohen’s kappa coefficient is calculated to measure the agreement between 
the clusters.  
6.3. Results 
6.3.1. Participant Characteristics 
The entire sample consisted of 166 women, with a self-reported biopsy diagnosis 
of CD (see Table One). The mean age was 30.1 years (SD=11.0; range =18-68), and 
participants had a mean of 6.1 years with a CD diagnosis (SD=8.2; range =2-61). 
Participants in the current sample were younger (p<.001) and had CD for fewer years 
(p=.03) when compared to the original study sample (Chapter Three).  
Inspection of participant contact details revealed that 7% of participants who 
participated in Study 1 also participated in the present study. These individuals were 
excluded from the analysis (n=10).  
6.3.2. Phase One: Impact of CD-FAB Scores 
Demographic, psychosocial and physical outcomes were compared across CD-
FAB scores using an ANOVA (see Table One).  
High scorers had greater psychological distress, fewer years with CD and a more 
impaired quality of life across a variety of domains (p < 0.003). The low scorers 
scored in the “normal” ranges for DASS-21, whereas the medium to high scorers 
scored within the “mild” and “moderate” ranges (Lovibond & Lovibond, 1995). 
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Compared to the low scorers, the medium scorers had fewer years with diagnosis, 
increased psychological distress, a greater fear of trying new foods and impaired 
quality of life. No significant differences were found between the medium and high 
scorers, and no differences were found across the physical outcomes 
(gastrointestinal symptoms, dietary management). Notably, although the 
relationship between EAT-26 scores and CD-FAB scores was not significant, the trend 
was approaching significance with higher CD-FAB scorers having higher EAT-26 
scores (F=2.8, p=. 006) suggesting that a similar but unique construct in being 
assessed by the CD-FAB, whereas BES scores did not differ according to CD-FAB 
scores (F=.75, p=. 48).  
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Table 1 
Demographic, psychosocial and Physical Outcomes Using the Tertiary Split on the 
CD-FAB. Data are presented as means.  
*p=.003 for ANOVA across all three groups; ap=.003 for T-Test across low and 
medium scorers; bp=.003 for T-Test across low and high CD-FAB scorers.  
  
 Low Scorers Medium 
Scorers 
High Scorers F Statistic  
Demographic Outcomes 
Age (years) 32.3 29.0 29.0  1.75 
BMI 22.6 22.7 21.9 .29 
Years with CD 8.5 5.0a 5.0b 3.69* 
Psychosocial Outcomes 
Depression 8.6 13.5a  13.5b  3.81* 
Anxiety 6.6  10.1a  11.6b  4.34* 
Stress 11.6 16.9a  15.8 b  4.13* 
Total DASS-21 26.7 40.5a 40.9b 5.3* 
EAT-26 9.1 13.9  13.9 2.80  
BES 10.8 11.9 12.8 .75 
Food 
Neophobia 
27.4 31.3a 33.9b 10.7* 
Total Quality of 
Life 
71.1 57.9a 53.6 b 16.03* 
Limitations 31.4 24.4a 21.9b 17.32* 
Health 17.1 13.6a 12.4 b 10.92* 
Treatment 5.5 5.5 5.5 .032 
Dysphoria 17.1 14.6a 14.2 b 7.12* 
Physical Outcomes 
GI Symptoms 1.6 1.8 1.8 .27 
Dietary 
Management 
1.6 1.7 1.6 .65 
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6.3.3. Phase Two: The Prevalence and Characteristics Associated with Disordered 
Eating in Coeliac Disease; Replication of Chapter Three 
6.3.4. Prevalence of Disordered Eating in Coeliac Disease  
Table Two reports the proportion of participants scoring above the clinical cut-
off for the EAT-26 and the BES and the mean total scores for the current study and 
the original study reported in Chapter Three for comparison. No difference in 
disordered eating scores across the two samples was found (p>.05), however, the 
distributions of EAT-26 and BES scores were positively skewed whereas the original 
study described a normal distribution. The decision was made to continue with the 
parametric analyses conducted in the original study, as the distribution of the 
residual errors was normal.  
Table 2 
Mean Scores and Percentage scoring above the clinical cut-offs for measures of 
disordered eating for the initial and current samples 
Measure Current Sample  Initial Sample  T-Test 
Eating Attitudes Test (>20) 12.3 (17.7%) 11.1 (15.7%) -.91 
Binge Eating Scale (>17) 11.8 (21.6%) 11.2 (19.4%) -.47 
The number in brackets represents the percentage of participants scoring above the 
pre-determined clinical cut-offs for the BES and EAT-26.  
6.3.5. Factors Associated with EAT-26 and BES scores  
Table Three shows the results for the hierarchical regressions for both EAT-26 
and BES scores from the current study. When predicting EAT-26 score, collectively 
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this model accounted for 43.5% of the variance in EAT-26 scores (F=(8,155)=14.1, 
p<.001; see Table Three) with dietary-management having a significant regression 
weight. Based on the examination of ß weights, gastrointestinal symptoms and 
dietary management had the major contribution to the model.  
When predicting BES score, collectively the disease non-specific factors model 
accounted for 45.5% of the variance in BES scores (F=(6,147)=19.6, p<.001; see Table 
Three) with age, depression and stress having significant regression weights. The 
addition of disease-specific factors only explained an additional 3% of the variance, 
with no significant change in R Square.
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Table 3 
Disease specific and Non-Specific Factors in Predicting EAT-26 and BES Scores in CD 
 Eating Attitudes Test Binge Eating Scale 
Predictors B B R2 F B B R2 F 
Non-specific 
Factors 
       
Age -.04 -.04   -.23 -.29*   
Body Mass Index .04 .02   .30 .19*   
Years with 
Condition 
.01 .01   .09 .09   
Depression .37 .16   .53 .35*   
Anxiety .74 .24*   -.18 -.11   
Stress .51 .22 .34 12.68* .50 .32* .46 19.61* 
Disease Specific 
Factors 
       
Age -.03 -.03   -.22 -.28*  
Body Mass Index .01 .02   .29 .18*  
Years with 
Condition 
.02 .02   .10 .11  
Depression .39 .17   .54 .36*  
Anxiety .56 .21   -.24 -.14  
Stress .50 .21   .49 .31*  
Gastrointestinal 
Symptoms 
1.55 1.8*   .44 .09   
Dietary-
management 
3.39 .23* .44 14.13* 1.41 .14 .49 16.35* 
*  Significance at p < 0.008. The significance of the F value refers to the F associated 
with each step. 
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6.3.6. Cluster Analysis 
Conducting a replication analysis using Blashfied and Macintyres (1980) method 
produced clusters that were similar to the original cluster analysis reported in 
Chapter Three. Cohen’s kappa coefficient was .42 (p<.001), suggesting moderate 
agreement between the current and the original cluster analysis.  
6.4. Discussion 
Individuals with CD frequently report concerns around food and cross-
contamination of food products which may lead to atypical food attitudes and 
behaviours (Chapter Two; Chapter Four). Recently, the CD-FAB has been created to 
assess these food attitudes and behaviours in CD (Chapter Five). The primary goal of 
this chapter was to explore the correlates of CD related food attitudes and beliefs, as 
assessed by the CD-FAB. Our second aim was to replicate the results of Chapter 
Three in a new sample of individuals with CD. 
This study used the CD-QoL, DASS-21 and measures of gastrointestinal symptoms 
and GFD management to explore the physical and psychosocial correlates of CD-FAB 
scores. Quality of life was affected across a variety of domains in individuals with 
high CD-FAB scores. Individuals above the 66th percentile of CD-FAB scores felt more 
socially limited by their CD, felt more concerned about their CD and were more 
concerned about the health consequences of CD compared to those below the 33rd 
percentile. The increased concern around food may result from concerns around 
one’s health and a fear of not managing the GFD. In addition, Hauser et al. (2010) 
found that anxiety was lower in individuals who lived alone, suggesting that certain 
social environments, such as eating with other people, may be perceived as a burden 
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for those with CD, which may provide one explanation for the perceived social 
limitations in the CD-FAB group with the highest scores. 
In addition, high CD-FAB scorers were more distressed, with individuals scoring in 
the “mild” and “moderate” severity categories on the DASS-21 (Lovibond & 
Lovibond, 1995) and had fewer years with CD. Those scoring low on the CD-FAB 
were in the “normal” ranges for the DASS-21. These findings are consistent with 
research suggesting that anxiety is greater in the first few years following a CD 
diagnosis when an individual is adjusting to the GFD (Addolorato et al., 2001). High 
scores on the CD-FAB indicate impaired psychosocial well-being but the interactions 
between these factors and years with a CD diagnosis are not clear.  
Self-reported gastrointestinal symptoms and GFD management were used to 
assess the physical impact of high CD-FAB scores. The number of gastrointestinal 
symptoms did not vary based on CD-FAB score and neither did self-reported GFD 
management. This is unsurprising, as according to the Theoretical Model of 
Disordered Eating in Gastrointestinal Disease, individuals with high CD-FAB scores 
should show strict management of the GFD, resulting in fewer gastrointestinal 
symptoms (Chapter Four).  
This research has added to the discriminative validity of the CD-FAB and suggests 
this tool does differ from established measures of disordered eating (the EAT-26 and 
BES). There was a weak but positive association between the CD-FAB and EAT-26, 
suggesting that the CD-FAB is measuring a construct similar to, but unique from 
disordered eating as assessed by the EAT-26. The EAT-26 contains items that assess a 
preoccupation around food and dietary restriction, so the small overlap between the 
CD-FAB and the EAT-26 makes theoretical sense. The CD-FAB was not associated 
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with BES scores, which contains items regarding over eating and a lack of control 
around food intake, highlighting the discriminant validity between these two 
questionnaires. Furthermore, when the CD-FAB was used as an outcome variable, 
the predictors differed from those that were important in predicting BES and EAT-26 
scores. Increased food neophobia was an important correlate of greater CD-FAB 
scores. This implies that those who score high on the CD-FAB are fearful around new 
foods; this reflects some of the beliefs presented in the Theoretical Model of 
Disordered Eating in Gastrointestinal Disease (Chapter Two). These results are also in 
line with the qualitative study presented in Chapter Four, which suggests that 
individuals who are fearful of cross contamination will restrict their food intake in 
certain environments to manage these fears. Further research should focus on how 
these concerns around food affect actual eating behaviours.  
In line with previous research, we found that 11-12% of individuals with CD 
scored above the clinical cut-offs for disordered eating according to the EAT-26 and 
BES (Chapter Three; Arigo, Anskis & Smyth 2012; Karwautz et al., 2008). We 
previously observed that factors related to the CD diagnosis (gastrointestinal 
symptoms and dietary management) were associated with the development of 
anorexic and bulimic attitudes and behaviours, whereas the nonspecific burden of a 
chronic health condition was associated with the development of binge eating 
behaviours in CD (Chapter Three). In line with these findings, we found that 
nonspecific factors were associated with the presence of binge eating behaviours, 
and gastrointestinal symptoms and dietary management were associated with 
anorexic and bulimic attitudes and behaviours. In addition, we successfully 
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replicated the cluster analysis reported in Chapter Three, in a new sample of 
individuals with CD.  
6.4.1. Limitations and Future Research 
The limitations reported in the original study (Chapter Three) are relevant to this 
study. Because of the cross-sectional nature of this design, we cannot determine the 
direction of causality between disordered eating patterns and other variables 
assessed. As in the original study, we relied on a self-reported biopsy confirmed 
diagnosis of CD. Future research should replicate this findings in a physician-
reported biopsy-confirmed sample of individuals with CD and should focus on using 
more objective measures of dietary-management such as anti-tissue 
transglutaminase assays, questionnaires designed to assess gluten-free dietary 
management (Leffler et al., 2009) and multi-modal approaches, including self-report 
and dietician assessment. The use of CD serology can enhance this type of research 
by assessing whether dietary management is improving or worsening over time, in 
combination with self-reported dietary management, psychosocial outcomes and 
disordered eating measures (Ho, 2012). However, what is striking and consistent 
across these two studies is the differing predictors for both EAT-26 scores and BES 
scores.  
High scores on the CD-FAB were associated with self-reported impaired quality of 
life and increased psychosocial impairment, indicating that individuals with 
increased CD-FAB scores are struggling with their CD. Although the physical impact 
of CD-FAB scores was assessed through dietary management and gastrointestinal 
symptoms, the physical outcome variables were limited. Impaired physical 
  
158 
 
consequences may result from the restrictive diets employed by those with high CD-
FAB scores; for example, these individuals may exclude certain types of food, 
preferring to only eat those foods that are deemed as safe (Chapter Four). This type 
of eating pattern may be associated with a poor nutritional profile, potentially 
resulting in anaemia and osteoporosis (Misra et al., 2006). Future research should 
examine these correlates in relation to the CD-FAB.  
6.4.2. Clinical Implications  
The observation that individuals with high CD-FAB scores have an impaired self-
reported quality of life and psychosocial well-being suggests that the use of the CD-
FAB is valuable in this population. More specifically, the observation that years with 
diagnosis, food neophobia and reported social limitations were associated with CD-
FAB scores indicates that individuals reporting limited dietary choices and those who 
are newly diagnosed may benefit from having dietician support, including 
assessment using the CD-FAB, to explore food attitudes and behaviours in relation to 
their CD diagnosis.  
The replication of the cluster analysis demonstrates consistent subtypes of 
eating pathology in individuals with CD. A focus on subgroups of people may allow a 
more efficient way of targeting healthcare and health resources; assessment and 
intervention around eating attitudes and behaviours within the context of CD may 
be essential in supporting psychosocial health. The replication of the cluster analysis 
indicates that there are three groups of individuals with CD: the low risk group who 
manage their CD well and have adaptive eating patterns, the high distress group who 
have problems with psychological distress and binge eating and the critical group 
  
159 
 
who score high on measures of anorexic and bulimic attitudes, and describe more 
difficulties in managing their GFD. Additionally, the CD-FAB appears to identify a 
group of individuals who experience concern around food. Although the traditional 
eating disorder measures such as the EAT-26 and the BES are useful in identifying 
disordered eating in CD, the CD-FAB may be a useful tool to understand eating 
concerns in the context of CD. Clinically, the CD-FAB may be used by dieticians to aid 
in the understanding of the beliefs around food and how these are related to eating 
behaviours in CD.   
6.5. Conclusions 
Research into the relationship between CD management and food attitudes and 
behaviours is becoming increasingly important. The results of the present study 
indicate that negative food attitudes and behaviours specifically related to CD are 
associated with impaired quality of life and psychosocial well-being. Future research 
should focus on understanding this sub-group of individuals with CD and look at 
ways to identify them and provide support. 
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CHAPTER SEVEN: BEHAVIOURAL CORRELATES OF THE COELIAC DISEASE FOOD 
ATTITUDES AND BEHAVIOURS QUESTIONNAIRE 
7.0. Chapter Rationale  
Chapter Six assessed the psychosocial and physical correlates of the CD-FAB. The 
results from Chapter Six and the qualitative results from Chapter Four provide 
support for the Theoretical Model of Disordered Eating in Gastrointestinal Disease. 
However, both of these studies were based on self-report measures of disordered 
eating. At present, it is not clear whether CD-FAB scores are related to actual food 
intake.  
The aim of this chapter, therefore, was to explore the associations between CD-
FAB scores, food intake and the processing of food-related information to explore 
the behavioural validity of the CD-FAB. Secondly, we hoped to replicate our previous 
findings by exploring the associations between the CD-FAB and psychosocial 
outcomes, using self-report questionnaires in a biopsy-confirmed sample of 
individuals with CD.  This chapter utilised a laboratory-based experiment in order to 
evaluate the Theoretical Model of Disordered Eating in Gastrointestinal Disease. 
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7.1. Introduction 
To avoid the consumption of gluten, individuals with CD need to be vigilant 
around the food they consume (Remes-Troche et al., 2006). However, according to 
the Theoretical Model of Disordered Eating in Gastrointestinal Disease, for some 
individuals with CD, hypervigilance can create concerns around food that are 
associated with disordered eating attitudes and behaviours (Chapter Four, Chapter 
Six). The Coeliac Disease Food Attitudes and Behaviours scale (CD-FAB; Chapter Five) 
has been designed to screen for these food concerns that contribute to disordered 
eating attitudes and behaviours. 
Individuals with CD, who report increased vigilance and concern around food, 
discuss these concerns in combination with dietary restriction (Chapter Four). These 
concerns and dietary-restriction are reported in unfamiliar settings or when an 
unknown individual is preparing food, in an attempt to maintain strict adherence to 
the GFD and prevent gastrointestinal symptoms (Chapter Four). High scores on the 
CD-FAB have been associated with a fear of trying new foods and an impaired quality 
of life, particularly in social domains (Chapter Six). The Theoretical Model of 
Disordered Eating in Gastrointestinal Disease assumed that vigilance around food 
might also contribute to disordered eating attitudes and behaviours in CD. Biased 
information processing of food may reinforce concerns about food content and 
preparation, resulting in concerns which contribute to disordered eating attitudes 
and behaviours.  
The measurement of eating behaviours and vigilance to food in CD has come 
from self-report measures. These self-report measures assume that individuals can 
accurately assess their own eating behaviours and tell us little about actual food 
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consumption and the behavioural validity of the CD-FAB. Additionally, the CD-FAB 
has only been validated in those with a self-reported diagnosis of CD (Chapter Six); 
there is need for replication in a sample with a biopsy-confirmed diagnosis of CD to 
extend the validity of the CD-FAB in this population. One way to address the 
limitations surrounding self-report measures is to measure food intake and food 
vigilance behaviourally. To examine the behavioural correlates of the CD-FAB we 
used a taste test to assess food intake and the dot-probe task to assess attentional 
bias towards food images.  
Taste-test paradigms have been widely used to examine food consumption in the 
laboratory (Healtherton, Herman & Polivy, 1991; Polivy & Herman 1991). Vartanian 
at el. (2013) described a modified version of the taste test paradigm, whereby 
participants are provided with three types of cookie and are asked to rate each of 
the cookies, taking a sip of water between each tasting. Participants were left alone, 
with the cookies, for ten minutes. Participants were told to help themselves to more 
cookies whilst waiting for the experimenter to return, as any left over cookies will be 
thrown away, to encourage consumption of the cookies.  Although the task is 
presented as a taste test, the aim is to measure food consumption. This task has 
been used to assess the influence of social models and portion sizes on food intake 
but has not been used in individuals with CD (Robinson et al., 2016; Vartanian et al., 
2013). Using this procedure in CD allows us to test food consumption and dietary 
restriction in an unfamiliar environment with unknown individuals (the researchers) 
presenting the food, creating further anxiety.  
To examine relationships between the CD-FAB and vigilance to food, the dot-
probe task was used (MacLeod, Mathews & Tata, 1986). Behaviourally, this vigilance 
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towards food is defined by the response to images of the threat stimulus, in the dot-
probe task. In a typical dot-probe task, participants are shown a pair of stimuli (one 
threatening, one neutral); these stimuli appear to the left and right of a fixation 
cross. The stimuli will disappear and a dot will either replace the threatening 
stimulus (congruent trials) or the neutral stimulus (incongruent trials). Attentional 
bias is calculated by subtracting the consistent trial reaction times from the 
inconsistent trial reaction times. Anxious individuals will respond faster to congruent 
trials when compared to incongruent trials; this is interpreted as a bias towards 
threatening information (MacLeod, Mathews & Tata, 1986). Visual attention biases 
have frequently been used to measure threat towards stimuli in phobias and eating 
disorders, but this task has not been used in CD (Cisler & Koster, 2010). 
As anxiety, in general, is the primary emotion related to food attitudes and 
concerns we anticipated that greater CD-FAB scores would be associated with a 
greater attentional bias towards threatening stimuli (i.e. gluten-containing food 
images). Based on the Theoretical Model of Disordered Eating in Gastrointestinal 
Disease, we further anticipated that greater CD-FAB scores would be associated with 
less food consumption. 
Aims 
In this chapter, we report the first behavioural, laboratory-based study in CD. 
Given the limitations of previous cross-sectional studies (Chapters Four, Six), this 
study explored the relationships between CD-FAB scores, attentional bias towards 
gluten-free and gluten-containing foods and food consumption in those with biopsy 
confirmed CD.  
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7.2. Methods 
Adults with CD living in the United Kingdom, ages between 18 and 69 years, with 
a biopsy-confirmed diagnosis of CD (confirmed via doctor’s letter) were eligible to 
take part in the study. Forty individuals were recruited using posters placed in the 
University of Birmingham food outlets and through snowballing methods, including 
social media. The study was advertised as “Individual Differences and Dietary 
Preferences in Coeliac Disease: A Taste Test” and the recruitment methods asked 
individuals to not eat for three hours prior to the study, to ensure a similar level of 
hunger across participants. The taste test was used to ensure participants were not 
aware that the aim was to assess food intake. 
All individuals were required to bring confirmation of their biopsy-confirmed CD 
diagnosis, in the form of a doctor’s letter. All participants had normal or corrected-
to-normal vision. Participants were excluded if 1) they reported having a dietary-
controlled condition other than CD (e.g. cystic fibrosis, type one diabetes); 2) they 
did not have evidence for a biopsy confirmed diagnosis for their condition (doctor’s 
letter or gluten-free prescription); and 3) if they had any other food allergies. No 
participants met the exclusion criteria.     
7.2.1. Measures 
The questionnaire measures used in this study are fully described in Chapter Six. 
Participants completed the Depression-Anxiety-Stress-21 scale (DASS-21; Lovibond & 
Lovibond, 1995), the Illness Perception Questionnaire-Revised (IPQ-R; Moss-Morris 
et al., 2002), the Food Neophobia Scale (FNS; Pliner & Hobden, 1992), the Eating 
Attitudes Test-26 (EAT-26; Garner, Olmsted, Bohr & Garfinkel, 1992), the Binge 
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Eating Scale (BES; Gormally, Black, Daston & Rardin, 1982), the Coeliac Disease Food 
Attitudes and Behaviours scale (CD-FAB; Chapter Five), the Coeliac Disease Quality of 
Life scale (Dorn et al., 2010). In addition, a series of visual analogue scales (VAS) 
were completed throughout the procedure (see below). Two open-ended questions, 
asking participants what they had eaten and drunk that day and when (based on a 
similar measure used by Thomas et al., 2014), were used to check individuals had 
not eaten for three hours prior to attending the laboratory. 
Visual Analogue Scales: A series of five VAS were completed at three points: prior 
to the experimental procedure, prior to the food taste test and on completion of the 
food taste test. These assessed current nausea, hunger, fullness, happiness and 
sadness (e.g. “Please rate how nauseous you feel at this moment”) and allowed us to 
control for these factors that influence food intake throughout the procedure. 
Participants were asked to mark the VAS on a 10cm line, describing how they felt 
with “Not at all” and “Extremely” as the anchors.  
Dot-Probe Task: The dot-probe task was presented on a computer using E-Prime 
2.0. One-hundred and twenty images, 30 gluten-free foods, 30 gluten-containing 
foods and 60 control stimuli matched for shape and colour were used; each image 
was presented twice. Gluten-containing and gluten-free images were matched for 
calorie, sugar and fat content. In order to make foods easily identifiable, all gluten-
free images were of foods that are naturally gluten-free (e.g. fruit, vegetables, nuts) 
and gluten-containing images consisted of typical gluten-containing foods (e.g. 
bread, cake, pasta; see Figure One). 
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Figure 1: Examples of food and control stimuli in the dot-probe task. A = control 
image for image B and gluten-containing image; C = control image for image D and 
gluten-free image 
Each trial began with the presentation of a fixation cross for 500 milliseconds 
(ms). Following this, a food stimulus (gluten-containing or gluten-free) and a control 
stimulus would appear either side (left/right) of the fixation cross for 500ms. A dot-
probe then replaced one of the stimuli. Participants were required to detect the 
location of the dot-probe as quickly and accurately as possible. The next trial would 
begin once participants had made their response. Participants completed a series of 
10 practice trials, followed by 1 block of experimental trials. In total, the dot-probe 
task consisted of 180 experimental trials. All trials were randomly ordered and the 
position of the probe was counterbalanced for side of presentation (left and right) 
and for image type (food image and control image) to control for order effects.  
Ten healthy controls and 10 individuals with CD piloted the dot-probe task by 
rating their familiarity with the food images and whether the food images were 
A B 
C D 
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gluten-free or gluten containing. The control participants also completed the dot-
probe task to ensure there was no difference between gluten-free and gluten-
containing attentional biases.  
Food Taste Task: Participants were served four foods to taste and rate on 
familiarity, palatability and previous consumption (e.g. “Have you seen this food item 
before?” rated on a yes/no scale), to control for factors that may influence food 
intake in CD (Four). Likability, sweetness, saltiness and bitterness (e.g. “How salty 
would you rate this food item?”) were rated on a 10cm VAS with “Extremely” and 
“Not at all” as the anchors. These items were used to maintain the cover story of the 
taste test and were not used in the analysis.  
The food taste task contained four gluten-free food types: Mrs Crimbles cheese 
bites (60g, 263.4 kcals), Pombears (30g, 190 kcals), Schar custard creams (125g, 625 
kcals) and Dairy Milk chocolate buttons (80g, 420 kcals). This combination of foods 
provided a selection of sweet and salty gluten-free foods in snack-sized pieces, 
making it hard to determine appropriate portion size (Herman & Polivy, 2005). This 
encouraged greater food consumption and ensured that there were a variety of food 
products for palatability. To ensure equal knowledge across participants and to 
reduce the risk of cross-contamination of gluten, the foods were presented in their 
packaging so participants could confirm the foods were gluten-free.  
The arrangement of the food was the same for all participants and individuals 
were free to eat as much food as they desired from each bowl. The foods were 
presented in four, separate glass bowls and were labelled plate one, two, three and 
four. A jug of water and a glass was provided. 
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Body Composition:  A BC-418 Tanita Body Composition Analyser was used to 
measure weight, body mass index (BMI) and body fat percentage. The lead 
researcher (RS) measured height.  
7.2.2. Procedure 
Sessions took place over lunchtime, between 12.00 and 14.00 pm. Participants 
were greeted and shown to a testing cubicle. After gaining written informed 
consent, confirming eligibility for the study and completing demographic measures, 
participants were asked to show the researcher their confirmation of CD diagnosis. 
Participants then completed a VAS to assess baseline mood and hunger.  
The researcher returned and described the dot-probe task. Individuals were sat 
approximately 50cm in front of the computer monitor and were required to place 
their left index finger on the “Z” key and their right index finger on the “M” key. 
Participants were instructed to select the “Z” key if the probe appeared on the left of 
the fixation cross and the “M” key if the probe appeared on the right of the fixation 
cross. Ten practice trials were completed, after which, the experimenter left the 
room. A second VAS was completed after completing the dot-probe task.  
On completion of the VAS, individuals were taken into a separate testing cubicle 
where the food taste test was conducted. Participants sat at a table with four glass 
bowls containing the packaged gluten-free foods (the weight of the food and 
packaging combined was recorded by the experimenter prior to the food taste task). 
Participants were presented with each food item one at a time, and were asked to 
read the ingredients and confirm the foods were gluten-free. The researcher 
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removed each food from its packaging and placed the food into its bowl (one food 
type per bowl).  
Participants tasted and rated the four foods, using the VAS scales, taking a sip of 
water between each food type. They were informed that all of the food would be 
thrown away at the end of the experiment, so after conducting the taste test they 
were informed they could eat as much food as they desired. Participants were left in 
the room for 10 minutes to complete the food taste test whilst the researcher left 
the room. The researcher then weighed and recorded the packaging of each food 
type. After 10 minutes, the researcher returned and removed the food bowls and 
the experimenter weighed the remaining food. The participant then completed the 
final VAS and questionnaire pack.  
Upon completion of the questionnaire pack, participants had their height, weight 
and body fat percentage calculated. Participants were asked what they believed the 
aims of the study to be and whether they were aware that their food intake was 
being measured. Finally, participants were provided with any of the food that they 
had not consumed in the food taste test, if desired, debriefed and thanked for their 
time.  
7.2.3. Ethical Approval 
Ethical approval was granted by the Psychology Research Ethics Committee, 
University of Birmingham.  
7.2.4. Statistical Analysis 
Data were analysed using the Statistics Package for the Social Sciences (SPSS) 
version 22.0. Due to the small sample size, effect sizes are reported throughout to 
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aid in the interpretation of results. Effects sizes were calculated for the various 
statistical tests using established effect size calculations as follows: 1) eta-squared 
(η²) for Analysis of Variance (small effect= 0.01; medium effect= 0.05; large effect= 
0.13; Cohen, 1988), and 2) Cohen’s d (d) for t-tests (small effect= 0.2; medium 
effect= 0.5; large effect= 0.8; Cohen, 1988). Increase in r2 was examined for 
regression models. (Cohen, 1988)  
Outliers: Dot-probe results were screened for accuracy and only the correct trials 
were analysed (15 trial data points removed). Data points +/- 3 standard deviations 
from the each participants’ mean were removed (55 data points removed). 0.9% of 
data points were removed from the analysis.  
Box-plots of the reaction time data and calories consumed were examined for 
outliers. One outlier was identified, this data point was not removed as removing 
this outlier had no effect on the results.  
A tertiary split was applied to CD-FAB scores responses received in this dataset, 
to divide individuals into high, medium and low scorers based on the 33rd and 66th 
percentiles. By using a tertiary split, we were able to explore differences in outcomes 
between high and low CD-FAB score whilst avoiding noise within the data from 
participants that scored close to the high/low cut-off. 
Demographics: Differences in psychosocial outcomes and baseline demographics 
were explored by conducting one-way ANOVAs. Two-way ANOVAs were used to 
explore associations between CD-FAB scores, hunger, mood, fullness and nausea 
throughout the procedure. 
Food Taste Test: Food intake was calculated as follows (start food weight – 
leftover food = total food consumed (grams)). The calorie content of consumed food 
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was calculated using the nutritional information on the packaging. The data were 
also analysed as grams consumed; there was no difference in the pattern of results 
so these data are not reported. Multiple regressions were used to explore the 
association between CD-FAB score and food intake whilst accounting for theoretical 
covariates and factors associated with food intake. Food familiarity, BMI, disordered 
eating scores and gender were used as covariates in the regression models. The four 
ratings of familiarity for each of the food types were combined into a composite 
food familiarity score ranging from 1 being unfamiliar with all of the food types, to 8 
being familiar with all food types.  
Dot-Probe Task: Attentional bias to gluten-free and gluten-containing food 
images was calculated separately. Attentional bias is calculated by subtracting the 
consistent trial reaction times from the inconsistent trial reaction times. Positive 
scores are taken as evidence for an attentional bias towards the stimulus and 
negative scores as a bias away from the stimulus (MacLeod et al., 1986). Paired t-
tests were used to compare differences in attentional bias for gluten-free and 
gluten-containing images.  The relationship between CD-FAB scores and attentional 
bias was explored through one-way ANOVA. Differences between all individuals with 
CD, regardless of CD-FAB score, were compared to the data from the pilot healthy 
controls to explore differences in attentional bias to gluten-free and gluten 
containing stimuli.  
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7.3. Results 
7.3.1. Pilot Study 
10 healthy controls (9 females, 1 male) piloted the dot-probe task (18-69 years). 
Healthy controls showed a mean bias of -5.1 to gluten-containing foods and -1.2 to 
gluten-free foods. Paired samples t-tests found no difference and a small effect size 
for attentional bias between food types (t= -.29,p= .78, d=-0.10).  Mean attentional 
bias scores were compared to zero, the theoretical non-bias point. No significant 
differences from zero, and only small effect sizes, were found for gluten-free (t= -.10, 
p= .92, d=0.05) and gluten-containing images (t= -.43, p= .68, d=0.19). All foods were 
named and identified by control participants. 
7.4. Main Results 
7.4.1. Sample Characteristics 
The sample consisted of 12 males and 29 females, with a mean age of 40.5 years 
(SD= 18.2; range= 18-69), a mean BMI of 24.6 (SD=5.2; range=17.6-44.7) and 8.8 
years with CD diagnosis (SD=11.1; range=2-55). The mean score on the CD-FAB was 
34.9 (SD=12.2; range=13-58).  
One-way ANOVAs found that high, medium and low CD-FAB scorers differed in 
terms of anxiety, overall distress, EAT-26 scores and quality of life (overall, and 
Limitations and Health sub-scales; see Table One). Post-hoc t-tests indicated that 
compared to the low scorers, high CD-FAB scorers had significantly higher anxiety, 
overall distress, EAT-26 and quality of life scores (p<.05); compared to the low CD-
FAB scorers, medium scorers had more impaired quality of life on the Limitations 
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subscale (see Table One). No differences were found in demographics between CD-
FAB groups.  
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Table 1  
Sample Characteristics Using the tertiary Split on the CD-FAB. Data are presented as 
Means.  
 High CD-
FAB Scorers 
Medium CD-
FAB Scorers 
Low CD-
FAB 
Scorers 
F Statistic  Effect 
Size 
Demographics  
Age 42.9 41.4 37.2 .33 0.02e 
BMI 23.4 26.6 23.7 1.65 0.08e 
Years with CD 8.6 8.6 9.2 .01 0.00 e 
Body Fat % 24.6 29.2 25.1 .85 0.04e 
Depression Anxiety Stress Scale 21  
Depression 8.3 5.9 9.1 1.29 0.07ee 
Anxiety 9.3 5.0 4.3b 1.99* 0.09ee 
Stress 12.6 11.4 10.3 .30 0.02e 
Total DASS 31.1 22.3 19.2b 1.41* 0.07ee 
CD Quality of Life  
Quality of Life 35.7 48.5 54.0bb 9.54** 0.36eee 
CDQoL 
Limitations 
 14.9 22.1a  26.2bb 15.22** 0.45eee 
CDQoL 
Dysphroia 
 9.8 5.8 6.6 1.25 0.06ee 
CDQoL Health 10.1 13.8 14.4bb 4.64* 0.21eee 
CDQoL 
Treatment 
 6.2 5.9  6.8 1.02 0.05e 
Disordered Eating and GFD Adherence (% scoring above clinical cut-off)  
GFD Adherence 13.0 12.9 11.6 .85 0.04e 
Total EAT 8.9 (0%) 6.4 (0%) 3.4b (0%) 3.78* 0.17eee 
Total BES 9.5 (26.7%) 10.8 (25%) 6.2 (7.1%) 1.64 0.08ee 
*p=.05; **p<.001 for ANOVA across all three groups; ap=.05; aap<.001 for T-Test 
across low and medium scorers; bp=.05; bbp<.001 for T-Test across low and high CD-
FAB scorers. Effect size using eta-squared: esmall effect; eemedium effect; eeelarge 
effect. 
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Baseline characteristics that could affect food intake were assessed throughout 
the procedure. Two-way ANOVAs revealed a main effect with large effect sizes, 
whereby participants felt less hungry (f (1, 39) = 12.83, p< .001, η2 = .19) and more 
full over time (f (1, 39) = 10.58, p< .001, η2 = .16; likely to be due to food 
consumption), this effect remained across high, medium and low CD-FAB scorers at 
each measurement time point (prior to dot-probe task, prior to taste test and post 
taste test). In addition there were two main effects, with medium effect sizes, 
whereby increasing CD-FAB score was linked with increases in both reported nausea 
(f (1, 39) = 6.78, p= .002, η2 = .12) and fullness (f (1, 39) = 4.49, p= .013, η2 = .07). No 
significant interactions were found.  
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Table 2 
VAS Scales Across the Experimental Procedure (Before the experiment (1), Prior to Taste Task (2) and After Taste Task (3)). Data are presented 
as means and standard deviations. Higher scores indicate greater happiness, sadness, nausea, fullness and hunger. 
 High CD-FAB Medium CD-FAB Low CD-FAB 
 1 2 3 1 2 3 1 2 3 
Happy  66.7 (14.8) 76.0 (12.4) 77.3 (10.5) 72.3 (20.7) 69.1 (16.3) 70.6(11.9) 72.7 (19.8) 80.5 (10.1) 80.3 (10.3) 
Nauseous (A) 10.4 (17.0) 8.9 (12.2)  13.2 (16.4) 3.5 (3.6) 4.7 (4.1) 6.3 (6.9) 3.0 (2.6) 3.4 (6.3) 3.3 (3.2) 
Sad  12.4 (15.4) 7.8 (8.5) 9.4 (14.4) 7.2 (11.9) 10.7 (11.6) 8.1 (9.9) 5.8 (12.0) 3.6 (3.5) 4.1 (4.4) 
Hungry (B) 53.7 (24.6) 51.1 (31.4) 25.0 (25.5) 40.8 (24.1) 51.6 (28.1) 23.0 (22.0) 50.8 (21.5) 63.5 (16.8) 39.5 (20.1) 
Fullness (A, B) 31.4 (25.9) 40.2 (28.3) 61.4 (28.0) 31.9 (26.1) 23.7 (18.9) 49.2 (20.3) 24.6 (21.7) 23.2 (18.2) 39.1 (20.8) 
A= main effect of CD-FAB group, B = main effect of time, C = interaction
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7.4.2. Food Taste Test 
Associations were found for overall calorie intake and three variables: BES, 
psychological distress and food familiarity (p<.05). Based on these significant 
relationships, these variables were entered into step one of the regression model. 
BMI, gender and EAT-26 scores were also included in step one, as these factors are 
commonly associated with food consumption (Pollard, Kirk & Cade, 2002). Total CD-
FAB scores were entered in step two to explore the relationship between CD-FAB 
scores and calorie intake.  
The first model accounted for 34.9% of the variance in calories consumed (f 
(1,39)=4.48, p=.002; see Table Three), with food familiarity and BES scores having 
significant positive regression weights.  The addition of CD-FAB scores did not 
explain any additional variance in calories consumed.  
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Table 3 
Factors Associated with Overall Calories Consumed  
Predictors B B R2 F R2 Change 
Model 1) Covariates  
Gender -102.26 -.21    
Body Mass Index -5.73 -.13    
Composite Food 
Familiarity  
132.61 -.40*    
BES Total 11.63 .36*    
EAT-26 -1.78 -.04    
DASS-21 3.56 .81 .45 4.48** .45** 
Model 2) CD-FAB  
Gender -101.20 -.21    
Body Mass Index -5.60 -.13    
Composite Food 
Familiarity  
132.42 .40*    
BES Total 11.42 .35*    
EAT-26 -2.35 -061    
DASS-21 3.51 .30    
CD-FAB Total .79 .04 .45 3.75** .00 
 
* = significance at p<.05; **p<.005. The significance of the F value refers to the F 
associated with each step.  
7.4.5. Dot-Probe Task 
Across CD participants, the overall mean attentional bias score for the gluten-
free foods was -1.0 (SD=60.3) compared to a mean of 5.5 (SD=34.0) for the gluten 
containing foods. A 2 (gluten-free images and gluten-containing images) x 3 (high, 
medium, low CD-FAB scorers) ANOVA was conducted to explore relationships 
between CD-FAB scores and attentional bias to gluten-free and gluten-containing 
food images.  
No significant main effects were found; there were small effects for food 
stimulus (f (1, 37) = .33, p= .57, η2= 0.01) and a medium effect size for CD-FAB score 
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(f (1, 37) = 1.80, p= .18, η2= 0.13). No significant interactions were found and only 
small effect sizes (f (2, 37) = 1.13, p= .34, η2= 0.06). The same pattern of results was 
found for the CD-FAB subscales.  
Post-hoc tests were used to further explore this data. The combined CD data 
was compared with the pilot data from healthy controls using T-tests. No differences 
were found between healthy controls and individuals with CD on measures of 
attentional bias for gluten-free images, and only small effect sizes (t (1,48)=1.08, 
p=.29, d= 0.16) but individuals with CD had a greater attentional bias towards gluten-
containing images compared to healthy controls, demonstrating a medium effect 
size (t (1,48)=2.03, p=.048, d= -.58). No other significant differences were found.  
7.4.6. Manipulation Check 
Participants were asked what they thought the aims of the study were and 
whether they were aware that the amount of food they consumed was being 
measured. 2.4% (n=1) of participants correctly guessed the aims of the study. 34.1% 
(n=17) of the sample reported that they were aware their food intake was being 
measured.  
7.5. Discussion 
The aim of this chapter was to explore the relationship between CD-FAB scores, 
food intake and attentional bias towards gluten-free and gluten-containing foods in 
individuals with a biopsy-confirmed CD diagnosis. CD-FAB scores were explored 
alongside measures of attentional bias towards gluten-free and gluten containing 
food images, and the amount of food consumed in a laboratory environment. 
Results revealed that CD-FAB scores were not associated with calorie intake and 
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attentional bias did not significantly differ according to CD-FAB scores but strong 
effect sizes were apparent for the dot-probe task; we were also able to replicate the 
psychological correlates of the CD-FAB in a biopsy-confirmed sample of individuals 
with CD.  
7.5.1. Food Taste Test 
Alterations in the amount of food consumed are a key feature of disordered 
eating patterns (APA, 2013). In relation to CD, some individuals find it challenging 
and may be unwilling to eat food outside the home in order to prevent gluten cross-
contamination and subsequent gastrointestinal symptoms (Chapter Four; Olsson, 
Hornell, Ivarsson & Sydner, 2008; Simpson et al., 2011). Contrary to our hypothesis, 
CD-FAB scores were not associated with calories consumed.  
There are two potential interpretations of this finding; greater concerns around 
food and cross-contamination may have no relationship with food intake in 
individuals with CD. However, this explanation seems unlikely, as the qualitative 
findings in Chapter Four suggested that dietary-restriction occurred in novel 
environments for those who had increased concerns around food; in addition, 
Chapter Six reported that increased CD-FAB scores were associated with an 
unwillingness to try new foods. Alternatively, these findings may stem from 
methodological limitations within this study. Although the laboratory environment is 
novel and we had anticipated that increased CD-FAB scores would be associated 
with reduced food intake, participants may have viewed this environment as a “safe” 
location to consume food. Participants were presented with pre-packaged gluten-
free foods, and were able to confirm this by checking the ingredients list. It is 
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possible that even those with concerns around food feel safe enough to consume 
food in a controlled, laboratory environment. Furthermore, individuals tended to be 
familiar with the foods presented and food familiarity was independently associated 
with calorie intake, highlighting the lack of novelty within the experimental set-up. 
The association between BES scores, food familiarity scores and increased food 
consumption is not surprising. As the BES measure contains items targeting food 
consumption, this positive association may be expected. BES scores have been 
associated with increased calorie consumption in healthy controls and this finding 
appears to be consistent in CD (Laessle & Schulz, 2009; Peterson et al., 2012).  
Additionally, our results show that food familiarity was associated with total calories 
consumed. This is in line with the qualitative findings from Chapter Four, which 
found that individuals with CD preferred to eat at food places they had been 
previously and preferred to consume foods they had experienced before. Sticking to 
eating and buying familiar food products is a strategy adopted by many individuals 
with CD, our findings highlight that this also translates into the amount of calories 
consumed (Food Standards Agency, 2009).  
7.5.2. Dot-Probe Task 
Within the disordered eating and anxiety/phobia literature, there is considerable 
evidence to suggest that individuals with concerns around food will orient their 
attention to the stimulus of fear (food images; Cisler & Koster, 2010; Faunce, 2002). 
Our data suggest that individuals with CD had a greater attentional bias towards 
gluten-containing images when compared to healthy controls, irrespective of CD-FAB 
scores. This highlights potential mechanisms by which individuals with CD may differ 
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from healthy controls.  Individuals with CD appear to be more sensitive to gluten-
containing food cues than healthy controls and this increased attentional bias 
towards food in CD may result from the need to be vigilant around gluten. Although 
no other literature reports this finding in CD, this is in line with qualitative reports 
that indicate increased food preoccupation in CD (Leffler et al., 2007; Yucel et al., 
2006). 
No significant main effects or interactions were found for food stimulus or CD-
FAB scores (gluten-free and gluten-containing images); this indicates that food 
stimuli are processed similarly across individuals with CD. It is premature to conclude 
that CD-FAB scores are not associated with attentional bias for food-related stimuli. 
Given the small sample size, limited statistical power may explain the lack of 
significance in the attentional bias comparisons. Alternatively, picture-based images 
may not be enough to influence attentional bias in those with high CD-FAB scores; 
paradigms that use actual food items instead of food images, may better reflect 
attentional bias in CD. Furthermore, this study would have benefited from an 
additional manipulation check to see whether the food images were associated with 
an increase in self-reported concern in participants. 
7.5.3. Questionnaires 
In line with our previous findings (Chapter Six), increased CD-FAB scores were 
associated with impaired quality of life and psychological distress in individuals with 
a biopsy-confirmed diagnosis of CD. The replication of these findings in a biopsy-
confirmed sample of individuals with CD further adds to the evidence that high CD-
FAB scores are associated with negative psychosocial outcomes and requires 
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assessment and intervention in the CD population. Additionally, we were able to 
replicate the finding that EAT-26 scores were associated with CD-FAB scores but 
there was a non-significant association between BES and CD-FAB scores. This adds to 
the discriminative validity of the CD-FAB, as discussed in Chapter Six.  
7.5.4. Limitations and Directions for Future Research 
The limitations of this study need to be noted. The distribution of CD-FAB scores 
across this sample was within the lower end of CD-FAB scores, with a maximum 
score of 58 out of a possible 77. The advertising of this study as a “taste test” may 
have prevented individuals with more extreme food concerns from volunteering to 
take part. Furthermore, the use of a tertiary split to divide individuals into high and 
low CD-FAB groups divides the group based on an arbitrary number. Without further 
exploration of the CD-FAB properties in large samples, we cannot establish clinically 
meaningful cut-offs. Future research needs to establish the cut-off for clinical 
impairment within the CD-FAB in order to examine the needs of those most at risk.  
By using a highly controlled environment for the experimental procedure; 
whereby individuals could see the food items in packages and read these packages, 
this may have created a setting that even those with food concerns may have viewed 
as safe. Further procedures should focus on modifying the food environment, by 
presenting participants with unpackaged gluten-free foods, to explore whether 
different levels of control within the environment affect food intake in CD. 
The replication of the association between CD-FAB scores and psychosocial 
outcomes in a biopsy-confirmed sample of CD further extends the findings from 
Chapter Six. Despite this, the tertiary split was applied to CD-FAB responses received 
 184 
within this dataset. As a result, the split of CD-FAB scores may differ across this 
dataset and Chapter Six, meaning the findings from both chapters are not directly 
comparable. Despite the limitations, this study demonstrates the application of 
laboratory based behavioural methods in CD. These methods provide a way of 
assessing the attentional biases within CD and measuring food consumption. In 
addition, 
The results from this study also further inform the development of the 
Theoretical Model of Disordered Eating in Gastrointestinal Disease. Future revisions 
of this model need to consider whether eating behaviours are affected by food 
concerns and whether there is a perceived level of safety that will allow even 
individuals with high CD-FAB scores to consume food in novel settings. 
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CHAPTER EIGHT: GENERAL DISCUSSION 
8.0. Chapter Rationale 
The overall aim of this thesis was to examine the relationship between 
disordered eating attitudes and behaviours and CD. This included the following aims: 
1) to develop a theoretical model to explain the development of disordered eating in 
CD; and 2) to empirically test some of the core assumptions proposed by this model. 
I will discuss how the thesis has answered these questions by assessing the 
contribution from each study and integrating the findings to evaluate and further 
develop the Theoretical Model of Disordered Eating in Gastrointestinal Disease.  
I will then discuss the clinical implications of this work and how this may be used 
in clinical practice to inform the treatment and support of individuals with CD. This 
will be followed by a discussion of the strengths and limitations of this work and 
directions for future research. 
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8.1. Overview of Findings 
This thesis sought to develop and evaluate a theory explaining disordered eating 
attitudes and behaviours in CD. The results presented in this thesis have explored 
the prevalence, experiences and factors associated with disordered eating in CD, in 
order to evaluate the Theoretical Model of Disordered Eating in Gastrointestinal 
Disease (Chapter Two). 
8.1.1. Development of the Theoretical Model of Disordered Eating in 
Gastrointestinal Disease 
A systematic review of the literature relating to disordered eating in dietary-
controlled gastrointestinal conditions assessed the current state of the literature and 
was used to develop the Theoretical Model of Disordered Eating in Gastrointestinal 
Disease (Chapter Two). This model was formed of distinct stages that were assessed 
in later chapters, through mixed methodologies.  
The literature review identified that the majority of research on disordered 
eating in gastrointestinal conditions was based on case studies; only nine papers 
were eligible to be included in the review. Overall, the prevalence rates of 
disordered eating across dietary-controlled gastrointestinal disorders were 5.3-
44.4% and these consisted of dietary restriction and bulimic pathologies. No 
assessments of binge-eating behaviours were made in any of the studies reported in 
the review (Chapter Two). Psychological distress, symptom severity and dietary 
management were found to be associated with disordered eating patterns; however, 
the direction of these associations were varied across papers. 
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Based upon the findings of this literature review, the Theoretical Model of 
Disordered Eating in Gastrointestinal Disease was developed. Briefly, the model 
suggests that there are two pathways that lead to disordered eating attitudes and 
behaviours in dietary-controlled gastrointestinal disease. The first pathway describes 
how distress around post-diagnosis weight change contributes to poor dietary-
management and disordered eating attitudes and behaviours. The second pathway 
describes increased hypervigilance and concern around food prepared in novel or 
unfamiliar environments.  These beliefs stem from the concern that all food has the 
potential to trigger gastrointestinal symptoms. In order to adapt to these beliefs, 
individuals respond by only eating in familiar settings, only eating familiar foods, or 
only eating foods that they have prepared themselves, resulting in a limited food 
intake and an impaired quality of life, particularly in social domains. The next section 
will discuss the findings of this thesis in the context of this model and suggest further 
modifications to this model.  
8.1.2. Prevalence of Disordered Eating in CD 
The Theoretical Model of Disordered Eating in Gastrointestinal Disease assumes 
that individuals with CD will be at risk for the development of disordered eating 
attitudes and behaviours. The combined prevalence rates in the general population 
for Anorexia Nervosa, Bulimia Nervosa and Binge Eating Disorder is 13.1% (Stice, 
Marti & Rohde, 2013) and disordered eating is estimated at 10% (Solmi et al., 2014).  
Throughout this thesis, clinical cut offs on the Eating Attitudes Test 26 (EAT-26; 
Garner & Garfinkel, 1979) and the Binge Eating scale (BES; Gormally, Black, Daston & 
Rardin, 1982) have been used to estimate the prevalence of disordered eating 
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attitudes and behaviours in CD. Within this thesis, 15.7-17.7% of participants scored 
above the cut-off on the EAT-26 and 19.4-21.6% on the BES (Chapters Three and Six), 
which is higher than the prevalence found in healthy controls. Furthermore, Chapter 
Three reported findings demonstrating that more individuals with CD scored above 
the clinical cut-off on the EAT-26 compared to healthy controls and those with type 
two diabetes. However, there was no difference in BES scores across all dietary-
controlled conditions reported compared to healthy controls. These findings support 
the assumption that there is an increased risk of disordered eating attitudes and 
behaviours in CD compared to healthy controls, as assessed by the EAT-26 and the 
BES.  Individuals with CD may also be at greater risk for bulimic and restriction 
behaviours, as assessed by the EAT-26, than those with other dietary-controlled 
conditions (type two diabetes and inflammatory bowel disease), whereas the 
presence of binge eating behaviours was similar across dietary-controlled chronic 
health conditions, but greater than healthy controls (Chapter Three).   
8.2. An Evaluation of Pathway One: Weight Change and Disordered Eating in 
Coeliac Disease  
Pathway one of the Theoretical Model of Disordered Eating in Gastrointestinal 
Disease is based on three main assumptions: 1) individuals will be upset by weight 
change that occurs after CD diagnosis and commencement of the GFD; 2) individuals 
will attribute this weight change to the GFD and 3) individuals will engage in the 
consumption of gluten to encourage the weight loss that can result from the 
gastrointestinal symptoms associated with CD. The consumption of gluten to 
promote weight loss can be conceptualised as a form of disordered eating, as misuse 
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of medication is defined as an inappropriate compensatory behaviour in the DSM-5 
(Simon et al., 2011). The evidence from this thesis will be used to evaluate each of 
the main assumptions in this pathway.  
8.2.1. Distress Surrounding Coeliac Disease Related Weight Change 
After CD diagnosis and initiation of the GFD, weight change (usually gain) 
commonly occurs (Kabbani et al., 2012). According to the model, this weight change 
can lead to distress and the development of disordered eating attitudes and 
behaviours (Chapter Two). Not all individuals will experience weight change after CD 
diagnosis; however, when weight change does occur this can be interpreted in a 
negative manner and strategies to reverse this weight change are made (Dowd et al., 
2013; Madden, Riordan & Knowles, 2016).  
The qualitative findings of Chapter Four found that individuals who scored high 
on measures of disordered eating, as assessed by the EAT-26 and the BES, described 
distress around post-diagnosis weight gain and a desire to regain their pre-diagnosis 
weight. Furthermore, difficulties in adapting to post-diagnosis body shape were 
described in combination with psychological distress, and dietary restriction was 
used to achieve weight loss in these individuals. These findings are in line with Leffler 
et al. (2007) who described three case studies where concerns around weight 
increased after starting the GFD and led to dietary restriction. In addition, Madden, 
Riordan and Knowles (2016) found that individuals were concerned with the rate of 
weight increase after starting the GFD and this led to concerns around weight 
management.  
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8.2.2. Post-Diagnosis Weight Change will be attributed to the Gluten-Free Diet 
The Theoretical Model of Disordered Eating in Gastrointestinal Disease proposes 
that those who experience distress around post-diagnosis weight change develop 
the belief that these weight changes are caused by the initiation of the GFD (Chapter 
Two). These beliefs are not unfounded: prior to CD diagnosis individuals may present 
as underweight and 21.5% experience clinically significant weight gain after starting 
the GFD (Kabbani et al., 2012). In addition, gluten-free foods have a greater 
nutritional imbalance compared to gluten-containing alternatives, including an 
increased calorie, sugar and fat content which may contribute to weight change in 
CD (Miranda et al., 2014).  
Madden, Riordan and Knowles (2016) found some support for this assumption; 
individuals with CD were concerned about unwanted weight gain and attributed this 
to the fat, sugar and salt content of manufactured gluten-free foods, leading to a 
desire to remove these foods from the diet. Additionally, the qualitative findings 
reported in Chapter Four found that individuals scoring high on measures of 
disordered eating had an increased awareness of the nutritional composition of 
gluten-free foods. Participants were distressed about the poor quality of gluten-free 
food, and this was perceived to be the cause of post-diagnosis weight gain. 
Furthermore, Rocha, Gandolfi and Snatos (2016) found that individuals who believed 
the GFD was nutritionally poor, reflected on the benefit of removing manufactured 
gluten-free foods from their diet, as they believed this would increase health and 
reduce their risk of obesity.  
Weight change in CD appears to be attributed to the nutritional content of 
gluten-free foods and this can lead to a desire to alter weight and/or diet. These 
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findings are similar to the process of insulin-related weight gain described in the 
Modified Dual Pathway Model (Peterson, Fischer & Young-Hyman, 2015). This model 
proposes that post-diagnosis weight gain in diabetes, associated with insulin 
therapy, creates a vulnerability to body dissatisfaction and dietary restraint. The 
Theoretical Model of Disordered Eating in Gastrointestinal Disease places this weight 
change in the context of CD; beliefs around the quality of the GFD can contribute to 
disordered eating attitudes and beliefs. 
8.2.3. Poor Dietary-Management will be used to Promote Weight Loss 
The Theoretical Model of Disordered Eating in Gastrointestinal Disease suggests 
that these beliefs around gluten-free foods will result in the intentional consumption 
of gluten to encourage gastrointestinal symptoms and subsequent weight loss as 
reported in case studies (Leffler et al., 2007; Yucel et al., 2006; Young et al., 2013).  
Within this thesis, no evidence was found for the intentional consumption of 
gluten to promote weight loss. No reports of intentional gluten consumption were 
described in the interviews with CD participants (Chapter Four); however, those 
scoring high on measures of disordered eating described less strict management of 
their GFD, particularly when eating outside the home. Furthermore, when asked 
about gluten consumption in an anonymous web-meditated survey, poor dietary 
management was associated with disordered eating scores (Chapter Three and Six).  
Chapters Three and Six found increased disordered eating scores, as assessed by 
the EAT-26, to be associated with self-reported gastrointestinal symptoms and self-
reported poor dietary management. In addition, these factors produced a separate 
group within the cluster analyses. One interpretation of the associations between 
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GFD management and gastrointestinal symptoms is that this results from intentional 
gluten consumption. However, another explanation is that this may reflect a bi-
directional relationship between gluten consumption and gastrointestinal 
symptoms, whereby poor dietary management leads to increased gastrointestinal 
symptoms and vice versa. In support of this interpretation, cross sectional studies 
have also found an association between disordered eating patterns and poor GFD 
management in CD (Arigo et al., 2012; Karwautz et al., 2008). However, it is not clear 
what the reasons underlying deliberate gluten consumption are, i.e. whether it is 
intentional, and whether deliberate gluten consumption relates to weight change. 
8.2.4. Disordered Eating Patterns Related to Pathway One 
The Theoretical Model of Disordered Eating in Gastrointestinal Disease suggests 
that a combination of the previous three factors can lead to the development of 
disordered eating attitudes and behaviours in CD. The EAT-26 was effective in 
identifying disordered eating attitudes and behaviours that were associated with 
difficulties in GFD management, gastrointestinal symptoms and distress around post-
diagnosis weight change.  
Those who reported difficulties following the GFD and increased gastrointestinal 
symptoms were identified by the EAT-26 (Chapters Three, Four and Six). This tool 
appears to be effective in identifying disordered eating in those with CD who engage 
in dietary-restriction, and/or deliberate gluten ingestion, with the intention of losing 
weight. As this behaviour is of particular importance to clinicians, further research 
should focus on the role of deliberate gluten consumption and disordered eating in 
CD, to establish the prevalence of and motivations behind this behaviour.  
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8.3. An Evaluation of Pathway Two: Food Concerns and Disordered Eating in 
Coeliac Disease  
The second pathway of the Theoretical Model of Disordered Eating in 
Gastrointestinal Disease consists of three main assumptions: 1) individuals 
experience severe gastrointestinal symptoms prior to diagnosis and a resolution of 
these symptoms when following the GFD; 2) the belief that all foods have cross-
contamination potential and an increased concern around food and 3) a fear of 
consuming food prepared in new environments or by unfamiliar people. These 
factors can lead to eating attitudes and behaviours that can be conceptualised as 
disordered, as these eating patterns are inflexible and impair psychosocial well-being 
(Freeland-Graves & Nitzke, 2013).  
8.3.1. Severe Gastrointestinal Symptoms Prior to Diagnosis and Reversal of 
Symptoms After Initiation of the Gluten-Free Diet  
According to the Theoretical Model of Disordered Eating in Gastrointestinal 
Disease, individuals at risk for disordered eating attitudes and behaviours will 
experience increased gastrointestinal symptoms prior to CD diagnosis. However, 
once commencing the GFD, these symptoms will resolve and individuals will believe 
in the effectiveness of their treatment. Severe symptoms surrounding diagnosis and 
beliefs about the effectiveness of the GFD have previously been associated with 
strict management of the GFD (Sainsbury & Mullan, 2011), however, no research has 
explored the relationship between these factors and the development of disordered 
eating attitudes and behaviours.    
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Symptoms at CD diagnosis and the resolution of these symptoms were not 
directly assessed in this thesis. However, the qualitative findings from Chapter Four 
indicated that greater concerns around food and cross-contamination were 
described by those who talked about the effectiveness of their GFD in terms of 
symptom resolution. The majority of these individuals also reflected on their pre-
diagnosis symptoms as uncomfortable and distressing. Although this lends some 
support to the model’s assumptions, this assumption was not fully assessed and 
further studies are needed to assess the symptoms prior to diagnosis, the effect 
these have on GFD management and on disordered eating attitudes and behaviours. 
8.3.2. The Belief that all Foods have Cross-Contamination potential 
According to the theoretical model, those who feel that their GFD is effective in 
reversing their CD-related symptoms may develop the belief that all foods have 
cross-contamination potential and an increased concern around food (Chapter Two). 
This occurs because the CD-related aversion symptoms that were triggered by 
gluten-containing foods may generalise across all unfamiliar food types, creating a 
general concern around food. Hypervigilance and preoccupation with food and 
sources of cross-contamination can also contribute to the development of 
disordered eating attitudes and behaviours. These concerns have consistently been 
reported in the CD literature and have been associated with reduced food 
consumption at social events (Rocha, Gandolfi & Santos, 2016; Silvester et al., 2016; 
Zarkadas et al., 2013). 
During qualitative interviews (Chapter Four), concerns around food and cross-
contamination were discussed in combination with restrictive eating behaviours and 
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strict management of the GFD. Although vigilance around food was described as 
necessary by the majority of participants, eating attitudes and behaviours were only 
affected in those with hypervigilance around food. Hypervigilance led to individuals 
being fearful of gluten in non-ingested-items, including wallpaper and food 
packaging, and these thoughts were allowed to affect their daily lives. Surprisingly, 
individuals describing these concerns did not score above the clinical cut-offs on the 
EAT-26 or the BES, and so these instruments would not have identified their 
disordered behaviours, and they did not discuss a desire to alter their body-shape 
and/or weight (Chapter Four). Other assessment tools were needed to understand 
and identify the concerns described by this pathway, leading to the work reported in 
Chapter Five. 
Chapter Five reported the development of the CD Food Attitudes and Behaviours 
Scale (CD-FAB) that was designed to explore these food concerns in the context of 
CD. This scale contained items that demonstrated a fear of food and the impact that 
this could have on individuals (e.g. I won’t eat food unless I have complete control 
over the preparation), as well as adaptive strategies to cope with concerns around 
food (e.g. I will happily prepare gluten foods for others, as long as it doesn’t come 
into contact with the food I’m preparing for myself). A high score on the CD-FAB 
indicates greater concerns around food, and was associated with an increase in 
anxiety and an impaired quality of life, particularly in social domains (Chapters Five, 
Six and Seven), supporting the assumptions of the Theoretical Model of Disordered 
Eating in Gastrointestinal Disease.  
The development of the CD-FAB allowed us to test the assumption that there 
would be food preoccupation in individuals with concerns around food and cross-
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contamination. Chapter Seven explored associations between the CD-FAB and 
attentional bias to gluten-free and gluten-containing food stimuli. Contrary to the 
model’s assumptions, CD-FAB scores were not significantly associated with 
attentional bias towards food images (gluten-free or gluten-containing), however 
individuals with CD had a greater attentional bias towards gluten-containing foods 
when compared to healthy controls. Furthermore, using the qualitative methods in 
Chapter Four found that individuals scoring high on measures of disordered eating 
consistently report greater focus around food and food content after their CD 
diagnosis. This thesis presents mixed evidence for the role of food preoccupation in 
the development of disordered eating attitudes and behaviours in CD. Given the 
limitations that were reported in Chapter Seven and the qualitative findings, it is too 
premature to conclude that food preoccupation does not contribute to disordered 
eating attitudes and behaviours, particularly given the importance of this 
relationship in other dietary-controlled chronic health conditions (Quick, Byrd-
Bredbenner & Neumark-Sztainer, 2013). Vigilance around food is important for the 
management of CD, however, the food concerns and preoccupation present in those 
scoring high on the CD-FAB may contribute to the development of disordered eating 
attitudes.  
8.3.3. A Fear of eating novel foods or food in novel environments 
The theoretical model proposed that beliefs and hypervigilance, previously 
discussed, around food and cross-contamination contribute to a fear of eating novel 
foods or eating in novel environments. These eating behaviours can be considered 
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disordered as they dominate daily thoughts and impair one’s ability to eat flexibly 
(Freeland-Graves & Nitzke, 2013).  
Vigilance around food, particularly when eating outside the home, is essential for 
all individuals with CD. Previous, qualitative reports have indicated that novel foods 
and food situations cause increased concern for individuals with CD. Individuals 
report constant anxiety mainly concerning instances of cross-contamination when 
eating outside the home and this is associated with the refusal of social invitations 
involving food (Black & Orfilia, 2011; Rose & Howard, 2013; Sverker et al., 2009). 
However, this vigilance becomes maladaptive when strategies to promote safety 
outside the home are not adopted and a fear of food develops. By carrying gluten-
free foods, reading restaurant menus and asking questions to restaurant staff, 
individuals with CD should be able to eat novel gluten-free items in novel 
environments (Rordian & Frognel, 2014).  
The development of the CD-FAB allowed us to test the assumption that there 
would be a fear of consuming food prepared in new environments or food prepared 
by unfamiliar people. Increased CD-FAB scores were associated with eating outside 
the home less often and a fear of trying new foods, as assessed by the Food 
Neophobia scale, which is in line with the concerns around food reported in 
qualitative accounts (Chapter Six). These findings are consistent with the model’s 
assumptions.  
Chapter Seven explored the relationships between the CD-FAB and its 
association with food intake in a laboratory setting. According to the Theoretical 
Model of Disordered Eating in Gastrointestinal Disease, individuals scoring high on 
the CD-FAB should consume less food in the laboratory, as this is an unfamiliar 
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environment. Contrary to the model’s assumptions, food intake (in terms of weight 
of food consumed in the lab) CD-FAB scores were not related. These findings may 
result from methodological limitations and the procedures failure to induce food 
anxiety; for example, the food in the laboratory was not unfamiliar to individuals 
with CD and was presented in a clinical environment. Further, the food was pre-
packaged and unwrapped in the laboratory at the University of Birmingham; 
participants may have believed that the University would not contaminate them 
with gluten.  These factors may have encouraged food consumption by individuals 
despite increased food concerns. Furthermore, the majority of individuals reported 
being familiar with the food items presented in the laboratory set-up. This food 
familiarity was independently associated with the amount of food consumed, 
providing some support to the assumption that unfamiliar foods would not be 
consumed in individuals with high CD-FAB scores.  
The proposal that hypervigilance around food is associated with the 
development of eating behaviours that can be considered disordered is not reflected 
in any of the theoretical models outlined in Chapter One. This is a unique component 
in the Theoretical Model of Disordered Eating in Gastrointestinal Disease and future 
research needs to explore its occurrence in other gastrointestinal conditions and the 
willingness to change this behaviour.  
8.3.4. Eating Attitudes and Behaviours Resulting from Pathway Two 
The CD-FAB is a novel tool that is effective in identifying those who report 
concerns around food and food preparation. Limiting food intake outside the home 
and in unfamiliar environments may be considered adaptive for those with CD; 
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however, the association of this with clinical levels of distress and impaired quality of 
life indicates that the eating attitudes and behaviours described by the CD-FAB can 
be conceptualised as maladaptive (Chapter Six). Further research is needed to 
explore the impact of these eating attitudes and beliefs on physical, behavioural and 
psychological outcomes.   
8.3.5. The Potential for a Third Pathway? 
The results described so far have largely provided support for the assumptions of 
the Theoretical Model of Disordered Eating in Gastrointestinal Disease. However, the 
findings of this thesis also suggest further modifications that need to be taken into 
account in future revisions of this model.  
Chapter Three explored the disease specific and nonspecific factors associated 
with disordered eating scores in CD. All of the dietary-controlled conditions (CD, 
inflammatory bowel disease, type two diabetes) scored equally high on the BES, and 
these scores were associated with psychological distress. These findings are 
consistent with Stice’s Dual Pathway Model (2002) which proposes that 
psychological distress is important in the development of disordered eating attitudes 
and behaviours (Dury, 2015; Stice, 2002). Additionally, the Modified Dual Pathway 
Model (Peterson, Fischer & Young-Hyman, 2015) proposes that disease-related 
distress further contributes to the risk of disordered eating in those with dietary-
controlled chronic health conditions. One interpretation of these findings is that 
binge eating behaviours result from the non-specific burden of living with a chronic 
health condition.  
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Strength to this argument was added by the results of Chapter Six, which found a 
positive association between psychological distress and BES scores in CD. 
Furthermore, cluster analyses indicated that individuals who scored high on 
measures of binge eating and psychological distress were a distinct group from those 
who had increased gastrointestinal symptoms, poor dietary management, and high 
scores of measures of Anorexic and Bulimic symptoms, as described by the first 
pathway of the model (Chapter Three and Six).  
The qualitative findings from Chapter Four indicate that individuals with high 
disordered eating scores would long for gluten-containing foods after their CD 
diagnosis. These feelings of loss and distress around food were associated with 
increased food consumption to compensate for the restrictive GFD. For some 
individuals this was associated with the need to hoard foods. In addition, individuals 
who reported feeling restricted by the need to follow a restricted dietary-regimen 
would consume increased amounts of food when it was available to them and use 
this food consumption to elevate their mood. Binge-eating behaviours have 
consistently been reported alongside low mood in the general population, and food 
consumption is used to elevate mood in these individuals (Emery, King, Fischer & 
Davis, 2013).  
These finding indicate that in addition to the two pathways described by the 
Theoretical Model of Disordered Eating in Gastrointestinal Disease, some individuals 
may find it hard to cope with the general stressors of a chronic health condition and 
the restrictive nature of the GFD, and cope with this by engaging in binge-type eating 
patterns. The pathways of the Theoretical Model of Disordered Eating in 
Gastrointestinal Disease, do not account for these factors; the addition of a third 
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pathway that describes how the general stressors of a chronic health condition, and 
the need to maintain a strict dietary regimen, can lead to binge eating behaviours in 
CD as assessed by the BES. 
This binge-eating pathway is similar to the relationships between negative affect, 
dietary restraint and disordered eating described in Stice’s (2002) Dual Pathway 
Model. Furthermore, Herman and Polivy’s (1984) Boundary Model can be used to 
understand the relationship between dietary restraint and binge eating. The 
Boundary Model suggests that those who restrict their intake are more responsive to 
food-related external stimuli and at risk for both under and overconsumption of 
food. Similar patterns of eating have been described in people with Type Two 
Diabetics who also follow a prescribed dietary regimen (Herpertz et al., 2001).  
8.4. The Revised Theoretical Model of Disordered Eating in Coeliac Disease 
Based on the findings from studies contained within this thesis, we were able to 
modify the Theoretical Model of Disordered Eating in Gastrointestinal Disease to 
describe the development of disordered eating attitudes and behaviours in CD and 
recommend appropriate tools to explore these eating attitudes and beliefs further. 
Stice’s Dual Pathway Model (Stice, 2001), which has been extensively researched in 
adolescents without long-term conditions, captures the broader aspects of 
disordered eating which are still relevant to the CD population. This model was not 
developed to be an all-encompassing model of disordered eating but rather a 
framework for the factors that occur alongside the diagnosis and management of 
CD, that are not accounted for in Stice’s model. As a result, the Theoretical Model of 
Disordered Eating in Gastrointestinal Disease can be seen as a model accounting for 
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the disease-specific factors that contribute to disordered eating attitudes and 
behaviours that occur within the broader context of the sociocultural factors 
accounted for by Stice’s model  
Figure One describes the revised model as applied to CD. The model is formed of 
three pathways, two disease-specific pathways that were described in the original 
model and one nonspecific pathway resulting from the burden of living with a 
chronic health condition. A brief description of each pathway can be found below.  
Pathway One: This pathway described individuals with increased concerns 
around food and cross-contamination. These individuals will have experienced 
distressing gastrointestinal symptoms prior to CD diagnosis but respond well to the 
GFD, experiencing symptom resolution. As a result, these individuals develop 
increased concerns around food prepared in unfamiliar environments or by 
unfamiliar individuals. Therefore, food consumption is limited in novel settings, but 
eating patterns are typical when food preparation is controlled. This dysfunctional 
focus on GFD management may lead to disordered eating motivated by the fear of 
gastrointestinal symptoms or the need to engage in dietary-restriction in 
environments that are viewed as unsafe but increased food consumption in 
environments that are perceived as safe. These eating attitudes and behaviours can 
be screened for using the CD-FAB.  
Pathway Two: This pathway describes those who exhibit disordered eating 
attitudes and behaviours more in line with traditional eating disorders that are 
motivated by the desire to change weight or body shape. These individuals will 
experience distress in response to weight changes that occur after the CD diagnosis 
and initiation of the GFD. As a result, the belief that the GFD is responsible for these 
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weight changes results in the deliberate consumption of gluten in order to promote 
weight loss through the physiological effect of gluten. These eating attitudes and 
behaviours can be screened for using the EAT-26.  
Pathway Three: This pathway describes disordered eating attitudes and 
behaviours that result from the nonspecific burden of living with and managing a 
chronic health condition. Those who experience distress surrounding their CD 
diagnosis and the adoption of the GFD, may feel that the GFD is too restrictive and 
report distress around the loss of gluten-containing foods and as a result may 
consume large quantities of food as a coping strategy to elevate their mood. These 
eating attitudes and behaviours can be screened for using the BES. 
In its present form, the model implies that disordered eating in CD is 
unidirectional in nature. The arrows between the constructs imply no association 
among the factors that may contribute to disordered eating attitudes and 
behaviours in CD. In addition, it is not clear whether individuals can move across 
disordered eating pathways or whether the pathways feed into one another. The 
qualitative results from Chapter Four indicate that individuals may engage in both a 
binge and restrictive eating pathology, suggesting that a multidimensional model 
where the pathways interact requires further exploration. Additionally, the 
exploration of operational feedback mechanisms that may reinforce disordered 
eating attitudes and behaviours is essential in this population.  
The clustering of items within the model needs further exploration.  Although the 
model describes a poor or good adaptation to diagnosis, the items reflected in the 
clusters (distress in response to weight gain; greater symptoms at diagnosis, 
resolution of these symptoms) relates more specifically to the physical and 
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psychosocial response to GFD treatment, and it is these responses to treatment that 
were reflected in the findings (Chapter Four). Furthermore, the model refers to 
Dysfunctional Illness Beliefs, which includes illness beliefs as well as emotional states 
(e.g. high anxiety). This lack of differentiation between emotional states and 
cognitions makes it challenging to specify relationships between disordered eating 
attitudes and behaviours in CD. Future revisions on the model need to explore the 
role of anxiety and illness beliefs in the development of disordered eating attitudes 
and behaviours and reflect on the terminology used within this model, to allow 
further understanding of the relationships between these emotions and cognitions.  
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Figure One: The revised model of disordered eating as applied to CD. Orange boxes 
indicate the type of disordered eating and method of identifying behaviour. 
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8.5. Clinical Implications 
At present, there are no studies assessing the effectiveness of interventions for 
disordered eating attitudes and behaviours in CD. The development and evaluation 
of the Theoretical Model of Disordered Eating in Gastrointestinal Disease provides a 
framework to explore this concept and can be utilised in the development of 
appropriate tools, to allow prevention and intervention strategies to follow. The 
Theoretical Model of Disordered Eating in Gastrointestinal Disease can help us 
understand disordered eating in CD and provides insight into service development. 
In combination with previous literature, the evidence throughout this thesis 
indicates that disordered eating attitudes and behaviours are present in CD 
(Chapters Two-Four, Six) and that these attitudes and behaviours are related 
specifically to the CD diagnosis (Chapter Three, Six). The presence of disordered 
eating attitudes and behaviours in CD affects both physical (gastrointestinal 
symptoms, GFD management) and psychosocial outcomes (quality of life, 
depression, anxiety, stress). As a result, these attitudes and behaviours need to be 
addressed in clinical practice as part of a full assessment into the management of CD 
and the GFD. The need to give higher priority to the psychological needs of those 
with CD has been consistently documented in the literature by numerous studies 
that show the interaction between psychological health and physical outcomes (e.g. 
Barratt, Leeds & Sanders, 2011; Casellas et al., 2015; Rose & Howard, 2014). Despite 
this evidence, psychological support is not available in the majority of 
gastrointestinal clinics in the UK and research assessing the impact of psychological 
interventions in CD is minimal (Addolorato et al., 2004; Sainsbury, Mullan & Sharpe, 
2013a). Based on the current evidence, specific intervention guidelines cannot be 
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made. However, within the chronic health literature a patient-centred approach that 
emphasised patient self-management in combination with professional support is 
the underlying principle for interventions in chronic health conditions (Mirzaei et al., 
2013). Patient-centred care has decreased symptom burden, reduced hospital 
admission rates and increased quality of life in a variety of chronic health conditions 
(Kane et al., 2015; McMillan et al., 2013; Rathert, Wyrwich & Boren, 2013). Due to 
the heterogeneity of disordered eating in coeliac disease, we recommend that future 
research focus on a personalised patient-centred approach in the assessment and 
care of disordered eating in CD.  
8.5.1. NICE Guidelines  
The current NICE guidelines for CD recommend that an individual be referred to 
a gastroenterology clinic when a diagnosis of CD has been confirmed (NICE, 2015). 
Upon diagnosis, the NICE guidelines recommend that the importance of the GFD is 
explained as well as information about food labelling, how to manage social 
situations, how to avoid cross contamination and the role of national and local CD 
support groups. However, the depth of information covered will largely depend on 
the expertise of the dietician (Madden, Riordan & Knowles, 2016). It is 
recommended that individuals be offered an annual review where weight and height 
are assessed, alongside symptoms, dietary-management and the need for specialist 
dietetic and nutritional advice. Further support is recommended if concerns are 
identified during the annual review. Despite these guidelines, follow-up at 
gastroenterology clinics is poor, dietetic support would need to be increased three-
fold in order to provide adequate support for CD across the UK, and specialist 
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dietician knowledge varies across the country (Madden, Riordan & Knowles, 2016; 
Nelson, Mendoza & McGough, 2007).  
The results of Chapter Four suggest discontent around the dietary support 
provided at diagnosis. Individuals expressed a desire for more information regarding 
potential weight change after commencing the GFD (“I think it would be helpful if the 
dietician had explained the weight change was to be expected. It’s unusual 
associating unhealthiness with thinness, it would have helped having that 
explained”). This is in line with previous research, which highlights the value of 
dietician-led services and the desire for more dietetic support in individuals with CD 
(Bebb, Lawson, Knight & Long, 2006; Kurien, Trott & Sanders, 2016; Madden, 
Riordan & Knowles, 2016). Furthermore, disordered eating attitudes and behaviours 
in CD were associated with distress surrounding weight change at diagnosis 
(Chapters Two and Four). The current NICE guidelines do not recommend that 
individuals newly diagnosed with CD are consulted about the benefits of a 
nutritionally balanced GFD and how the initiation of the GFD may influence weight 
change and body shape, despite individuals with CD explaining the benefits of this 
type of support (Madden, Riordan & Knowles, 2016). This is surprising given the 
evidence for poor nutritional status in CD, which has been attributed to poor diet 
quality and management of the GFD (Abenavoli et al., 2015; Oso & Fraser, 2005; 
Theethira, Dennis & Leffler, 2014; Zuccotti et al., 2012). Therefore, it is 
recommended that research informing clinical guidelines should focus on the role of 
educating all newly diagnosed individuals with CD about the nutritional content of 
gluten-free foods and possible weight changes after starting the GFD, as well as how 
to manage these weight changes. 
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8.5.2. Support for Individuals with CD and Disordered Eating Attitudes and 
Behaviours 
As discussed previously, upon CD diagnosis, dietetic support should focus on 
supporting healthy eating in the context of CD, promoting firstly, healthy eating but 
including education about the nutritional content of gluten-free foods and the 
potential for weight change after starting the GFD. For individuals who attend annual 
clinical appointments, these should be used to assess concerns that might indicate 
disordered eating attitudes and behaviours. The findings of this thesis indicate that 
healthcare professionals working with CD need educating about the symptoms of 
disordered eating attitudes and behaviours. Furthermore, for individuals who 
express concerns around food or weight, referrals should be made to a specialist 
dietary service where more targeted support can be provided. It is at this point of 
contact where the presence of more traditional eating disorders can be assessed, 
using the EAT-26 or the BES. The CD-FAB will be a useful tool for those who 
experience concerns around food and express difficulties eating outside the home. 
The CD-FAB, and its subscales, will allow the dietary team to assess the adaption of 
the individual to their GFD, it also enables assessment of food concerns, the severity 
of these concerns and whether these are resulting in maladaptive or adaptive 
behaviour. This information can be used to develop further research and patient-
centred intervention plans in order to improve physical and psychosocial health 
outcomes in individuals with CD.  
The presence of disordered eating attitudes and behaviours in CD and the 
complex interplay of psychosocial factors, suggests the need for psychological 
services in gastroenterology practices. Although dieticians and gastroenterologists 
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are ideally placed to reduce the risk of disordered eating through CD-related 
education, information on the consequences of disordered eating, and the 
importance of the GFD and healthy eating, psychological assessment may be 
beneficial for identifying individuals with disordered eating attitudes and behaviours 
who may be a greater risk of distress. Early referral to an eating disorder specialist 
should occur once a diagnosis has been confirmed to allow appropriate formulations 
and treatment plans to be developed.  
8.5.3. Strengths, Limitations and Future Research 
Throughout the thesis, a number of limitations have been noted. In this section, 
a number of noteworthy limitations will be noted. These limitations centre on 
recruitment bias, the limitations of self-report methods, the measures of disordered 
eating used and the limitations of cross-sectional studies.  
Throughout this thesis there are limitations in terms of recruitment. Chapters 
Three and Four used online strategies to recruit individuals with CD. Online 
strategies tend to target young individuals who are considered Internet “savvy” and 
may direct attention away from older age groups (Remillard et al., 2014). In addition, 
recruitment took place via the charity Coeliac UK.  Individuals recruited from Coeliac 
UK are predominantly female, white and well educated (Ford et al., 2012); these 
factors are reflected throughout our participant characteristics. To address these 
limitations, Chapters Five, Six and Seven used offline recruitment strategies across 
the University of Birmingham campus and snowball techniques. Although this 
addresses the limitations of online recruitment techniques, this may result in a 
younger and more educated sample (Sear, 1986). Despite these limitations in 
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sampling, the correlates of disordered eating attitudes and behaviours were 
consistent through all studies. Future research may focus on extending these 
findings to a more representative sample of individuals with CD. Given the increasing 
age of diagnosis within CD it is important to prioritise and see whether these findings 
extend to this age group (Rashtak & Murray, 2011).   
The majority of chapters within this thesis have used self-report methods to 
assess CD diagnosis, psychological and physical well-being. These methodologies are 
largely limited by participant’s introspective ability, whether they can take on an 
accurate view of their psychological well-being, and response bias is a particularly 
important limitation when assessing dietary management (Shim, Oh & King, 2014). 
Furthermore, Chapters Three-Six recruited individuals based on a self-reported 
diagnosis of CD.  Although individuals had the option to select their method of 
diagnosis, we cannot confirm that all participants were biopsy confirmed. However, 
the results from Chapter Seven required evidence for a biopsy confirmed diagnosis 
for CD and the questionnaire results in this chapter replicated the results of Chapters 
Three and Six.  
Improvements could have been made throughout the thesis by using more 
objective measures of dietary management such as the CD Adherence scale (Leffler 
et al., 2009) or dietician assessment of dietary management; however, self-report 
measures were a useful first step to identify the direction of associations. In 
addition, physical examinations may be used to assess gastrointestinal symptoms 
and the physical impact of disordered eating attitudes and behaviours, and 
assessments of antibody levels would further inform the impact on CD-related 
outcomes. As a result, future research should prioritise a multidisciplinary 
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perspective in order to assess the psychological and physical factors related to 
disordered eating in CD.  
This thesis has used the EAT-26 and BES to evaluate the presence of disordered 
eating in CD. Although these tools are useful for assessing disordered eating 
symptoms, they cannot provide a clinical diagnosis of an eating disorder. Diagnostic 
clinical interviews should be used to establish the presence of clinical levels of 
disordered eating. Furthermore, although used in CD (Arigo et al., 2012; Karwautz et 
al., 2008), these tools have not been validated in a CD population. Chapter Three 
conducted confirmatory factor analyses on these questionnaires and identified an 
appropriate factor solution for the CD population, however, this needs to be 
replicated in larger samples before we can fully assess what these scores mean for 
those with CD.  
The development of the CD-FAB, a CD specific tool for disordered eating 
attitudes and behaviours, is a considerable strength of this thesis. This tool was 
shown to have good psychometric properties and high scores are associated with 
clinical impairment in psychological distress and quality of life. However, further 
development is needed to assess the physical consequences of high CD-FAB scores 
and to establish a clinical cut off for CD-FAB scores. In addition, further development 
in large samples is needed to understand meaningful changes on the CD-FAB.  
The majority of analyses conducted in this thesis are cross-sectional in nature, 
meaning the directional nature of the variables related to disordered eating 
attitudes and behaviours in CD could not be assessed. Although the Theoretical 
Model of Disordered Eating in Gastrointestinal Disease assumes that disordered 
eating attitudes and behaviours develop after CD diagnosis, due to the cross-
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sectional nature of data collection, causality cannot be assumed. Gastrointestinal 
symptoms are frequently associated with eating disorder symptomology, however, 
when CD is not evident these symptoms resolve once weight has been restored 
(Kaltsa et al., 2015). The direction of this relationship can be understood further 
through the use of longitudinal studies in individuals before the point of diagnosis 
and throughout their years living with CD. This will not only allow a better 
understanding of the prevalence and factors associated with disordered eating and 
CD, but would shed light on the directional relationship between disordered eating 
and CD. However, despite these limitations, the use of mixed methodologies, using 
both qualitative and quantitative techniques, to explore disordered eating in the 
context of CD is a considerable strength of this thesis.  
8.6. Conclusions 
The aim of this thesis was to further our understanding of disordered eating in 
CD by developing and evaluating a model that emerged from a systemic review. 
Overall, this thesis indicates that disordered eating is prevalent in CD and is 
associated with factors directly related to CD management as well as more general 
factors such as psychological distress. In addition, the types of disordered eating 
attitudes and behaviours vary from Binge Eating, anorexic and bulimic thoughts to a 
CD-specific hyper-vigilance around food. All disordered eating types were associated 
with negative psychosocial outcomes. However, despite the high prevalence of 
disordered eating attitudes and behaviours, the majority of individuals with CD will 
consume a healthy GFD. 
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This thesis highlights how complex the management of CD can be, and the 
complex interactions between biological, psychological and social factors. This has 
implications for both researchers and clinicians working with CD. Due to the 
importance of physical (gastrointestinal symptoms and weight change) and 
psychological (anxiety, depression, stress) factors in the development of disordered 
eating attitudes and behaviours, this thesis highlights the need for a person-centred, 
biopsychosocial approach in the management of CD.  
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Appendix A: Chapter Two Search Criteria 
Search Term One: CD; C*oeliac disease; Gluten intolerance; IBS; Irritable bowel syndrome; 
IBD; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis  
 
Search Term Two: Eating disorder; Anorexi*; Bulimi*; Binge; EDNOS; Obes*; Eating distress; 
Dysfunctional eating; Disturbed eating; Eating habits; Nocturnal eating; Night eating; Pica; 
Eating attitudes   
 261 
Appendix B: Chapter Three Supplementary Tables 
Supplementary Table One 
Disease specific and Non-Specific Factors in Predicting EAT-26 Scores in 
Inflammatory Bowel Disease 
Predictors B B R2 F R2 Change 
Model 1) Non-specific Factors 
Age .01 .01    
Body Mass Index -.09 -.05    
Years with Condition -.09 -.07    
DASS-21 .16 .50 .25 6.48* .25* 
Model 2) Disease Specific Factors 
Age -.03 -.04    
Body Mass Index .02 .01    
Years with Condition -.08 -.07    
DASS-21 .12 .39*    
Gastrointestinal 
Symptoms 
.51 .34*    
Dietary-
management 
.61 .05 .59 6.57* .09 
* = significance at p<.008. The significance of the F value refers to the F associated 
with each step.  
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Supplementary Table Two 
Disease specific and Non-Specific Factors in Predicting EAT-26 Scores Type Two 
Diabetes 
Predictors B B R2 F R2 Change 
Model 1) Non-specific Factors 
Age .25 .50    
Body Mass Index .40 .23    
Years with Condition .12 .15    
DASS-21 .11 .53 .21 3.76 .22 
Model 2) Disease Specific Factors 
Age .16 .32    
Body Mass Index .54 .31    
Years with Condition .14 .19    
DASS-21 .11 .53    
Gastrointestinal 
Symptoms 
-.46 -.08    
Dietary-
management 
-1.79 -.21 .24 2.84 .03 
* = significance at p<.008. The significance of the F value refers to the F 
associated with each step.  
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Supplementary Table Three 
Disease specific and Non-Specific Factors in Predicting BES Scores Type Two Diabetes 
Predictors B B R2 F R2 Change 
Model 1) Non-specific Factors 
Age -.37 -.58*    
Body Mass Index .64 .29*    
Years with Condition -.12 -.13    
DASS-21 .09 .35* .74 38.15* .74* 
Model 2) Disease Specific Factors 
Age -.34 -.53*    
Body Mass Index .61 .28*    
Years with Condition -.12 -.13    
DASS-21 .09 .33    
Gastrointestinal 
Symptoms 
1.01 .14    
Dietary-
management 
.39 .04 .75 6.75* .02 
* = significance at p<.008. The significance of the F value refers to the F 
associated with each step.  
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Supplementary Table Four 
Disease specific and Non-Specific Factors in Predicting BES Scores in Inflammatory 
Bowel Disease 
Predictors B B R2 F R2 Change 
Model 1) Non-specific Factors 
Age -.06 -.09    
Body Mass Index .10 .07    
Years with Condition .01 .01    
DASS-21 .10 .38* .40 3.74 .156 
Model 2) Disease Specific Factors 
Age -.05 -.08    
Body Mass Index .07 .05    
Years with Condition .02 .01    
DASS-21 .10 .40*    
Gastrointestinal 
Symptoms 
-.08 -.06    
Dietary-
management 
.63 .06 .41 2.58* .01 
* = significance at p<.008. The significance of the F value refers to the F 
associated with each step.  
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Appendix C - The CD-FAB 
 
The Coeliac Disease Food Attitudes and Beliefs Scale (CD-FAB) 
Instructions: This is a questionnaire is designed to explore food attitudes and beliefs in 
coeliac disease. Some questions may not apply to you; this is because we are trying to assess 
a range of beliefs about coeliac disease and managing the gluten-free diet. Please fill out the 
form below as accurately, honestly and completely as possible. There are no right or wrong 
answers. All of your responses are confidential.  
 
Please tick the box that best describes your response to the question.    
 
 
Strongly 
Agree (7) 
Agree (6) 
Somewhat 
Agree (5) 
Neither 
Agree nor 
Disagree (4) 
Somewhat 
Disagree (3) 
Disagree (2) 
Strongly 
Disagree (1) 
Because of My Coeliac Disease… 
I get concerned 
being near 
others when 
they are eating 
gluten 
       
I am afraid to 
eat outside my 
home 
       
I am afraid to 
touch gluten-
containing 
foods 
 
       
I get worried 
when eating 
with strangers 
       
I find it hard to 
eat gluten-free 
foods that look 
like the gluten-
containing-
foods that have 
made me ill in 
the past 
       
I will only eat 
food that I have 
prepared myself 
 
       
My concerns 
about cross-
contamination 
prevent me 
from going to 
socal events 
involving food 
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Despite having Coeliac Disease… 
I enjoy going 
out for meals as 
much as I did 
before my 
diagnosis * 
 
       
I am 
comfortable 
eating gluten-
free food from 
other people’s 
kitchens * 
 
       
Being 
contaminated 
by gluten in the 
past, hasn’t 
stopped me 
from enjoying 
restaurants * 
 
       
If I ask 
questions, I can 
normally find 
gluten-free food 
to eat * 
 
       
 
 
Reverse 8, 9, 10, 11 and add to make total score.  
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Appendix D – Questionnaires  
 
DASS- 21 
 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how 
much the statement applied to you over the past week. There are no right or wrong 
answers. Do not spend too much time on any statement. 
 
 
Over the past week… 
Did not 
apply to 
me at all 
Applied 
to me to 
some 
degree, 
or some 
of the 
time 
Applied to 
me to a 
considerable 
degree, or a 
good part of 
the time 
Applied 
to me 
very 
much, or 
most of 
the time 
I found it hard to wind down 0 1 2 3 
I was aware of dryness in my 
mouth 
0 1 2 3 
I couldn’t seem to experience any 
positive feeling at all 
0 1 2 3 
I experienced breathing difficulty 
(e.g., excessively rapid breathing, 
breathlessness in the absence of 
physical exertion) 
0 1 2 3 
I found it difficult to work up the 
initiative to do things 
0 1 2 3 
I tended to over-react to situations 0 1 2 3 
I experienced trembling (e.g., in 
the hands) 
0 1 2 3 
I felt that I was using a lot of 
nervous energy 
0 1 2 3 
I was worried about situations in 
which I might panic and make a fool of 
myself 
0 1 2 3 
I felt that I had nothing to look 
forward to 
0 1 2 3 
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I found myself getting agitated 0 1 2 3 
I found it difficult to relax 0 1 2 3 
I felt down-hearted and blue 0 1 2 3 
I was intolerant of anything that 
kept me from getting on with what I 
was doing 
0 1 2 3 
I felt I was close to panic 0 1 2 3 
I was unable to become 
enthusiastic about anything 
0 1 2 3 
I felt I wasn’t worth much as a 
person 
0 1 2 3 
I felt that I was rather touchy 0 1 2 3 
I was aware of the action of my 
heart in the absence of physical 
exertion (e.g., sense of heart rate 
increase, heart missing a beat) 
0 1 2 3 
I felt scared without any good 
reason 
0 1 2 3 
I felt that life was meaningless 0 1 2 3 
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Eating Attitudes Test-26 
 
Instructions: This tool looks at your patterns of eating. Please fill out the form below 
as accurately, honestly and completely as possible. There are no right or wrong 
answers. 
 
Please tick the box that applies most to you 
 
 Always Usually Often Sometimes Rarely Never 
I am terrified about 
being overweight 
      
I avoid eating when I 
am hungry 
      
I find myself 
preoccupied with 
food 
      
I have gone on eating 
binges where I feel 
that I may not be able 
to stop 
      
I cut my food into 
small pieces 
      
I am aware of the 
calorie content of the 
foods that I eat 
      
I particularly avoid 
foods with a high 
carbohydrate content 
(i.e. bread, rice, 
potatoes, etc.) 
      
I feel that others 
would prefer it if I ate 
more 
      
I vomit after I have 
eaten 
      
I feel extremely guilty 
after eating 
      
 Always Usually Often Sometimes Rarely Never 
I am occupied with a 
desire to be thinner 
      
I think about burning 
up calories when I 
exercise 
      
Other people think I 
am too thin 
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I am preoccupied 
with the thought of 
having fat on my 
body 
      
I take longer than 
others to eat my 
meals 
      
I avoid foods with 
sugar in them 
      
I eat diet foods       
I feel that food 
controls my life 
      
I display self-control 
around food 
      
I feel that others 
pressure me to eat 
      
I give too much time 
and thought to food 
      
I feel uncomfortable 
after eating sweets 
      
I engage in dieting 
behaviour 
      
I like my stomach to 
be empty 
      
I have the impulse to 
vomit after meals 
      
I enjoy trying new 
rich foods 
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Binge Eating Scale 
 
Below are groups of numbered statements. Read all of the statements in each group and 
mark on this sheet the one that best describes the way you feel about the problems you 
have controlling your eating behaviour. 
 
Question 
Number 
Statement 
Please tick the 
statement that 
best describes 
the way you 
feel 
1 
I don’t feel self-conscious about my weight or body size 
when I’m with others. 
 
I feel concerned about how I look to others, but it 
normally does not make me feel disappointed with 
myself. 
 
I do get self-conscious about my appearance and weight 
which makes me feel disappointed in myself. 
 
I feel very self-conscious about my weight and 
frequently, I feel intense shame and disgust for myself. I try 
to avoid social contacts because of my self-consciousness. 
 
2 
I don’t have any difficulty eating slowly in the proper 
manner. 
 
Although I seem to “gobble down” foods, I don’t end up 
feeling stuffed because of eating too much. 
 
At times, I tend to eat quickly and then, I feel 
uncomfortably full afterwards. 
 
I have the habit of bolting down my food, without really 
chewing it. When this happens I usually feel uncomfortably 
stuffed because I’ve eaten too much. 
 
3 
I feel capable to control my eating urges when I want to.  
I feel like I have failed to control my eating more than the 
average person. 
 
I feel utterly helpless when it comes to feeling in control 
of my eating urges. 
 
Because I feel so helpless about controlling my eating I 
have become very desperate about trying to get in control. 
 
4 
I don’t have the habit of eating when I’m bored.  
I sometimes eat when I’m bored, but often I’m able to 
“get busy” and get my mind off food. 
 
I have a regular habit of eating when I’m bored, but 
occasionally, I can use some other activity to get my mind off 
eating. 
 
I have a strong habit of eating when I’m bored. Nothing 
seems to help me break the habit. 
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5 
I’m usually physically hungry when I eat something.  
Occasionally, I eat something on impulse even though I 
really am not hungry. 
 
I have the regular habit of eating foods that I might not 
really enjoy, to satisfy a hungry feeling even though 
physically, I don’t need the food. 
 
Even though I’m not physically hungry, 1 get a hungry 
feeling in my mouth that only seems to be satisfied when I 
eat a food, like a sandwich, that fills my mouth. Sometimes, 
when I eat the food to satisfy my mouth hunger, I then spit 
the food out so I won’t gain weight. 
 
6 
I don’t feel any guilt or self-hate after I overeat.  
After I overeat, occasionally I feel guilt or self-hate.  
Almost all the time I experience strong guilt or self-hate 
after I overeat. 
 
7 
I don’t lose total control of my eating when dieting even 
after periods when I overeat. 
 
Sometimes when I eat a “forbidden food” on a diet, I feel 
like I “blew it” and eat even more. 
 
Frequently, I have the habit of saying to myself, “I’ve 
blown it now, why not go all the way” when I overeat on a 
diet. When that happens I eat even more. 
 
I have a regular habit of starting strict diets for myself, 
but I break the diets by going on an eating binge. My life 
seems to be either a “feast” or “famine.” 
 
8 
I rarely eat so much food that I feel uncomfortably 
stuffed afterwards. 
 
Usually about once a month, I eat such a quantity of 
food, I end up feeling very stuffed. 
 
I have regular periods during the month when I eat large 
amounts of food, either at mealtime or at snacks. 
 
I eat so much food that I regularly feel quite 
uncomfortable after eating and sometimes a bit nauseous. 
 
9 
My level of calorie intake does not go up very high or go 
down very low on a regular basis 
 
Sometimes after I overeat, I will try to reduce my caloric 
intake to almost nothing to compensate for the excess 
calories I’ve eaten 
 
I have a regular habit of overeating during the night. It 
seems that my routine is not to be hungry in the morning but 
I overeat in the evening 
 
In my adult years, I have had week-long periods where I 
practically starve myself. This follows periods when I overeat. 
It seems I live a life of either “feast or famine” 
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10 
I usually am able to stop eating when I want to. I know 
when “enough is enough.” 
 
Every so often, I experience a compulsion to eat which I 
can’t seem to control. 
 
Frequently, I experience strong urges to eat which I seem 
unable to control, but at other times I can control my eating 
urges. 
 
I feel incapable of controlling urges to eat. I have a fear 
of not being able to stop eating voluntarily. 
 
11 
I don’t have any problem stopping eating when I feel full.  
I usually can stop eating when I feel full but occasionally 
overeat leaving me feeling uncomfortably stuffed. 
 
I have a problem stopping eating once I start and usually 
I feel uncomfortable stuffed after I eat a meal. 
 
Because I have a problem not being able to stop eating 
when I want, I sometimes have to induce vomiting to relieve 
my stuffed feeling. 
 
12 
I seem to eat just as much when I’m with others (family, 
social gatherings) as when I’m by myself. 
 
Sometimes, when I’m with other persons, I don’t eat as 
much as I want to eat because I’m self-conscious about my 
eating. 
 
Frequently, I eat only a small amount of food when 
others are present, because I’m very embarrassed about my 
eating. 
 
I feel so ashamed about overeating that I pick times to 
overeat when I know no one will see me. I feel like a “closet 
eater.” 
 
13 
I eat three meals a day with only an occasional between 
meal snacks. 
 
I eat 3 meals a day, but I also normally snack between 
meals. 
 
When I am snacking heavily, I get in the habit of skipping 
regular meals. 
 
There are regular periods when I seem to be continually 
eating, with no planned meals. 
 
14 
I don’t think much about trying to control unwanted 
eating urges. 
 
At least some of the time, I feel my thoughts are pre-
occupied with trying to control my eating urges. 
 
I feel that frequently I spend much time thinking about 
how much I ate or about trying not to eat anymore. 
 
It seems to me that most of my waking hours are pre-
occupied by thoughts about eating or not eating. I feel like 
I’m constantly struggling not to eat. 
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15 
I don’t think about food a great deal.  
I have strong cravings for food but they last only for brief 
periods of time. 
 
I have days when I can’t seem to think about anything 
else but food. 
 
Most of my days seem to be pre-occupied with thoughts 
about food. I feel like 
I live to eat. 
 
16 
I usually know whether or not I’m physically hungry. I 
take the right portion of food to satisfy me. 
 
Occasionally, I feel uncertain about knowing whether or 
not I’m physically hungry. At these times it’s hard to know 
how much food I should take to satisfy me. 
 
Even though I might know how many calories I should 
eat, I don’t have any idea what is a “normal” amount of food 
for me. 
 
 
 
  
 275 
Coeliac Disease Quality of Life 
 
Please think about your life over the past month (30 days), and look at the 
statements below. Each statement has five possible responses. For each statement, 
please tick one box that best describes your feelings 
 
 Not at all Slightly Moderatel
y 
Quite a bit A great 
deal 
I feel limited by this disease      
I feel worried that I will suffer 
from this disease 
     
I feel concerned that this disease 
will cause other health problems 
     
I feel worried about my increased 
risk of cancer from this disease 
     
I feel socially stigmatised for 
having this disease 
     
I feel like I’m limited in eating 
meals with co-workers 
     
I feel like I am not able to have 
special foods like birthday cake 
and pizza 
     
I feel that the diet is sufficient 
treatment for my disease 
     
I feel that there are not enough 
choices for treatment 
     
I feel depressed because of my 
disease 
     
I feel frightened by having this 
disease 
     
I feel like I don’t know enough 
about the disease 
     
I feel overwhelmed about having 
this disease 
     
I have trouble socialising because 
of my disease 
     
I find it difficult to take long trips 
because of my disease 
     
I feel like I cannot live a normal 
life because of my disease 
     
I feel afraid to eat out because 
my food may be contaminated 
     
I feel worried about the 
increased risk of one of my family 
members having coeliac disease 
     
I feel like I think about food all 
the time 
     
I feel concerned that my long-
term health will be affected 
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Gluten-Free Diet Adherence Questionnaire 
Please circle the response that most adequately reflects how you feel 
 
Have you been bothered by low 
energy level during the past 4 
weeks? 
None of the 
time 
A little of 
the time 
Some of the time Most of the 
time 
All of the 
time 
Have you been bothered by 
headaches during the past 4 
weeks? 
None of the 
time 
A little of 
the time 
Some of the time Most of the 
time 
All of the 
time 
I am able to follow a GFD when 
dining outside my home 
Strongly 
agree 
Somewhat 
agree 
Neither agree nor 
disagree 
Somewhat 
disagree 
Strongly 
disagree 
Before I do something I carefully 
consider the consequences 
Strongly 
agree 
Somewhat 
agree 
Neither agree nor 
disagree 
Somewhat 
disagree 
Strongly 
disagree 
I do not consider myself a failure Strongly 
agree 
Somewhat 
agree 
Neither agree nor 
disagree 
Somewhat 
disagree 
Strongly 
disagree 
How important to your health are 
accidental gluten exposures? 
Very 
important 
Somewhat 
important 
Neutral/unsure A little 
important 
Not at all 
important 
Over the past 4 weeks, how many 
times have you eaten foods 
containing gluten on purpose? 
0 (never) 1–2 3–5 6–10 >10 
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Food Neophobia Scale 
 
Please select the statement which most applies to you: 
 
 Disagree 
Strongly 
Disagree 
Moderate
ly  
Disagree 
Slightly 
Neither 
Disagree 
nor 
Agree 
Agree 
Slightly 
Agree 
Moderately 
Agree 
Strongly 
I am very 
particular about 
the foods I will 
eat 
       
I don’t trust new 
foods 
       
If I don’t know 
what is in a food, 
I won’t try it 
       
I will eat almost 
anything 
       
I am afraid to eat 
things I have 
never had before 
       
I am constantly 
sampling new 
and different 
foods 
       
I like to try new 
ethic restaurants 
       
At dinner parties, 
I would try a new 
food 
       
I like food from 
different 
countries 
       
Ethnic foods look 
weird to eat 
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Illness Perception Questionnaire Revised – Symptom Scale 
 
Listed below are a number of symptoms that you may or may not have experienced 
this symptom over the last four weeks. Please indicate by circling Yes or No, whether 
you have experienced any of these symptoms and if you have. 
Symptom 
I have experienced this symptom over the 
last 4 weeks 
Abdominal Pain Yes No 
Sore Throat Yes No 
Nausea Yes No 
Weight Loss Yes No 
Fatigue Yes No 
Stiff Joints Yes No 
Sore Eyes Yes No 
Headaches Yes No 
Upset Stomach/Diarrhoea Yes No 
Sleep Difficulties Yes No 
Dizziness Yes No 
Loss of Strength Yes No 
Bloating Yes No 
Excessive Wind Yes No 
Breathlessness Yes No 
Constipation Yes No 
Heartburn/Indigestion Yes No 
Mouth Ulcers Yes No 
Wheeziness Yes No 
Hair Loss Yes No 
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Appendix E – Focus Group Guide  
Introduction 
Hello, welcome to the focus group. Firstly, I’d like to thank you all for coming 
today and I look forward to hearing all of your contributions. My name is Rosie and I 
am a Phd student from the University of Birmingham. I am currently involved in 
some research looking into the anxiety around food in people with coeliac disease.  
You were invited to this group because you all live with coeliac disease and 
therefore, know the most about coeliac disease! Please feel free to share your points 
of view with the group, even if it differs from what others have said. There are no 
right or wrong answers in this group and I am interested in what all of you have to 
say. Any difference in opinion will help to fuel a discussion, so please don’t be afraid 
to state any alternative views.  
Please help yourself to tea and coffee, and [directions to bathroom]. If you would 
all read through your information sheet and sign the consent form if you are happy 
to take part in the discussion and don’t mind being recorded during the discussion.  
[Health and safety rules depending on location] 
Ground Rules 
Before we begin, let me share some ground rules. Please speak up clearly, no matter 
what your opinion. Only one person should talk at a time and everyone should listen 
to the person who is speaking and respect their opinions.. I will be recording the 
session because I don't want to miss any of your comments, but, please note that all 
contributions will be anonymised and neither your identity nor the identity of your 
service will be associated with transcribed material.Please turn off your mobile 
phones but if you do need to leave the room, please do so quietly  
The duration of the focus group discussion will be approximately 1 hour. Does 
anybody have any questions? 
Firstly, let's find out some more about each person. Can you tell us your name and 
background? 
Questions 
• How do you manage your coeliac disease and what symptoms do you 
experience? 
o Nausea, tummy ache, headache 
o Gluten-free diet 
o What effect would accidental gluten-consumption have on you? 
• How does it differ managing your diet inside your home compared to outside 
your home?  
o Is it more difficult managing the diet outside the home? 
o How does awareness about cross-contamination affect your dietary 
management? 
o Do you avoid eating outside the home because there is no guarantee 
that the food is gluten free?  
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o Does the availability of gluten free foods make it difficult to manage 
your diet in some settings? 
o Does your coeliac disease make it harder to socialise around food? 
o Do the challenges involved in managing your diet mean that you have 
to eat less food in some settings? 
• What kind of eating environment makes you feel safe and what makes you 
feel more concerned? 
o Do you trust gluten free foods? 
o Do you find it more difficult to eat outside the house with your 
friends? 
o Do you get concerned when eating new or unfamiliar foods?  
o Is it important for you to clean up your kitchenware after contact with 
gluten-containing foods? 
o Is it important for you to have a sense of control over your food 
preparation?  
o Does reading food labels make you feel safer around unfamiliar 
foods? 
• When you’re out and about, shopping for the day, do you ever have concerns 
about food availability? 
o How do you cope with the food availability?  
o Are you adventurous with food and restaurant choices?  
o Do you limit the amount you eat when you are out all day?  
o Do you feel that restaurants are able to accommodate your dietary 
needs? 
o Do you trust it when people say their food is gluten free?  
• Do you feel safe preparing gluten-containing foods for others? 
o What if the gluten-containing food comes into contact with the food 
you have prepared for yourself?  
o Do you get anxious when others are eating gluten around you? 
o Do you prefer to keep a completely gluten free home?  
• Do you find it hard to eat foods that resemble those you have previously had 
a severe reaction to? 
o Has this changed throughout your diagnosis? 
o Has your coeliac disease make you scared of food?  
o Does coeliac disease affect the way you feel about food?  
Summary 
What do you all feel were the main points that came from this session? Did 
anything surprise you? Is there anything you would like to discuss further?  
Closing Statements 
Thank you for taking part today, I’m hoping the answers you have given will help 
direct future research into coeliac disease. If you do want to withdraw your data 
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please let me know as soon as possible, either after the session or by email. Does 
anyone have any questions?  
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Appendix E – Ethical Approval 
Chapter Three 
Re:  “Disturbed Eating Practices in Coeliac Disease” 
Application for amendment ERN_14-0015B 
  
Thank you for the above application for amendment, which was reviewed by the 
Science, Technology, Engineering and Mathematics Ethical Review Committee.  
  
On behalf of the Committee, I can confirm that this amendment now has full ethical 
approval. 
 
Chapter Four 
Re:  “Food Preferences and Individual Differences in Coeliac Disease” 
Application for Ethical Review ERN_15-0370 
  
Thank you for your application for ethical review for the above project, which was 
reviewed by the Science, Technology, Engineering and Mathematics Ethical Review 
Committee.  
  
On behalf of the Committee, I can confirm the conditions of approval for the study 
have been met and this study now has full ethical approval. 
 
Chapters Five and Six 
Re:  “Development of a Food Anxiety Questionnaire in Coeliac Disease” 
Application for Amendment ERN_15-0370A 
  
Thank you for your application for amendment to the above study.  This has now 
been reviewed by the Science, Technology, Engineering and Mathematics Ethical 
Review Committee.  
 
On behalf of the Committee, I can confirm that this amendment now has full ethical 
approval. 
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Chapter Seven 
Re:  “Food Attitudes, Attentional Bias and Eating Behaviours in Coeliac Disease: A 
Laboratory Study” 
Application for Ethical Review ERN_16-0410 
  
Thank you for your application for ethical review for the above project, which was 
reviewed by the Science, Technology, Engineering and Mathematics Ethical Review 
Committee.  
  
On behalf of the Committee, I confirm that this study now has full ethical approval. 
  
 
 
